{"SLR NAME":"Clinical epidemiology and outcome of ICU-admitted patients with or without mechanical ventilation in COVID-19 patients - a rapid systematic review and meta-analysis","References":[{"title1":"Biased and unbiased estimation of the average length of stay in intensive care units in the Covid-19 pandemic","References":[{"title2":"World Health Organization. Coronavirus disease 2019 (COVID-19) Situation report-91, 2020. https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200420-sitrep-91-covid-19.pdf. Accessed 21 Apr 2020.","References":[]},{"title2":"Ferguson NM, Laydon D, Nedjati-Gilani G, Imai N, Ainslie K, Baguelin M, et al. Impact of non-pharmaceutical interventions (NPIs) to reduce COVID-19 mortality and healthcare demand. Imperial College COVID-19 Response Team, London, March, 16. 2020. https://www.imperial.ac.uk/medicine/departments/school-public-health/infectious-disease-epidemiology/mrc-global-infectious-disease-analysis/covid-19/report-9-impact-of-npis-on-covid-19. Accessed 21 Apr 2020.","References":[]},{"title2":"Sante Publique France. Point quotidien infection au nouveau coronavirus (SARS-CoV-2): Nombre de personnes actuellement en reanimation ou soins intensifs pour COVID-19. https://geodes.santepubliquefrance.fr/#c=indicator&amp;f=0&amp;i=covid_hospit.rea&amp;s=2020-04-13&amp;t=a01&amp;view=map1. Accessed 14 Apr 2020.","References":[]},{"title2":"Ministre des Solidarites et de la Sante. Conference de presse du Premier Ministre le 28 Mars 2020. https://www.youtube.com/watch?v=VkdbuSv3N-k. Accessed 21 Apr 2020.","References":[]},{"title2":"Baseline characteristics and outcomes of 1591 patients infected with SARS-CoV-2 admitted to ICUs of the Lombardy Region Italy","References":[]},{"title2":"Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-Infected pneumonia in Wuhan China","References":[]},{"title2":"Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study","References":[{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study"},{"title3":"A novel coronavirus from patients with pneumonia in China, 2019"},{"title3":"First case of 2019 novel coronavirus in the United States"},{"title3":"Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China"},{"title3":"Clinical management of severe acute respiratory infection when novel coronavirus (nCoV) infection is suspected"},{"title3":"Critically ill patients with 2009 influenza A(H1N1) in Mexico"},{"title3":"Critically ill patients with severe acute respiratory syndrome"},{"title3":"Critically ill patients with 2009 influenza A(H1N1) infection in Canada"},{"title3":"KDIGO clinical practice guideline for acute kidney injury"},{"title3":"Wuhan: Britons to be evacuated as scientists estimate 44 000 cases of 2019-nCOV in the city"},{"title3":"Acute respiratory distress syndrome in critically ill patients with severe acute respiratory syndrome"},{"title3":"Short-term outcome of critically ill patients with severe acute respiratory syndrome"},{"title3":"Clinical course and outcomes of critically ill patients with Middle East respiratory syndrome coronavirus infection"},{"title3":"SARS and MERS: recent insights into emerging coronaviruses"},{"title3":"Epidemiology, patterns of care, and mortality for patients with acute respiratory distress syndrome in intensive care units in 50 countries"},{"title3":"China built a hospital in 10 days to battle coronavirus"},{"title3":"Transmission of 2019-nCoV infection from an asymptomatic contact in Germany"},{"title3":"Asymptomatic cases complicate efforts"},{"title3":"Multiple organ infection and the pathogenesis of SARS"},{"title3":"Middle East respiratory syndrome coronavirus efficiently infects human primary T lymphocytes and activates the extrinsic and intrinsic apoptosis pathways"},{"title3":"T-cell immunity of SARS-CoV: implications for vaccine development against MERS-CoV"},{"title3":"Practice of diagnosis and management of acute respiratory distress syndrome in mainland China: a cross-sectional study"},{"title3":"Clinical evidence does not support corticosteroid treatment for 2019-nCoV lung injury"}]},{"title2":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study","References":[{"title3":"The novel coronavirus originating in Wuhan, China: challenges for global health governance"},{"title3":"Severe acute respiratory syndrome-related coronavirus: the species and its viruses:a statement of the Coronavirus Study Group"},{"title3":"Short term outcome and risk factors for adverse clinical outcomes in adults with severe acute respiratory syndrome (SARS)"},{"title3":"Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study"},{"title3":"Management of adults with hospital-acquired and ventilator-associated pneumonia: 2016 clinical practice guidelines by the Infectious Diseases Society of America and the American Thoracic Society"},{"title3":"KDIGO clinical practice guidelines for acute kidney injury"},{"title3":"Acute respiratory distress syndrome: the Berlin Definition"},{"title3":"Chinese management guideline for COVID-19 (version 6.0)"},{"title3":"Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study"},{"title3":"Middle East respiratory syndrome"},{"title3":"Outcomes and prognostic factors in 267 patients with severe acute respiratory syndrome in Hong Kong"},{"title3":"Predictors of mortality in Middle East respiratory syndrome (MERS)"},{"title3":"Exacerbated innate host response to SARS-CoV in aged non-human primates"},{"title3":"The immunopathogenesis of sepsis in elderly patients"},{"title3":"The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3)"},{"title3":"Serial evaluation of the SOFA score to predict outcome in critically ill patients"},{"title3":"Disease severity and clinical outcomes of community-acquired pneumonia caused by non-influenza respiratory viruses in adults: a multicentre prospective registry study from the CAP-China Network"},{"title3":"Community-acquired pneumonia requiring admission to an intensive care unit: a descriptive study"},{"title3":"Acute pneumonia and the cardiovascular system"},{"title3":"Association between influenza vaccination and cardiovascular outcomes in high-risk patients: a meta-analysis"},{"title3":"Laboratory-confirmed respiratory infections as predictors of hospital admission for myocardial infarction and stroke: time-series analysis of English data for 2004-2015"},{"title3":"Prevalence and significance of coagulation abnormalities in community-acquired pneumonia"},{"title3":"D-dimer is a significant prognostic factor in patients with suspected infection and sepsis"},{"title3":"Risk of myocardial infarction and stroke after acute infection or vaccination"},{"title3":"Cardiac complications in patients with community-acquired pneumonia: incidence, timing, risk factors, and association with short-term mortality"},{"title3":"Cardiovascular complications of acute respiratory infections: current research and future directions"},{"title3":"Regulation of ACE2 in cardiac myocytes and fibroblasts"},{"title3":"ACE2 and vasoactive peptides: novel players in cardiovascular/renal remodeling and hypertension"},{"title3":"Pathological findings of COVID-19 associated with acute respiratory distress syndrome"},{"title3":"Persistent shedding of viable SARS-CoV in urine and stool of SARS patients during the convalescent phase"},{"title3":"Viral shedding and antibody response in 37 patients with Middle East Respiratory Syndrome coronavirus infection"},{"title3":"Viral load kinetics of MERS coronavirus infection"},{"title3":"Factors associated with prolonged viral shedding in patients with avian influenza A(H7N9) virus infection"},{"title3":"SARS-CoV-2 viral load in upper respiratory specimens of infected patients"}]},{"title2":"Projecting hospital utilization during the COVID-19 outbreaks in the United States","References":[{"title3":"A novel coronavirus from patients with pneumonia in China, 2019"},{"title3":"First case of 2019 novel Coronavirus in the United States"},{"title3":"Trends in critical care beds and use among population groups and medicare and medicaid beneficiaries in the United States: 2000-2010"},{"title3":"Critically ill patients with 2009 influenza A(H1N1) infection in Canada"},{"title3":"The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19):China, 2020"},{"title3":"Risk of influenza infection with low vaccine effectiveness: The role of avoidance behaviour"},{"title3":"COVID-19 control in China during mass population movements at New Year"},{"title3":"Effectiveness of a school district closure for pandemic influenza A (H1N1) on acute respiratory illnesses in the community: A natural experiment"},{"title3":"Traveling towards disease: Transportation barriers to health care access"},{"title3":"The effect of individual movements and interventions on the spread of influenza in long-term care facilities"},{"title3":"On the relative role of different age groups in influenza epidemics"},{"title3":"Projecting social contact matrices in 152 countries using contact surveys and demographic data"},{"title3":"Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia"},{"title3":"Substantial undocumented infection facilitates the rapid dissemination of novel coronavirus (SARS-CoV2)"},{"title3":"Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China"},{"title3":"Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study"},{"title3":"[The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19) in China] [in Chinese]"}]},{"title2":"Locally informed simulation to predict hospital capacity needs during the COVID-19 pandemic","References":[]},{"title2":"Goh G. The Epidemic Calculator. https://gabgoh.github.io/COVID/index.html. Accessed 14 Apr 2020.","References":[]},{"title2":"Hill A, Levy M, XIe S, Sheen J, Shinnick J, Gheorghe A, et al. Modeling COVID-19 spread vs healthcare capacity. https://alhill.shinyapps.io/COVID19seir. Accessed 21 Apr 2020.","References":[]},{"title2":"IHME COVID-19 health service utilization forecasting team, Murray CJ. Forecasting COVID-19 impact on hospital bed-days, ICU-days, ventilator-days and deaths by US state in the next 4 months. medRxiv. Cold Spring Harbor Laboratory Press; 2020;2020.03.27.20043752.","References":[]},{"title2":"Radiological findings from 81 patients with COVID-19 pneumonia in Wuhan, China: a descriptive study","References":[{"title3":"Novel coronavirus:China"},{"title3":"Coronavirus disease (COVID-19) outbreak"},{"title3":"Evolution of the novel coronavirus from the ongoing Wuhan outbreak and modeling of its spike protein for risk of human transmission"},{"title3":"Notes from the field: a novel coronavirus genome identified in a cluster of pneumonia cases:Wuhan, China 2019-2020"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Novel coronavirus:Thailand (ex-China)"},{"title3":"Novel coronavirus:Japan (ex-China)"},{"title3":"Novel coronavirus:Republic of Korea (ex-China)"},{"title3":"First travel-related case of 2019 novel coronavirus detected in United States"},{"title3":"A cluster of cases of severe acute respiratory syndrome in Hong Kong"},{"title3":"Epidemiological, demographic, and clinical characteristics of 47 cases of Middle East respiratory syndrome coronavirus disease from Saudi Arabia: a descriptive study"},{"title3":"Clinical management of severe acute respiratory infection when novel coronavirus (2019-nCoV) infection is suspected: interim guidance"},{"title3":"A novel coronavirus associated with severe acute respiratory syndrome"},{"title3":"Newly discovered coronavirus as the primary cause of severe acute respiratory syndrome"},{"title3":"Middle East respiratory syndrome coronavirus (MERS-CoV): announcement of the Coronavirus Study Group"},{"title3":"Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia"},{"title3":"Epidemiological, clinical and viral characteristics of fatal cases of human avian influenza A (H7N9) virus in Zhejiang Province, China"},{"title3":"Clinical features and factors associated with outcomes of patients infected with a novel influenza A (H7N9) virus: a preliminary study"},{"title3":"A major outbreak of severe acute respiratory syndrome in Hong Kong"},{"title3":"Emerging H7N9 influenza A (novel reassortant avian-origin) pneumonia: radiologic findings"},{"title3":"Severe acute respiratory syndrome: radiographic and CT findings"},{"title3":"Thin-section CT of severe acute respiratory syndrome: evaluation of 73 patients exposed to or with the disease"},{"title3":"Clinical and imaging findings in patients with severe acute respiratory syndrome"},{"title3":"CT correlation with outcomes in 15 patients with acute Middle East respiratory syndrome coronavirus"},{"title3":"Middle East respiratory syndrome coronavirus (MERS-CoV) infection: chest CT findings"},{"title3":"Acute Middle East respiratory syndrome coronavirus: temporal lung changes observed on the chest radiographs of 55 patients"},{"title3":"The radiologic manifestations of H5N1 avian influenza"},{"title3":"Organizing pneumonia: perilobular pattern at thin-section CT"},{"title3":"An official American Thoracic Society/European Respiratory Society statement: update of the international multidisciplinary classification of the idiopathic interstitial pneumonias"}]},{"title2":"Clinical characteristics of coronavirus disease 2019 in China","References":[{"title3":"Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia."},{"title3":"Challenges in laboratory diagnosis of the novel coronavirus SARS-CoV-2."},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China."},{"title3":"First case of 2019 novel Coronavirus in the United States."},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study."},{"title3":"A novel coronavirus associated with severe acute respiratory syndrome."},{"title3":"A preventive and control strategy for COVID-19 infection: an experience from a Third-Tier Chinese City."},{"title3":"An emerging coronavirus causing pneumonia outbreak in Wuhan, China: calling for developing therapeutic and prophylactic strategies."},{"title3":"Measures for diagnosing and treating infections by a novel coronavirus responsible for a pneumonia outbreak originating in Wuhan, China."},{"title3":"Perspectives on therapeutic neutralizing antibodies against the Novel Coronavirus SARS-CoV-2."},{"title3":"COVID-19, an emerging coronavirus infection: advances and prospects in designing and developing vaccines, immunotherapeutics, and therapeutics."},{"title3":"Transplantation of ACE2(-) mesenchymal stem cells improves the outcome of patients with COVID-19 pneumonia."},{"title3":"On the use of corticosteroids for 2019-nCoV pneumonia."},{"title3":"Comprehensive analysis of drugs to treat SARSCoV2 infection: mechanistic insights into current COVID19 therapies (Review)."},{"title3":"The role of telemedicine during the COVID-19 epidemic in China-experience from Shandong province."},{"title3":"Human umbilical cord-derived mesenchymal stem cell therapy in patients with COVID-19: a phase 1 clinical trial."},{"title3":"Intravenous infusion of human umbilical cord Wharton's jelly-derived mesenchymal stem cells as a potential treatment for patients with COVID-19 pneumonia."},{"title3":"Flattening the COVID-19 curve with natural killer cell based immunotherapies."},{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster."},{"title3":"Full-genome evolutionary analysis of the novel corona virus (2019-nCoV) rejects the hypothesis of emergence as a result of a recent recombination event."},{"title3":"Epidemiologic and clinical characteristics of novel coronavirus infections involving 13 patients outside Wuhan, China."},{"title3":"Spatio-temporal metabolokinetics and efficacy of human placenta-derived mesenchymal stem/stromal cells on mice with refractory Crohn's-like enterocutaneous fistula."},{"title3":"High-efficient generation of VCAM-1(+) mesenchymal stem cells with multidimensional superiorities in signatures and efficacy on aplastic anaemia mice."},{"title3":"Systematic comparison of hUC-MSCs at various passages reveals the variations of signatures and therapeutic effect on acute graft-versus-host disease."},{"title3":"JNKi- and DAC-programmed mesenchymal stem/stromal cells from hESCs facilitate hematopoiesis and alleviate hind limb ischemia."},{"title3":"Identification of a novel coronavirus in patients with severe acute respiratory syndrome."},{"title3":"Studies on viral pneumonia related to novel coronavirus SARS-CoV-2, SARS-CoV, and MERS-CoV: a literature review."},{"title3":"Three emerging coronaviruses in two decades."},{"title3":"The epidemic of 2019-novel-coronavirus (2019-nCoV) pneumonia and insights for emerging infectious diseases in the future."},{"title3":"Coronaviruses - drug discovery and therapeutic options."},{"title3":"The pathogenicity of SARS-CoV-2 in hACE2 transgenic mice."},{"title3":"Acute respiratory distress syndrome: the Berlin Definition."},{"title3":"Pediatric acute respiratory distress syndrome: definition, incidence, and epidemiology: proceedings from the Pediatric Acute Lung Injury Consensus Conference."},{"title3":"Eicosanoid storm in infection and inflammation."},{"title3":"Decoding the enigma of antiviral crisis: does one target molecule regulate all?"}]},{"title2":"Clinical features and short-term outcomes of 18 patients with corona virus disease 2019 in intensive care unit","References":[]},{"title2":"Potential biases in estimating absolute and relative case-fatality risks during outbreaks","References":[{"title3":"Studies needed to address public health challenges of the 2009 H1N1 influenza pandemic: insights from modeling"},{"title3":"Randomised controlled trials for Ebola: practical and ethical issues"},{"title3":"Middle East respiratory syndrome coronavirus: quantification of the extent of the epidemic, surveillance biases, and transmissibility"},{"title3":"Improving the evidence base for decision making during a pandemic: the example of 2009 influenza A/H1N1"},{"title3":"Human infection with avian influenza A H7N9 virus: an assessment of clinical severity"},{"title3":"Seroevidence for H5N1 influenza infections in humans: meta-analysis"},{"title3":"Comment on &quot;Seroevidence for H5N1 influenza infections in humans: meta-analysis&quot;"},{"title3":"Epidemiological determinants of spread of causal agent of severe acute respiratory syndrome in Hong Kong"},{"title3":"The severity of pandemic H1N1 influenza in the United States, from April to July 2009: a Bayesian analysis"},{"title3":"Changes in severity of 2009 pandemic A/H1N1 influenza in England: a Bayesian evidence synthesis"},{"title3":"Pandemic influenza A(H1N1)v in New Zealand: the experience from April to August 2009"},{"title3":"Under-reporting and case fatality estimates for emerging epidemics"},{"title3":"Notes from the field: outbreak of 2009 pandemic influenza A (H1N1) virus at a large public university in Delaware, April-May 2009"},{"title3":"Pandemic potential of a strain of influenza A (H1N1): early findings"},{"title3":"Use of cumulative incidence of novel influenza A/H1N1 in foreign travelers to estimate lower bounds on cumulative incidence in Mexico"},{"title3":"Optimizing the precision of case fatality ratio estimates under the surveillance pyramid approach"},{"title3":"Estimating infection attack rates and severity in real time during an influenza pandemic: analysis of serial cross-sectional serologic surveillance data"},{"title3":"The infection attack rate and severity of 2009 pandemic H1N1 influenza in Hong Kong"},{"title3":"Transmission scenarios for Middle East Respiratory Syndrome Coronavirus (MERS-CoV) and how to tell them apart"},{"title3":"Assessing the severity of the novel influenza A/H1N1 pandemic"},{"title3":"Ebola virus disease in West Africa:the first 9 months of the epidemic and forward projections"},{"title3":"Case fatality rate for Ebola virus disease in west Africa"},{"title3":"Methods for estimating the case fatality ratio for a novel, emerging infectious disease"},{"title3":"Non-parametric estimation of the case fatality ratio with competing risks data: an application to Severe Acute Respiratory Syndrome (SARS)"},{"title3":"Managing and reducing uncertainty in an emerging influenza pandemic"},{"title3":"Assessment and control for confounding by indication in observational studies"},{"title3":"Effectiveness of neuraminidase inhibitors in reducing mortality in patients admitted to hospital with influenza A H1N1pdm09 virus infection: a meta-analysis of individual participant data"},{"title3":"Effectiveness of antiviral treatment in human influenza A(H5N1) infections: analysis of a Global Patient Registry"},{"title3":"Strengthening observational evidence for antiviral effectiveness in influenza A (H5N1)"},{"title3":"Determinants of antiviral effectiveness in influenza virus A subtype H5N1"},{"title3":"A structural approach to selection bias"},{"title3":"Basic methods for sensitivity analysis of biases"},{"title3":"Risk factors for severe outcomes following 2009 influenza A (H1N1) infection: a global pooled analysis"},{"title3":"Pandemic (H1N1) 2009 surveillance for severe illness and response, New York, New York, USA, April-July 2009"},{"title3":"Investigation of elevated case-fatality rate in poliomyelitis outbreak in Pointe Noire, Republic of Congo, 2010"},{"title3":"Ebola hemorrhagic fever and pregnancy"},{"title3":"Use of risk adjustment in setting budgets and measuring performance in primary care II: advantages, disadvantages, and practicalities"},{"title3":"Evaluating novel therapies during the Ebola epidemic"},{"title3":"Bloom B (2014) Ebola: The Teaching and Learning Moment. Harvard International Review http://hirharvardedu/archives/7500."},{"title3":"Household transmission of 2009 pandemic influenza A (H1N1) virus in the United States"}]}]},{"title1":"Clinical Characteristics and Short-Term Outcomes of Severe Patients With COVID-19 in Wuhan, China","References":[{"title2":"A novel coronavirus from patients with pneumonia in China, 2019","References":[{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study"},{"title3":"A novel coronavirus from patients with pneumonia in China, 2019"},{"title3":"Inferring the hosts of coronavirus using dual statistical models based on nucleotide composition"},{"title3":"Importation and human-to-human transmission of a novel coronavirus in Vietnam"},{"title3":"2019 novel coronavirus (2019-nCoV) outbreak: a new challenge"},{"title3":"Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan"},{"title3":"Identification of a novel coronavirus causing severe pneumonia in human: a descriptive study"},{"title3":"A new coronavirus associated with human respiratory disease in China"},{"title3":"Measures for diagnosing and treating infections by a novel coronavirus responsible for a pneumonia outbreak originating in Wuhan, China"},{"title3":"Novel Wuhan (2019-nCoV) coronavirus"},{"title3":"Severe acute respiratory syndrome coronavirus phylogeny: toward consensus"},{"title3":"Diagnosis and treatment of new coronavirus pneumonia (trial version 7) [J / OL]. Tianjin J Tradit Chin Med. 2020;1-5. http://kns.cnki.net/kcms/detail/12.1349.R.20200304.1638.006.html. Accessed 3 June 2020."},{"title3":"Clinical outcome of standardized oxygen therapy nursing strategy in COVID-19"},{"title3":"Radiological findings from 81 patients with COVID-19 pneumonia in Wuhan, China: a descriptive study"},{"title3":"Evolution of the novel coronavirus from the ongoing Wuhan outbreak and modeling of its spike protein for risk of human transmission"},{"title3":"Angiotensin-converting enzyme 2: a functional receptor for SARS coronavirus"},{"title3":"Single-cell RNA-seq data analysis on the receptor ACE2 expression reveals the potential risk of different human organs vulnerable to 2019-nCoV infection"},{"title3":"High expression of ACE2 receptor of 2019-nCoV on the epithelial cells of oral mucosa"},{"title3":"Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis"},{"title3":"Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation"},{"title3":"Organ distribution of severe acute respiratory syndrome (SARS) associated coronavirus (SARS-CoV) in SARS patients: implications for pathogenesis and virus transmission pathways"},{"title3":"Significant changes of peripheral T lymphocyte subsets in patients with severe acute respiratory syndrome"},{"title3":"Overlapping and discrete aspects of the pathology and pathogenesis of the emerging human pathogenic coronaviruses SARS-CoV, MERS-CoV, and 2019-nCoV"},{"title3":"Lactate dehydrogenase and C-reactive protein as predictors of respiratory failure in CoVID-19 patients"},{"title3":"Lactate dehydrogenase, an independent risk factor of severe COVID-19 patients: a retrospective and observational study"},{"title3":"C-reactive protein correlates with computed tomographic findings and predicts severe COVID-19 early"},{"title3":"Eosinopenia and elevated C-reactive protein facilitate triage of COVID-19 patients in fever clinic: a retrospective case-control study"},{"title3":"Association of cardiac injury with mortality in hospitalized patients with COVID-19 in Wuhan, China"},{"title3":"Cardiovascular implications of fatal outcomes of patients with coronavirus disease 2019 (COVID-19)"},{"title3":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study"},{"title3":"Human ipsc-derived cardiomyocytes are susceptible to Sars-Cov-2 infection"},{"title3":"Cardiovascular complications in COVID-19"},{"title3":"COVID-19 pandemic and troponin: indirect myocardial injury, myocardial inflammation or myocarditis?"},{"title3":"Endothelial cell infection and endotheliitis in COVID-19"}]},{"title2":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China","References":[{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster"},{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: adescriptivestudy"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study"},{"title3":"First case of 2019 novel coronavirus in the United States"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Lung CT image of a confirmed case of the 2019 novel coronavirus (2019-nCoV) infected pneumonia (With differential diagnosis of the SARS)"},{"title3":"Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia"},{"title3":"Role of neutrophil to lymphocyte and monocyte to lymphocyte ratios in the diagnosis of bacterial infection in patients with fever"},{"title3":"Coronavirus infections-more than just the common cold"},{"title3":"The association between the neutrophil-to-lymphocyte ratio and mortality in critical illness: an observational cohort study"},{"title3":"A new coronavirus associated with human respiratory disease in China"},{"title3":"Monocyte/lymphocyte ratio as a better predictor of cardiovascular and all-cause mortality in hemodialysis patients: a prospective cohort study"},{"title3":"Ratio of neutrophil to lymphocyte counts-rapid and simple parameter of systemic inflammation and stress in critically ill"},{"title3":"Neutrophil-lymphocyte ratio as an early new marker in AIV-H7N9-infected patients: a retrospective study"}]},{"title2":"Clinical characteristics of Coronavirus Disease 2019 in China","References":[{"title3":"Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia."},{"title3":"Challenges in laboratory diagnosis of the novel coronavirus SARS-CoV-2."},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China."},{"title3":"First case of 2019 novel Coronavirus in the United States."},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study."},{"title3":"A novel coronavirus associated with severe acute respiratory syndrome."},{"title3":"A preventive and control strategy for COVID-19 infection: an experience from a Third-Tier Chinese City."},{"title3":"An emerging coronavirus causing pneumonia outbreak in Wuhan, China: calling for developing therapeutic and prophylactic strategies."},{"title3":"Measures for diagnosing and treating infections by a novel coronavirus responsible for a pneumonia outbreak originating in Wuhan, China."},{"title3":"Perspectives on therapeutic neutralizing antibodies against the Novel Coronavirus SARS-CoV-2."},{"title3":"COVID-19, an emerging coronavirus infection: advances and prospects in designing and developing vaccines, immunotherapeutics, and therapeutics."},{"title3":"Transplantation of ACE2(-) mesenchymal stem cells improves the outcome of patients with COVID-19 pneumonia."},{"title3":"On the use of corticosteroids for 2019-nCoV pneumonia."},{"title3":"Comprehensive analysis of drugs to treat SARSCoV2 infection: mechanistic insights into current COVID19 therapies (Review)."},{"title3":"The role of telemedicine during the COVID-19 epidemic in China-experience from Shandong province."},{"title3":"Human umbilical cord-derived mesenchymal stem cell therapy in patients with COVID-19: a phase 1 clinical trial."},{"title3":"Intravenous infusion of human umbilical cord Wharton's jelly-derived mesenchymal stem cells as a potential treatment for patients with COVID-19 pneumonia."},{"title3":"Flattening the COVID-19 curve with natural killer cell based immunotherapies."},{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster."},{"title3":"Full-genome evolutionary analysis of the novel corona virus (2019-nCoV) rejects the hypothesis of emergence as a result of a recent recombination event."},{"title3":"Epidemiologic and clinical characteristics of novel coronavirus infections involving 13 patients outside Wuhan, China."},{"title3":"Spatio-temporal metabolokinetics and efficacy of human placenta-derived mesenchymal stem/stromal cells on mice with refractory Crohn's-like enterocutaneous fistula."},{"title3":"High-efficient generation of VCAM-1(+) mesenchymal stem cells with multidimensional superiorities in signatures and efficacy on aplastic anaemia mice."},{"title3":"Systematic comparison of hUC-MSCs at various passages reveals the variations of signatures and therapeutic effect on acute graft-versus-host disease."},{"title3":"JNKi- and DAC-programmed mesenchymal stem/stromal cells from hESCs facilitate hematopoiesis and alleviate hind limb ischemia."},{"title3":"Identification of a novel coronavirus in patients with severe acute respiratory syndrome."},{"title3":"Studies on viral pneumonia related to novel coronavirus SARS-CoV-2, SARS-CoV, and MERS-CoV: a literature review."},{"title3":"Three emerging coronaviruses in two decades."},{"title3":"The epidemic of 2019-novel-coronavirus (2019-nCoV) pneumonia and insights for emerging infectious diseases in the future."},{"title3":"Coronaviruses - drug discovery and therapeutic options."},{"title3":"The pathogenicity of SARS-CoV-2 in hACE2 transgenic mice."},{"title3":"Acute respiratory distress syndrome: the Berlin Definition."},{"title3":"Pediatric acute respiratory distress syndrome: definition, incidence, and epidemiology: proceedings from the Pediatric Acute Lung Injury Consensus Conference."},{"title3":"Eicosanoid storm in infection and inflammation."},{"title3":"Decoding the enigma of antiviral crisis: does one target molecule regulate all?"}]},{"title2":"Clinical findings in a group of patients infected with the 2019 novel coronavirus (SARS-Cov-2) outside of Wuhan, China: retrospective case series","References":[]},{"title2":"Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study","References":[]},{"title2":"Epidemiological, clinical and virological characteristics of 74 cases of coronavirus-infected disease (2019). (COVID-19) with gastrointestinal symptoms","References":[{"title3":"Outbreak of pneumonia of unknown etiology in Wuhan, China: the mystery and the miracle"},{"title3":"Preliminary estimation of the basic reproduction number of novel coronavirus (2019-nCoV) in China, from 2019 to 2020: a data-driven analysis in the early phase of the outbreak"},{"title3":"Potential for global spread of a novel coronavirus from China"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia"},{"title3":"Nowcasting and forecasting the potential domestic and international spread of the 2019-nCoV outbreak originating in Wuhan, China: a modelling study"},{"title3":"Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding"},{"title3":"Receptor recognition by the novel coronavirus from Wuhan: an analysis based on decade-long structural studies of SARS coronavirus"},{"title3":"The association between domestic train transportation and novel coronavirus (2019-nCoV) outbreak in China from 2019 to 2020: a data-driven correlational report"},{"title3":"First case of 2019 novel coronavirus in the United States"},{"title3":"The digestive system is a potentila route of 2019-nCov infection: a bioinformatics analysis based on single-cell transcriptomes"},{"title3":"Clinical management of severe acute respiratory infection when novel coronavirus (nCoV) infection is suspected: interim guidance"},{"title3":"Clinical characteristics of coronavirus disease 2019 in China"},{"title3":"Coronavirus infections and immune responses"},{"title3":"Evaluation of coronavirus in tears and conjunctival secretions of patients with SARS-CoV-2 infection"},{"title3":"Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China"},{"title3":"Manifestations of digestive system in hospitalized patients with novel coronavirus pneumonia in Wuhan, China: a single-center, descriptive study"},{"title3":"Dynamic RNA modifications in gene expression regulation"},{"title3":"N6-methyladenosine-dependent regulation of messenger RNA stability"},{"title3":"Posttranscriptional m(6)A Editing of HIV-1 mRNAs Enhances Viral Gene Expression"},{"title3":"N6-Methyladenosine in Flaviviridae viral RNA genomes regulates infection"},{"title3":"Suppression of RNA recognition by Toll-like receptors: the impact of nucleoside modification and the evolutionary origin of RNA"},{"title3":"Epitranscriptomic enhancement of influenza A virus gene expression and replication"},{"title3":"Epigenetic landscape during coronavirus infection"},{"title3":"Molecular mechanisms of coronavirus RNA capping and methylation"},{"title3":"A SARS-like cluster of circulating bat coronaviruses shows potential for human emergence"},{"title3":"Pathogenic human coronavirus infections: causes and consequences of cytokine storm and immunopathology"},{"title3":"Viral load of SARS-CoV-2 in clinical samples"}]},{"title2":"Risk factors associated with acute respiratory distress syndrome and death in patients with Coronavirus Disease (2019). pneumonia in Wuhan, China","References":[]},{"title2":"Diabetes is a risk factor for the progression and prognosis of COVID-19","References":[{"title3":"Diabetes is a risk factor for the progression and prognosis of COVID-19"},{"title3":" https://www.cdc.gov/diabetes/basics/diabetes.html. Accessed April 10, 2020."},{"title3":"The immune system's involvement in obesity-driven type 2 diabetes"},{"title3":" https://bit.ly/2xjKnOF. Accessed April 10, 2020."},{"title3":"Severe outcomes among patients with coronavirus disease 2019-United States, February 12-March 16, 2020"}]},{"title2":"Diagnosis and treatment protocol for novel coronavirus pneumonia (Trial Version 7)","References":[]},{"title2":"Characteristics of and important lessons from the Coronavirus Disease 2019. (COVID-19) outbreak in China","References":[]},{"title2":"Epidemiology of COVID-19 among children in China","References":[{"title3":"World Health Organization. Coronavirus disease 2019 (COVID-19) Situation Report - 83 [press release]. Available from: https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200412-sitrep-83-covid-19.pdf?sfvrsn=697ce98d_4. Accessed April 12, 2020."},{"title3":"Epidemiology of COVID-19 among children in China"},{"title3":"Control and Prevention. Coronavirus Disease 2019 in Children : United States, February 12-April 2, 2020"},{"title3":"Clinical characteristics of coronavirus disease 2019 in China"},{"title3":"SARS-CoV-2 infection in children"},{"title3":"Detection of COVID-19 in children in early January 2020 in Wuhan, China"},{"title3":"Novel coronavirus infection in hospitalized infants under 1 year of age in China"},{"title3":"Characteristics of pediatric SARS-CoV-2 infection and potential evidence for persistent fecal viral shedding"},{"title3":"A 55-day-old female infant infected with COVID 19: presenting with pneumonia, liver injury, and heart damage"},{"title3":"Coronavirus infections in children including COVID-19: An overview of the epidemiology, clinical features, diagnosis, treatment and prevention options in children"},{"title3":"Chest CT findings in coronavirus disease-19 (COVID-19): relationship to duration of infection"}]},{"title2":"COVID-19 with different severity_ a multi-center study of clinical features","References":[]},{"title2":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study","References":[{"title3":"Outbreak of pneumonia of unknown etiology in Wuhan China: the mystery and the miracle"},{"title3":"The continuing 2019-nCoV epidemic threat of novel coronaviruses to global health - the latest 2019 novel coronavirus outbreak in Wuhan, China"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Clinical management of severe acute respiratory infection when Novel coronavirus (nCoV) infection is suspected: interim guidance"},{"title3":"MERS, SARS and other coronaviruses as causes of pneumonia"},{"title3":"Identification of a novel coronavirus in patients with severe acute respiratory syndrome"},{"title3":"Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia"},{"title3":"Clinical features predicting mortality risk in patients with viral pneumonia: the MuLBSTA score"},{"title3":"Discovery of a rich gene pool of bat SARS-related coronaviruses provides new insights into the origin of SARS coronavirus"},{"title3":"Cross-host evolution of severe acute respiratory syndrome coronavirus in palm civet and human"},{"title3":"Middle East respiratory syndrome coronavirus in dromedary camels: an outbreak investigation"},{"title3":"Evidence for camel-to-human transmission of MERS coronavirus"},{"title3":"Surveillance of bat coronaviruses in Kenya identifies relatives of human coronaviruses NL63 and 229E and their recombination history"},{"title3":"Origin and evolution of pathogenic coronaviruses"},{"title3":"Fatal swine acute diarrhoea syndrome caused by an HKU2-related coronavirus of bat origin"},{"title3":"Evolution of the novel coronavirus from the ongoing Wuhan outbreak and modeling of its spike protein for the risk of human transmission"},{"title3":"Wuhan coronavirus has strong ability to infect humans. Press release"},{"title3":"From SARS to MERS, thrusting coronaviruses into the spotlight"},{"title3":"Prevalence of comorbidities in the Middle East respiratory syndrome coronavirus (MERS-CoV): a systematic review and meta-analysis"},{"title3":"Sex-based differences in susceptibility to severe acute respiratory syndrome coronavirus infection"},{"title3":"Sexual dimorphism in innate immunity"},{"title3":"Pathophysiology and burden of infection in patients with diabetes mellitus and peripheral vascular disease: focus on skin and soft-tissue infections"},{"title3":"Clinical findings in 111 cases of influenza A (H7N9) virus infection"},{"title3":"Clinical features of three avian influenza H7N9 virus-infected patients in Shanghai"},{"title3":"T-cell immunity of SARS-CoV: implications for vaccine development against MERS-CoV"}]},{"title2":"Neurologic manifestations of hospitalized patients with Coronavirus Disease 2019 in Wuhan, China","References":[]},{"title2":"Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China","References":[]},{"title2":"Clinical characteristics and therapeutic procedure for four cases with 2019 novel coronavirus pneumonia receiving combined Chinese and Western medicine treatment","References":[]},{"title2":"Multiple organ infection the pathogenesis of SARS","References":[{"title3":"World Health Organization. Communicable Disease Surveillance &amp; Response (CSR). Severe Acute Respiratory Syndrome (SARS). Available at: http://www.who.int/csr/sars/en (accessed July 11, 2005)."},{"title3":"World Health Organization. May 1, 2003. Case definitions for surveillance of severe acute respiratory syndrome (SARS). Available at: http://www.who.int/csr/sars/casedefinition/en/."},{"title3":"Lossi L., P. Aimar, E. Beltramo, and A. Merighi. 2002. Immunogold labeling techniques for transmission electron microscopy: applications in cell and molecular biology. Gold and Silver Staining: Techniques in Molecular Morphology. G.W. Hacker and J. Gu, editors. CRC Press, Boca Raton, FL. 147-167"},{"title3":"Shi, S.R., J. Gu, J.F. Turrens, R.J. Cote, and C.R. Taylor. 2000. Development of AR technique: philosophy and theoretical base. Antigen Retrieval. S.R. Shi, J. Gu, C.R. Taylor, editors., Eaton Publishing Co. Natick, MA. 17-39."}]},{"title2":"Clinical characteristics of 113 deceased patients with coronavirus disease 2019: retrospective study","References":[]},{"title2":"Lymphopenia predicts disease severity of COVID-19: a descriptive and predictive study","References":[{"title3":"Lymphopenia predicts disease severity of COVID-19: a descriptive and predictive study"}]},{"title2":"Clinical and immunological features of severe and moderate coronavirus disease 2019","References":[]},{"title2":"Call to action for the cardiovascular side of COVID-19","References":[]},{"title2":"Multicenter analysis of clinical characteristics and outcome of COVID-19 patients with liver injury","References":[]},{"title2":"Characteristics of liver tests in COVID-19 patients","References":[{"title3":"Prospective Latin American cohort evaluating outcomes of patients with COVID-19 and abnormal liver tests on admission"},{"title3":"The liver in times of COVID-19: what hepatologists should know"},{"title3":"Involvement of liver in COVID-19: systematic review and meta-analysis"},{"title3":"Clinical features of COVID-19-Related liver functional abnormality"},{"title3":"COVID 19 and liver: an A-Z literature review"},{"title3":"Systemic inflammation as fuel for acute liver injury in COVID-19"},{"title3":"Severe liver failure during SARS-CoV-2 infection"},{"title3":"Incidence, risk factors, and prognosis of abnormal liver biochemical tests in COVID-19 patients: a systematic review and meta-analysis"},{"title3":"Prognostic value of liver biochemical parameters for COVID-19 mortality"},{"title3":"The effect of liver test abnormalities on the prognosis of COVID-19"},{"title3":"Liver involvement is not associated with mortality: results from a large cohort of SARS-CoV-2-positive patients"},{"title3":"Liver tests abnormalities in COVID-19: trick or treat?"},{"title3":"Diagnosis and treatment of corona virus disease-19 (7th trial edition)"}]},{"title2":"Traditional Chinese medicine for COVID-19 treatment","References":[{"title3":"COVID-19 Possible Medical Treatments"},{"title3":"Clinical observation of Jinhua Qinggan granule in treating novel coronavirus infection pneumonia"},{"title3":"Focus on Receptors for Coronaviruses with Special Reference to Angiotensin-Converting Enzyme 2 as a Potential Drug Target - A Perspective"},{"title3":"Chinese Therapeutic Strategy for Fighting COVID-19 and Potential Small-Molecule Inhibitors against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)"},{"title3":"Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis"},{"title3":"Arbidol as a broad-spectrum antiviral: An update"},{"title3":"Pharmacologic treatments for coronavirus disease 2019 (COVID-19): A review"},{"title3":"The anti-influenza virus drug, arbidol is an efficient inhibitor of SARS-CoV-2 in vitro"},{"title3":"Efficacy and safety of lopinavir/ritonavir or arbidol in adult patients with mild/moderate COVID-19: An exploratory randomized controlled trial"},{"title3":"Umifenovir treatment is not associated with improved outcomes in patients with coronavirus disease 2019: A retrospective study"},{"title3":"SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor"},{"title3":"Protease inhibitors targeting coronavirus and filovirus entry"},{"title3":"Chloroquine is a potent inhibitor of SARS coronavirus infection and spread"},{"title3":"Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro"},{"title3":"Lopinavir/ritonavir in the treatment of HIV-1 infection: A review"},{"title3":"A Trial of Lopinavir-Ritonavir in Adults Hospitalized with Severe Covid-19"},{"title3":"Role of lopinavir/ritonavir in the treatment of SARS: Initial virological and clinical findings"},{"title3":"Remdesivir for severe acute respiratory syndrome coronavirus 2 causing COVID-19: An evaluation of the evidence"},{"title3":"Comparative therapeutic efficacy of remdesivir and combination lopinavir, ritonavir, and interferon beta against MERS-CoV"},{"title3":"Remdesivir in adults with severe COVID-19: A randomised, double-blind, placebo-controlled, multicentre trial"},{"title3":" US National Institutes of Health (NIH). Interim COVID-19 treatment guidelines. "},{"title3":"Remdesivir and COVID-19"},{"title3":"Coronavirus Disease 2019 Treatment: A Review of Early and Emerging Options"},{"title3":"Potential interventions for novel coronavirus in China: A systematic review"},{"title3":"Severe acute respiratory syndrome: Report of treatment and outcome after a major outbreak"},{"title3":"Cytokine Storms: Understanding COVID-19"},{"title3":" , , , , , , , , , , 2020b. Aberrant Pathogenic GM-CSF T Cells and Inflammatory CD14 CD16 Monocytes in Severe Pulmonary Syndrome Patients of a New Coronavirus. bioRxiv. "},{"title3":"Therapeutic efficacy of humanized recombinant anti-interleukin-6 receptor antibody in children with systemic-onset juvenile idiopathic arthritis"},{"title3":"Effective treatment of severe COVID-19 patients with tocilizumab"},{"title3":"Characteristics of SARS-CoV-2 and COVID-19"},{"title3":"Advances in the possible treatment of COVID-19: A review"},{"title3":"Interferon-beta 1a and SARS coronavirus replication"},{"title3":"Severe acute respiratory syndrome-related coronavirus is inhibited by interferon-alpha"},{"title3":"Type I Interferon Susceptibility Distinguishes SARS-CoV-2 from SARS-CoV"},{"title3":"Role of interferon therapy in severe COVID-19: The COVIFERON randomized controlled trial"},{"title3":"A potentially effective treatment for COVID-19: A systematic review and meta-analysis of convalescent plasma therapy in treating severe infectious disease"},{"title3":"Reflections on treatment of COVID-19 with traditional Chinese medicine"},{"title3":"Moderation-integrated-balance presupposition of Chinese medicine compound and pharmacological problems in traditional Chinese drug research"},{"title3":"Use of animal products in traditional Chinese medicine: Environmental impact and health hazards"},{"title3":"Good practice in reviewing and publishing studies on herbal medicine, with special emphasis on traditional Chinese medicine and Chinese materia medica"},{"title3":"Why Chinese medicine is heading for clinics around the world"},{"title3":"Study on the compatible proportion and mechanism of Armeniacae Semen and Radix Platycodi in relieving cough, relieving asthma and expectorant"},{"title3":"Clinical efficacy of different doses of jinhuaqinggan granule on influenza and serum levels of cytokines"},{"title3":"Diagnosis and treatment Protocol for novel coronavirus pneumonia (trial version 7)"},{"title3":"Research progress of traditional Chinese medicine against COVID-19"},{"title3":"Preliminary exploration of the mechanism of Qingfei Paidu decoction against novel coronavirus pneumonia based on network pharmacology and molecular docking technology"},{"title3":"Investigating mechanism of QingFei PaiDu Tang for treatment of COVID-19 by network pharmacology"},{"title3":"Efficacy of herbal medicine (Xuanfei Baidu decoction) combined with conventional drug in treating COVID-19: A pilot randomized clinical trial"},{"title3":"Characteristics of registered clinical trials on traditional Chinese medicine for coronavirus disease 2019 (COVID-19): A scoping review"},{"title3":"Exploring active compounds of Jinhua Qinggan granules for prevention of COVID-19 based on network pharmacology and molecular docking"},{"title3":"Effect of Jinhua Qinggan granules on novel coronavirus pneumonia in patients"},{"title3":"Lianhuaqingwen exerts anti-viral and anti-inflammatory activity against novel coronavirus (SARS-CoV-2)"},{"title3":"Efficacy and safety of Lianhuaqingwen capsules, a repurposed Chinese herb, in patients with coronavirus disease 2019: A multicenter, prospective, randomized controlled trial"},{"title3":"Qualitative and quantitative analysis of the major constituents in Chinese medical preparation Lianhua-Qingwen capsule by UPLC-DAD-QTOF-MS"},{"title3":"The effect of Xuebijing injection on immune regulation in SIRS patients"},{"title3":"Xuebijing injection in the treatment of COVID-19: A retrospective case-control study"},{"title3":"Resveratrol extracted from Chinese herbal medicines: A novel therapeutic strategy for lung diseases"},{"title3":"Novel type of potential anticancer agents derived from chrysophanol and emodin. Some structure-activity relationship studies"},{"title3":"Emodin (3-methyl-1, 6, 8-trihydroxyanthraquinone) inhibits TNF-induced NF-kappaB activation, IkappaB degradation, and expression of cell surface adhesion proteins in human vascular endothelial cells"},{"title3":"Emodin: A review of its pharmacology, toxicity and pharmacokinetics"},{"title3":"Emodin blocks the SARS coronavirus spike protein and angiotensin-converting enzyme 2 interaction"},{"title3":"Transcriptional suppression of androgen receptor by 18beta-glycyrrhetinic acid in LNCaP human prostate cancer cells"},{"title3":"Glycyrrhizin, an active component of liquorice roots, and replication of SARS-associated coronavirus"},{"title3":"Antiviral activity of glycyrrhizic acid derivatives against SARS-coronavirus"},{"title3":"Glycyrrhizin Effectively Inhibits SARS-CoV-2 Replication by Inhibiting the Viral Main Protease"},{"title3":"Potential Leads from Liquorice Against SARS-CoV-2 Main Protease using Molecular Docking Simulation Studies"},{"title3":"A Review of the Pharmacological Effects of the Dried Root of Polygonum cuspidatum (Hu Zhang) and Its Constituents"},{"title3":"Polygonum cuspidatum and its active components inhibit replication of the influenza virus through toll-like receptor 9-induced interferon beta expression"},{"title3":"Effective inhibition of MERS-CoV infection by resveratrol"},{"title3":"Anti-inflammatory plant flavonoids and cellular action mechanisms"},{"title3":"Understanding chinese medicine and western medicine to reach the maximum treatment benefit"},{"title3":"Antioxidant potential of antiviral drug umifenovir"},{"title3":"Clinical observation of Lianhua Qingwen Capsule combined with ribavirin injection in treating viral upper respiratory tract infection"},{"title3":"Effect of combination antiviral therapy on hematological profiles in 151 adults hospitalized with severe coronavirus disease 2019"}]},{"title2":"Traditional Chinese medicine in the treatment of patients infected with 2019-new Coronavirus (SARS-CoV-2): a review and perspective","References":[{"title3":"Return of the Coronavirus: 2019-nCoV"},{"title3":"Coronavirus in China"},{"title3":"WHO Director-General's remarks at the media briefing on 2019-nCoV on 11 February 2020"},{"title3":"Clinical characteristics of 2019 novel coronavirus infection in China"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Situation Report-29"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study"},{"title3":"A pneumonia outbreak associated with a new coronavirus of probable bat origin"},{"title3":"Genome Composition and Divergence of the Novel Coronavirus (2019-nCoV) Originating in China"},{"title3":"Coronaviruses - drug discovery and therapeutic options"},{"title3":"Chest CT for Typical 2019-nCoV Pneumonia: Relationship to Negative RT-PCR Testing"},{"title3":"Therapeutic options for the 2019 novel coronavirus (2019-nCoV)"},{"title3":"Chinese herbal medicine for severe acute respiratory syndrome: a systematic review and meta-analysis"},{"title3":"Traditional Chinese herbal medicine as a source of molecules with antiviral activity"},{"title3":"The efficacy of Chinese medicine for SARS: a review of Chinese publications after the crisis"},{"title3":"A rapid advice guideline for the diagnosis and treatment of 2019 novel coronavirus (2019-nCoV) infected pneumonia (standard version)"},{"title3":"The Novel Coronavirus: A Bird's Eye View"},{"title3":"Nucleosides for the treatment of respiratory RNA virus infections"},{"title3":"New Nucleoside Analogues for the Treatment of Hemorrhagic Fever Virus Infections"},{"title3":"Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro"},{"title3":"Broad-spectrum antiviral GS-5734 inhibits both epidemic and zoonotic coronaviruses"},{"title3":"Potential Interventions for Novel Coronavirus in China: A Systemic Review"},{"title3":"First Case of 2019 Novel Coronavirus in the United States"},{"title3":"Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and corona virus disease-2019 (COVID-19): the epidemic and the challenges"},{"title3":"New insights into the antiviral effects of chloroquine"},{"title3":"Anti-malaria drug chloroquine is highly effective in treating avian influenza A H5N1 virus infection in an animal model"},{"title3":"Plasma inflammatory cytokines and chemokines in severe acute respiratory syndrome"},{"title3":"Expression of elevated levels of pro-inflammatory cytokines in SARS-CoV-infected ACE2+ cells in SARS patients: relation to the acute lung injury and pathogenesis of SARS"},{"title3":"Distinct immune response in two MERS-CoV-infected patients: can we go from bench to bedside?"},{"title3":"Treatment with interferon-alpha2b and ribavirin improves outcome in MERS-CoV-infected rhesus macaques"},{"title3":"SARS: systematic review of treatment effects"},{"title3":"Corticosteroids as adjunctive therapy in the treatment of influenza"},{"title3":"Corticosteroid Therapy for Critically Ill Patients with Middle East Respiratory Syndrome"},{"title3":"Clinical evidence does not support corticosteroid treatment for 2019-nCoV lung injury"},{"title3":"Hyperimmune IV immunoglobulin treatment: a multicenter double-blind randomized controlled trial for patients with severe 2009 influenza A(H1N1) infection"},{"title3":"Can Chinese Medicine Be Used for Prevention of Corona Virus Disease 2019 (COVID-19)? A Review of Historical Classics, Research Evidence and Current Prevention Programs"},{"title3":"TCM treatment of infectious atypical pneumonia-a report of 16 cases"},{"title3":"Chinese herbs combined with Western medicine for severe acute respiratory syndrome (SARS)"},{"title3":"Effect of integrated traditional Chinese and Western medicine on SARS: a review of clinical evidence"},{"title3":"Management and prevention of SARS in China"},{"title3":"The Severe Acute Respiratory Syndrome"},{"title3":"Severe Acute Respiratory Syndrome"},{"title3":"Statistical evidence for the usefulness of Chinese medicine in the treatment of SARS"},{"title3":"Lau, Leung PC, Wong ELY, Fong C, Cheng KF, Zhang SC, et al. Using Herbal Medicine as a Means of Prevention Experience During the SARS Crisis"},{"title3":"Immunomodulatory effects of a traditional Chinese medicine with potential antiviral activity: a self-control study"},{"title3":"Can herbal medicine assist against avian flu? Learning from the experience of using supplementary treatment with Chinese medicine on SARS or SARS-like infectious disease in 2003"},{"title3":"Glycyrrhizin, an active component of liquorice roots, and replication of SARS-associated coronavirus"},{"title3":"In vitro susceptibility of 10 clinical isolates of SARS coronavirus to selected antiviral compounds"},{"title3":"Virtual screening for finding natural inhibitor against cathepsin-L for SARS therapy"},{"title3":"Traditional Chinese medicine in the treatment of acute respiratory tract infections"},{"title3":"Natural products: a continuing source of novel drug leads"},{"title3":"Anti-SARS coronavirus 3C-like protease effects of Rheum palmatum L"},{"title3":"Immunomodulatory activities of the herbal formula Kwan Du Bu Fei Dang in healthy subjects: a randomised, double-blind, placebo-controlled study"},{"title3":"Immunomodulatory and anti-SARS activities of Houttuynia cordata"},{"title3":"A study on anti-SARS-CoV 3CL protein of flavonoids from litchi chinensis sonn core"},{"title3":"Anti-SARS coronavirus 3C-like protease effects of Isatis indigotica root and plant-derived phenolic compounds"},{"title3":"Flavonoid-mediated inhibition of SARS coronavirus 3C-like protease expressed in Pichia pastoris"},{"title3":"Inhibition of SARS-CoV 3CL protease by flavonoids"},{"title3":"Characteristics of flavonoids as potent MERS-CoV 3C-like protease inhibitors"},{"title3":"Identification of myricetin and scutellarein as novel chemical inhibitors of the SARS coronavirus helicase, nsP13"},{"title3":"Small molecules targeting severe acute respiratory syndrome human coronavirus"},{"title3":"The SARS Coronavirus receptor ACE 2 A potential target for antiviral therapy"},{"title3":"Functional assessment of cell entry and receptor usage for lineage B beta-coronaviruses, including 2019-nCoV"},{"title3":"Identification of residues in the receptor-binding domain (RBD) of the spike protein of human coronavirus NL63 that are critical for the RBD-ACE2 receptor interaction"},{"title3":"Evolution of the novel coronavirus from the ongoing Wuhan outbreak and modeling of its spike protein for risk of human transmission"},{"title3":"Emodin blocks the SARS coronavirus spike protein and angiotensin-converting enzyme 2 interaction"},{"title3":"Inhibitory activities of baicalin against renin and angiotensin-converting enzyme"},{"title3":"Nicotianamine is a novel angiotensin-converting enzyme 2 inhibitor in soybean"},{"title3":"Neuroprotective Effect of Scutellarin on Ischemic Cerebral Injury by Down-Regulating the Expression of Angiotensin-Converting Enzyme and AT1 Receptor"},{"title3":"Small molecules blocking the entry of severe acute respiratory syndrome coronavirus into host cells"},{"title3":"Emodin inhibits current through SARS-associated coronavirus 3a protein"},{"title3":"Kaempferol Derivatives as Antiviral Drugs against the 3a Channel Protein of Coronavirus"},{"title3":"Antiviral effects of saikosaponins on human coronavirus 229E in vitro"},{"title3":"Liquorice may tackle SARS"},{"title3":"Toona sinensis Roem tender leaf extract inhibits SARS coronavirus replication"},{"title3":"Drug treatment options for the 2019-new coronavirus (2019-nCoV)"},{"title3":"Effects of Shuanghuanglian and Qingkailing, two multi-components of traditional Chinese medicinal preparations, on human leukocyte function"},{"title3":"Shuang-Huang-Lian exerts anti-inflammatory and anti-oxidative activities in lipopolysaccharide-stimulated murine alveolar macrophages"},{"title3":"Indirubin-3'-oxime as an antiviral and immunomodulatory agent in treatment of severe human influenza virus infection"},{"title3":"The Chinese prescription lianhuaqingwen capsule exerts anti-influenza activity through the inhibition of viral propagation and impacts immune function"},{"title3":"Effect of Lianhuaqingwen Capsules on Airway Inflammation in Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease"},{"title3":"Identification of natural compounds with antiviral activities against SARS-associated coronavirus"},{"title3":"Anti-Human Coronavirus (anti-HCoV) Triterpenoids from the Leaves of Euphorbia Neriifolia"},{"title3":"Bioactive Pyranoxanthones from the Roots of Calophyllum blancoi"},{"title3":"Transcript of press conference in 17, February, 2020"},{"title3":"Notice on the issunance of guidelines of diagnosis and treatment for 2019-nCoV infected pneumonia (version 6)"},{"title3":"Application of integrative medicine protocols on treatment of coronavirus disease 2019"},{"title3":"Compilation of drug information for the diagnosis and treatment of COVID-19 (version 1)"},{"title3":"Analysis on prevention plan of corona virus disease-19 (COVID-19) by traditional Chinese medicine in various regions"},{"title3":"Investigating the mechanism of Qing-Fei-Pai-Du-Tang for the treatment of Novel Coronavirus Pneumonia by network pharmacology"},{"title3":"Retrospective Clinical Analysis on Treatment of Novel Coronavirus-infected Pneumonia with Traditional Chinese Medicine Lianhua Qingwen"},{"title3":"Treatment of suspected new coronavirus pneumonia with Chinese medicine Lianhua Qingwen Clinical observation of 63 suspected cases"},{"title3":"Cytokine storms caused by 2019-nCoV and drug therapy"},{"title3":"Characterization of chenodeoxycholic acid as an endogenous antagonist of the G-coupled formyl peptide receptors"},{"title3":"Regulatory effects of deoxycholic acid, a component of the anti-inflammatory traditional Chinese medicine Niuhuang, on human leukocyte response to chemoattractants"},{"title3":"Tannic acid is an inhibitor of CXCL12 (SDF-1alpha)/CXCR4 with antiangiogenic activity"},{"title3":"Shikonin, a component of chinese herbal medicine, inhibits chemokine receptor function and suppresses human immunodeficiency virus type 1"},{"title3":"Chemokines and chemokine receptors as novel therapeutic targets in rheumatoid arthritis (RA): inhibitory effects of traditional Chinese medicinal components"},{"title3":"Triptolide, a constituent of immunosuppressive Chinese herbal medicine, is a potent suppressor of dendritic-cell maturation and trafficking"},{"title3":"Effects of Chinese medicinal components on chemokine receptors: theory, results and methodology"},{"title3":"Ancient herbal component may be a novel therapeutic for gouty arthritis"},{"title3":"Shen Fu injection activate the macrophage NF-kB of rats' alveolar induced by LPS"},{"title3":"Mechanism of Re Du Ning injection on anti-acute lung injury in rats based on cytokines storm"},{"title3":"Tetrandrine inhibits differentiation of proinflammatory subsets of T helper cells but spares de novo differentiation of iTreg cells"},{"title3":"Potential Natural Compounds for Preventing 2019-nCoV Infection"},{"title3":"Aristolochic acids and their derivatives are widely implicated in liver cancers in Taiwan and throughout Asia"},{"title3":"Analysis of the adverse reactions induced by natural product-derived drugs"},{"title3":"Herb-drug interactions"},{"title3":"The Effects and Mechanism of Yinqiao Powder on Upper Respiratory Tract Infection"},{"title3":"Effects of different principles of Traditional Chinese Medicine treatment on TLR7/NF-kappaB signaling pathway in influenza virus infected mice"},{"title3":"The use of an herbal formula by hospital care workers during the severe acute respiratory syndrome epidemic in Hong Kong to prevent severe acute respiratory syndrome transmission, relieve influenza-related symptoms, and improve quality of life: a prospective cohort study"},{"title3":"Yu Ping Feng San, an Ancient Chinese Herbal Decoction, Induces Gene Expression of Anti-viral Proteins and Inhibits Neuraminidase Activity"},{"title3":"Antiinflammatory and immunoregulatory effects of total glucosides of Yupingfeng powder"},{"title3":"Chinese medicine injection shuanghuanglian for treatment of acute upper respiratory tract infection: a systematic review of randomized controlled trials"},{"title3":"A literature report on the treatment of SARS by stages with traditional Chinese medicine"},{"title3":"Research progress of Da Yuan Yin on the treatment of infectious diseases"},{"title3":"Natural Bis-Benzylisoquinoline Alkaloids-Tetrandrine, Fangchinoline, and Cepharanthine, Inhibit Human Coronavirus OC43 Infection of MRC-5 Human Lung Cells"}]},{"title2":"Characteristics of lymphocyte subsets and cytokines in peripheral blood of 123 hospitalized patients with 2019 novel coronavirus pneumonia (NCP)","References":[]},{"title2":"Cytokine storm in COVID-19 and treatment","References":[{"title3":"Coronavirus Disease (COVID-19) Pandemic"},{"title3":"Thoughts on the alveolar phase of COVID-19"},{"title3":"Endothelial cell infection and endotheliitis in COVID-19"},{"title3":"COVID-19: Consider cytokine storm syndromes and immunosuppression"},{"title3":"Lung compartmentalization of inflammatory biomarkers in COVID-19-related ARDS"},{"title3":"Alveolar compartmentalization of inflammatory and immune cell biomarkers in pneumonia-related ARDS"},{"title3":"Cytokine Levels in Critically Ill Patients with COVID-19 and Other Conditions"},{"title3":"Immune cartography of macrophage activation syndrome in the COVID-19 era"},{"title3":"Current Effective Therapeutics in Management of COVID-19"},{"title3":"Interleukin-1 Receptor Blockade Is Associated with Reduced Mortality in Sepsis Patients with Features of Macrophage Activation Syndrome: Reanalysis of a Prior Phase III Trial"},{"title3":"Clinical efficacy of anakinra to mitigate CAR T-cell therapy-associated toxicity in large B-cell lymphoma"},{"title3":"CAR T cell-induced cytokine release syndrome is mediated by macrophages and abated by IL-1 blockade"},{"title3":"Use of Anakinra to Prevent Mechanical Ventilation in Severe COVID-19: A Case Series"},{"title3":"Safety and efficacy of early high-dose IV anakinra in severe COVID-19 lung disease"},{"title3":"Anakinra combined with methylprednisolone in patients with severe COVID-19 pneumonia and hyperinflammation: An observational cohort study"},{"title3":"Interleukin-1 and interleukin-6 inhibition compared with standard management in patients with COVID-19 and hyperinflammation: A cohort study"},{"title3":"Efficacy of early anti-inflammatory treatment with high doses of intravenous anakinra with or without glucocorticoids in patients with severe COVID-19 pneumonia"},{"title3":"RCI-COVID-19 Study Group. Anakinra treatment in critically ill COVID-19 patients: A prospective cohort study"},{"title3":"An open label trial of anakinra to prevent respiratory failure in COVID-19"},{"title3":"Anakinra in hospitalized patients with severe COVID-19 pneumonia requiring oxygen therapy: Results of a prospective, open-label, interventional study"},{"title3":"Effect of anakinra on mortality in patients with COVID-19: A systematic review and patient-level meta-analysis"},{"title3":"Early treatment of COVID-19 with anakinra guided by soluble urokinase plasminogen receptor plasma levels: A double-blind, randomized controlled phase 3 trial"},{"title3":"Use of Anti-Cytokine Therapy in Kidney Transplant Recipients with COVID-19"},{"title3":"Multistate Modeling of COVID-19 Patients Using a Large Multicentric Prospective Cohort of Critically Ill Patients"},{"title3":"Anakinra versus Baricitinib: Different Strategies for Patients Hospitalized with COVID-19"},{"title3":"The Effect of Anakinra in Hospitalized Patients with COVID-19: An Updated Systematic Review and Meta-Analysis"},{"title3":"Comparative Study of Cytokine Storm Treatment in Patients with COVID-19 Pneumonia Using Immunomodulators"},{"title3":"Effect of anakinra versus usual care in adults in hospital with COVID-19 and mild-to-moderate pneumonia (CORIMUNO-ANA-1): A randomised controlled trial"}]},{"title2":"Analysis of clinical features of 29 patients with 2019 novel coronavirus pneumonia","References":[]},{"title2":"COVID-19: consider cytokine storm syndromes and immunosuppression","References":[{"title3":"Coronavirus disease 2019 (COVID-19)situation report - 52"},{"title3":"Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China"},{"title3":"Adult haemophagocytic syndrome"},{"title3":"Macrophage activation-like syndrome: a distinct entity leading to early death in sepsis"},{"title3":"Pulmonary involvement in patients with hemophagocytic lymphohistiocytosis"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Clinical evidence does not support corticosteroid treatment for 2019-nCoV lung injury"},{"title3":"Interleukin-1 receptor blockade is associated with reduced mortality in sepsis patients with features of macrophage activation syndrome: reanalysis of a prior phase iii trial"},{"title3":"A multicenter, randomized controlled trial for the efficacy and safety of tocilizumab in the treatment of new coronavirus pneumonia (COVID-19)"},{"title3":"Baricitinib as potential treatment for 2019-nCoV acute respiratory disease"},{"title3":"Development and validation of the HScore, a score for the diagnosis of reactive hemophagocytic syndrome"}]},{"title2":"On the alert for cytokine storm: Immunopathology in COVID-19","References":[{"title3":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study"},{"title3":"Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan, China"},{"title3":"Clinical and immunologic features in severe and moderate coronavirus disease 2019"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Benefit of anakinra in treating pediatric secondary hemophagocytic lymphohistiocytosis"},{"title3":"Interleukin-18 diagnostically distinguishes and pathogenically promotes human and murine macrophage activation syndrome"},{"title3":"Whole-exome sequencing reveals mutations in genes linked to hemophagocytic lymphohistiocytosis and macrophage activation syndrome in fatal cases of H1N1 influenza"},{"title3":"A personalized diagnostic and treatment approach for macrophage activation syndrome and secondary hemophagocytic lymphohistiocytosis in adults"},{"title3":"How we manage hyperferritinemic sepsis-related multiple organ dysfunction syndrome/macrophage activation syndrome/secondary hemophagocytic lymphohistiocytosis histiocytosis"},{"title3":"Interleukin-1 receptor blockade is associated with reduced mortality in sepsis patients with features of macrophage activation syndrome: reanalysis of a prior phase III trial"},{"title3":"Chimeric antigen receptor T cells for sustained remissions in leukemia"},{"title3":"Lung pathology of fatal severe acute respiratory syndrome"},{"title3":"An interferon-gamma-related cytokine storm in SARS patients"},{"title3":"Coronavirus disease (2019). Interim clinical guidance for management of patients with confirmed coronavirus disease (COVID-19)"},{"title3":"Corticosteroids as adjunctive therapy in the treatment of influenza: an updated Cochrane systematic review and meta-analysis"},{"title3":"Effects of early corticosteroid treatment on plasma SARS-associated coronavirus RNA concentrations in adult patients"},{"title3":"Calm in the midst of cytokine storm: a collaborative approach to the diagnosis and treatment of hemophagocytic lymphohistiocytosis and macrophage activation syndrome"}]},{"title2":"Lower tidal volume ventilation and plasma cytokine markers of inflammation in patients with acute lung injury","References":[]},{"title2":"G. Acute respiratory distress syndrome in critically ill patients with severe acute respiratory syndrome","References":[]},{"title2":"Adaptive immune cells temper initial innate responses","References":[{"title3":"Innate immunity: the virtues of a nonclonal system of recognition"},{"title3":"Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene"},{"title3":"Protozoan encounters with Toll-like receptor signalling pathways: implications for host parasitism"},{"title3":"Cooperation of Toll-like receptor signals in innate immune defence"},{"title3":"Persistence of mouse hepatitis virus A59 RNA in a slow virus demyelinating infection in mice as detected by in situ hybridization"},{"title3":"Mouse hepatitis virus"},{"title3":"TLR3 in antiviral immunity: key player or bystander?"},{"title3":"Bacterial superantigens"},{"title3":"Mice deficient for the 55 kd tumor necrosis factor receptor are resistant to endotoxic shock, yet succumb to L. monocytogenes infection"},{"title3":"Septic shock: pathogenesis"},{"title3":"CD4+CD25+ T(R) cells suppress innate immune pathology through cytokine-dependent mechanisms"},{"title3":"Regulatory T cells prevent catastrophic autoimmunity throughout the lifespan of mice"},{"title3":"Regulatory T cell lineage specification by the forkhead transcription factor foxp3"},{"title3":"Interaction between conventional dendritic cells and natural killer cells is integral to the activation of effective antiviral immunity"},{"title3":"Functional interactions between dendritic cells and NK cells during viral infection"},{"title3":"Dendritic cells directly trigger NK cell functions: cross-talk relevant in innate anti-tumor immune responses in vivo"},{"title3":"Dendritic cell maturation by innate lymphocytes: coordinated stimulation of innate and adaptive immunity"},{"title3":"NK-dependent DC maturation is mediated by TNFalpha and IFNgamma released upon engagement of the NKp30 triggering receptor"},{"title3":"Early T cell response to allografts occurring prior to alloantigen priming up-regulates innate-mediated inflammation and graft necrosis"}]},{"title2":"T cell responses are required for protection from clinical disease and for virus clearance in severe acute respiratory syndrome coronavirus-infected mice","References":[]}]},{"title1":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study","References":[{"title2":"The novel coronavirus originating in Wuhan, China: challenges for global health governance","References":[]},{"title2":"Severe acute respiratory syndrome-related coronavirus: the species and its viruses:a statement of the Coronavirus Study Group","References":[]},{"title2":"Short term outcome and risk factors for adverse clinical outcomes in adults with severe acute respiratory syndrome (SARS)","References":[]},{"title2":"Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia","References":[{"title3":"The 2019-nCoV Outbreak Joint Field Epidemiology Investigation Team, Li Q. Notes from the field: an outbreak of NCIP (2019-nCoV) infection in China : Wuhan, Hubei Province, 2019-2020."},{"title3":"A novel coronavirus genome identified in a cluster of pneumonia cases : Wuhan, China 2019-2020."},{"title3":"A novel coronavirus from patients with pneumonia in China, 2019."},{"title3":"Use of national pneumonia surveillance to describe influenza A(H7N9) virus epidemiology, China, 2004-2013."},{"title3":"A novel coronavirus emerging in China : key questions for impact assessment."},{"title3":"Evidence for camel-to-human transmission of MERS coronavirus."},{"title3":"Transmission dynamics and control of severe acute respiratory syndrome."},{"title3":"Dynamically modeling SARS and other newly emerging respiratory illnesses: past, present, and future."},{"title3":"Coronavirus infections : more than just the common cold."},{"title3":"Another decade, another coronavirus."},{"title3":"SARS and MERS: recent insights into emerging coronaviruses."},{"title3":"MERS, SARS, and Ebola: the role of super-spreaders in infectious disease."},{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster."},{"title3":"Real-time tentative assessment of the epidemiological characteristics of novel coronavirus infections in Wuhan, China, as at January 2020."},{"title3":"How to maintain surveillance for novel influenza A H1N1 when there are too many cases to count."}]},{"title2":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China","References":[{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster"},{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: adescriptivestudy"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study"},{"title3":"First case of 2019 novel coronavirus in the United States"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Lung CT image of a confirmed case of the 2019 novel coronavirus (2019-nCoV) infected pneumonia (With differential diagnosis of the SARS)"},{"title3":"Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia"},{"title3":"Role of neutrophil to lymphocyte and monocyte to lymphocyte ratios in the diagnosis of bacterial infection in patients with fever"},{"title3":"Coronavirus infections-more than just the common cold"},{"title3":"The association between the neutrophil-to-lymphocyte ratio and mortality in critical illness: an observational cohort study"},{"title3":"A new coronavirus associated with human respiratory disease in China"},{"title3":"Monocyte/lymphocyte ratio as a better predictor of cardiovascular and all-cause mortality in hemodialysis patients: a prospective cohort study"},{"title3":"Ratio of neutrophil to lymphocyte counts-rapid and simple parameter of systemic inflammation and stress in critically ill"},{"title3":"Neutrophil-lymphocyte ratio as an early new marker in AIV-H7N9-infected patients: a retrospective study"}]},{"title2":"Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China","References":[]},{"title2":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study","References":[{"title3":"Outbreak of pneumonia of unknown etiology in Wuhan China: the mystery and the miracle"},{"title3":"The continuing 2019-nCoV epidemic threat of novel coronaviruses to global health - the latest 2019 novel coronavirus outbreak in Wuhan, China"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Clinical management of severe acute respiratory infection when Novel coronavirus (nCoV) infection is suspected: interim guidance"},{"title3":"MERS, SARS and other coronaviruses as causes of pneumonia"},{"title3":"Identification of a novel coronavirus in patients with severe acute respiratory syndrome"},{"title3":"Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia"},{"title3":"Clinical features predicting mortality risk in patients with viral pneumonia: the MuLBSTA score"},{"title3":"Discovery of a rich gene pool of bat SARS-related coronaviruses provides new insights into the origin of SARS coronavirus"},{"title3":"Cross-host evolution of severe acute respiratory syndrome coronavirus in palm civet and human"},{"title3":"Middle East respiratory syndrome coronavirus in dromedary camels: an outbreak investigation"},{"title3":"Evidence for camel-to-human transmission of MERS coronavirus"},{"title3":"Surveillance of bat coronaviruses in Kenya identifies relatives of human coronaviruses NL63 and 229E and their recombination history"},{"title3":"Origin and evolution of pathogenic coronaviruses"},{"title3":"Fatal swine acute diarrhoea syndrome caused by an HKU2-related coronavirus of bat origin"},{"title3":"Evolution of the novel coronavirus from the ongoing Wuhan outbreak and modeling of its spike protein for the risk of human transmission"},{"title3":"Wuhan coronavirus has strong ability to infect humans. Press release"},{"title3":"From SARS to MERS, thrusting coronaviruses into the spotlight"},{"title3":"Prevalence of comorbidities in the Middle East respiratory syndrome coronavirus (MERS-CoV): a systematic review and meta-analysis"},{"title3":"Sex-based differences in susceptibility to severe acute respiratory syndrome coronavirus infection"},{"title3":"Sexual dimorphism in innate immunity"},{"title3":"Pathophysiology and burden of infection in patients with diabetes mellitus and peripheral vascular disease: focus on skin and soft-tissue infections"},{"title3":"Clinical findings in 111 cases of influenza A (H7N9) virus infection"},{"title3":"Clinical features of three avian influenza H7N9 virus-infected patients in Shanghai"},{"title3":"T-cell immunity of SARS-CoV: implications for vaccine development against MERS-CoV"}]},{"title2":"Management of adults with hospital-acquired and ventilator-associated pneumonia: 2016 clinical practice guidelines by the Infectious Diseases Society of America and the American Thoracic Society","References":[]},{"title2":"KDIGO clinical practice guidelines for acute kidney injury","References":[]},{"title2":"Acute respiratory distress syndrome: the Berlin Definition","References":[]},{"title2":"Chinese management guideline for COVID-19 (version 6.0)","References":[]},{"title2":"Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study","References":[{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study"},{"title3":"A novel coronavirus from patients with pneumonia in China, 2019"},{"title3":"First case of 2019 novel coronavirus in the United States"},{"title3":"Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China"},{"title3":"Clinical management of severe acute respiratory infection when novel coronavirus (nCoV) infection is suspected"},{"title3":"Critically ill patients with 2009 influenza A(H1N1) in Mexico"},{"title3":"Critically ill patients with severe acute respiratory syndrome"},{"title3":"Critically ill patients with 2009 influenza A(H1N1) infection in Canada"},{"title3":"KDIGO clinical practice guideline for acute kidney injury"},{"title3":"Wuhan: Britons to be evacuated as scientists estimate 44 000 cases of 2019-nCOV in the city"},{"title3":"Acute respiratory distress syndrome in critically ill patients with severe acute respiratory syndrome"},{"title3":"Short-term outcome of critically ill patients with severe acute respiratory syndrome"},{"title3":"Clinical course and outcomes of critically ill patients with Middle East respiratory syndrome coronavirus infection"},{"title3":"SARS and MERS: recent insights into emerging coronaviruses"},{"title3":"Epidemiology, patterns of care, and mortality for patients with acute respiratory distress syndrome in intensive care units in 50 countries"},{"title3":"China built a hospital in 10 days to battle coronavirus"},{"title3":"Transmission of 2019-nCoV infection from an asymptomatic contact in Germany"},{"title3":"Asymptomatic cases complicate efforts"},{"title3":"Multiple organ infection and the pathogenesis of SARS"},{"title3":"Middle East respiratory syndrome coronavirus efficiently infects human primary T lymphocytes and activates the extrinsic and intrinsic apoptosis pathways"},{"title3":"T-cell immunity of SARS-CoV: implications for vaccine development against MERS-CoV"},{"title3":"Practice of diagnosis and management of acute respiratory distress syndrome in mainland China: a cross-sectional study"},{"title3":"Clinical evidence does not support corticosteroid treatment for 2019-nCoV lung injury"}]},{"title2":"Middle East respiratory syndrome","References":[]},{"title2":"Outcomes and prognostic factors in 267 patients with severe acute respiratory syndrome in Hong Kong","References":[]},{"title2":"Predictors of mortality in Middle East respiratory syndrome (MERS)","References":[{"title3":"Middle East Respiratory Syndrome-Coronavirus (MERS-CoV): a case-controlstudy of hospitalized patients"},{"title3":"Predictors of MERS-CoV infection: a large case control study of patients presenting with ILI at a MERS-CoV referral hospital in Saudi Arabia"},{"title3":"A comparative study of clinical presentation and risk factors for adverse outcome in patients hospitalised with acute respiratory disease due to MERS coronavirus or other causes"},{"title3":"Differential Cell count and CRP level in Blood as predictors for Middle East respiratory syndrome coronavirus infection in acute febrile patients during nosocomial outbreak"},{"title3":"Managing MERS-CoV in the healthcare setting"},{"title3":"Hospital outbreak of Middle East respiratory syndrome coronavirus"},{"title3":"Epidemiological, demographic, and clinical characteristics of 47 cases of Middle East respiratory syndrome coronavirus disease from Saudi Arabia: a descriptive study"},{"title3":"High fatality rates and associated factors in two hospital outbreaks of MERS in Daejeon, the Republic of Korea"},{"title3":"A cohort-study of patients suspected for MERS-CoV in a referral hospital in Saudi Arabia"},{"title3":"Middle East respiratory syndrome coronavirus (MERS-CoV) outbreak in South Korea, 2015: epidemiology, characteristics and public health implications"},{"title3":"Clinical presentation and outcomes of Middle East respiratory syndrome in the Republic of Korea"},{"title3":"Clinical aspects and outcomes of 70 patients with Middle East respiratory syndrome coronavirus infection: a single-center experience in Saudi Arabia"},{"title3":"Imported cases of Middle East respiratory syndrome: an update"},{"title3":"Travel implications of emerging coronaviruses: SARS and MERS-CoV"},{"title3":"The characteristics of Middle eastern respiratory syndrome coronavirus transmission dynamics in South Korea"},{"title3":"Middle East respiratory syndrome coronavirus outbreak in the Republic of Korea"},{"title3":"Middle East respiratory syndrome coronavirus (MERS-CoV): prevention in travelers"},{"title3":"Systematic review of emerging respiratory viruses at the Hajj and possible coinfection with Streptococcus pneumoniae"},{"title3":"Asymptomatic Middle East Respiratory Syndrome Coronavirus (MERS-CoV) infection: extent and implications for infection control: a systematic review"},{"title3":"Epidemiology and predictors of survival of MERS-CoV infections in Riyadh region, 2014-2015"},{"title3":"Assays for laboratory confirmation of novel human coronavirus (hCoV-EMC) infections"},{"title3":"Influenza is more common than Middle East Respiratory Syndrome Coronavirus (MERS-CoV) among hospitalized adult Saudi patients"},{"title3":"Drivers of MERS-CoV transmission: what do we know?"},{"title3":"Middle East respiratory syndrome coronavirus: epidemiology and disease control measures"},{"title3":"Taking stock of the first 133 mers coronavirus cases globally-is the epidemic changing?"},{"title3":"State of knowledge and data gaps of Middle East respiratory syndrome coronavirus (MERS-CoV) in humans"},{"title3":"The predictors of 3- and 30-day mortality in 660 MERS-CoV patients"},{"title3":"Corticosteroid therapy for critically ill patients with Middle East respiratory syndrome"},{"title3":"Clinical aspects and outcomes of 70 patients with Middle East respiratory syndrome coronavirus infection: a single-center experience in Saudi Arabia"},{"title3":"Renal complications and their prognosis in Korean patients with Middle East respiratory syndrome-coronavirus from the central MERS-cov designated hospital"},{"title3":"Critically ill patients with the Middle East respiratory syndrome"},{"title3":"Extracorporeal membrane oxygenation for severe Middle East respiratory syndrome coronavirus"}]},{"title2":"Exacerbated innate host response to SARS-CoV in aged non-human primates","References":[{"title3":"Innate immunity and inflammation in ageing: a key for understanding age-related diseases."},{"title3":"Aging."},{"title3":"Aging and innate immune cells."},{"title3":"The role of immunity in susceptibility to respiratory infection in the aging lung."},{"title3":"Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study."},{"title3":"Severe acute respiratory syndrome."},{"title3":"An interferon-gamma-related cytokine storm in SARS patients."},{"title3":"Characterization of cytokine/chemokine profiles of severe acute respiratory syndrome."},{"title3":"The acute respiratory distress syndrome."},{"title3":"Clinical presentations and outcome of severe acute respiratory syndrome in children."},{"title3":"Clinical picture, diagnosis, treatment and outcome of severe acute respiratory syndrome (SARS) in children."},{"title3":"Severe acute respiratory syndrome in children."},{"title3":"Interferon-mediated immunopathological events are associated with atypical innate and adaptive immune responses in patients with severe acute respiratory syndrome."},{"title3":"Participation of both host and virus factors in induction of severe acute respiratory syndrome (SARS) in F344 rats infected with SARS coronavirus."},{"title3":"Early enhanced expression of interferon-inducible protein-10 (CXCL-10) and other chemokines predicts adverse outcome in severe acute respiratory syndrome."},{"title3":"Plasma inflammatory cytokines and chemokines in severe acute respiratory syndrome."},{"title3":"Cytokine responses in severe acute respiratory syndrome coronavirus-infected macrophages in vitro: possible relevance to pathogenesis."},{"title3":"Chemokine up-regulation in SARS-coronavirus-infected, monocyte-derived human dendritic cells."},{"title3":"Functional genomics highlights differential induction of antiviral pathways in the lungs of SARS-CoV-infected macaques."},{"title3":"Prognostic determinants of acute respiratory distress syndrome in adults: impact on clinical trial design."},{"title3":"Aetiology: Koch's postulates fulfilled for SARS virus."},{"title3":"Pegylated interferon-alpha protects type 1 pneumocytes against SARS coronavirus infection in macaques."},{"title3":"Newly discovered coronavirus as the primary cause of severe acute respiratory syndrome."},{"title3":"Transcriptional mechanisms of acute lung injury."},{"title3":"Identification of oxidative stress and Toll-like receptor 4 signaling as a key pathway of acute lung injury."},{"title3":"A global test for groups of genes: testing association with a clinical outcome."},{"title3":"Acid aspiration-induced lung injury in rabbits is mediated by interleukin-8-dependent mechanisms."},{"title3":"Acid-induced lung injury. Protective effect of anti-interleukin-8 pretreatment on alveolar epithelial barrier function in rabbits."},{"title3":"Unbiased reconstruction of a mammalian transcriptional network mediating pathogen responses."},{"title3":"Acetylation of Stat1 modulates NF-kappaB activity."},{"title3":"Pathogen recognition and innate immunity."},{"title3":"The interleukin 1 receptor: ligand interactions and signal transduction."},{"title3":"Nonhuman primate models for SARS."},{"title3":"The molecular inflammatory process in aging."},{"title3":"Regulation of neutral sphingomyelinase-2 by GSH: a new insight to the role of oxidative stress in aging-associated inflammation."},{"title3":"IL-1R1/MyD88 signaling and the inflammasome are essential in pulmonary inflammation and fibrosis in mice."},{"title3":"Immunosenescence: emerging challenges for an ageing population."},{"title3":"Aging and proinflammatory cytokines."},{"title3":"Inflamm-aging. An evolutionary perspective on immunosenescence."},{"title3":"The membrane protein of SARS-CoV suppresses NF-kappaB activation."},{"title3":"SARS coronavirus and innate immunity."},{"title3":"Severe acute respiratory syndrome coronavirus open reading frame (ORF) 3b, ORF 6, and nucleocapsid proteins function as interferon antagonists."},{"title3":"Genomic Analysis Reveals Age Dependent Innate Immune Responses to SARS Coronavirus."},{"title3":"Early upregulation of acute respiratory distress syndrome-associated cytokines promotes lethal disease in an aged-mouse model of severe acute respiratory syndrome coronavirus infection."},{"title3":"Control of coronavirus infection through plasmacytoid dendritic-cell-derived type I interferon."},{"title3":"Dysregulation of TLR3 impairs the innate immune response to West Nile virus in the elderly."},{"title3":"Altered cytokine production in the elderly."},{"title3":"Macrophage hypo-responsiveness to interferon-gamma in aged mice is associated with impaired signaling through Jak-STAT."},{"title3":"Distinct and nonredundant in vivo functions of IFNAR on myeloid cells limit autoimmunity in the central nervous system."},{"title3":"Suppression of experimental allergic encephalomyelitis by interferon."},{"title3":"Anti-inflammatory properties of Type I interferons."},{"title3":"The type I IFN induction pathway constrains Th17-mediated autoimmune inflammation in mice."},{"title3":"Treatment with recombinant interferon-beta reduces inflammation and slows cartilage destruction in the collagen-induced arthritis model of rheumatoid arthritis."},{"title3":"Mechanism of IFN-beta-mediated inhibition of IL-8 gene expression in astroglioma cells."},{"title3":"When signaling pathways collide: positive and negative regulation of toll-like receptor signal transduction."},{"title3":"TAM receptors are pleiotropic inhibitors of the innate immune response."},{"title3":"Interferon-alpha stimulates production of interleukin-10 in activated CD4+ T cells and monocytes."},{"title3":"Differential effects of TNF-alpha and IFN-gamma on gene transcription mediated by NF-kappaB-Stat1 interactions."},{"title3":"Influenza A virus inhibits type I IFN signaling via NF-kappaB-dependent induction of SOCS-3 expression."},{"title3":"NFkappaB negatively regulates interferon-induced gene expression and anti-influenza activity."},{"title3":"Mouse-passaged severe acute respiratory syndrome-associated coronavirus leads to lethal pulmonary edema and diffuse alveolar damage in adult but not young mice."},{"title3":"Interferon alfacon-1 plus corticosteroids in severe acute respiratory syndrome: a preliminary study."},{"title3":"Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method."},{"title3":"Variance stabilization applied to microarray data calibration and to the quantification of differential expression."},{"title3":"Some thoughts on clinical trials, especially problems of multiplicity."},{"title3":"Linear models and empirical bayes methods for assessing differential expression in microarray experiments."},{"title3":"Controlling the false discovery rate: a practical and powerful approach to multiple testing."}]},{"title2":"The immunopathogenesis of sepsis in elderly patients","References":[]},{"title2":"The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3)","References":[{"title3":"The role of glucocorticoids as adjunctive treatment for sepsis in the modern era"},{"title3":"Corticosteroids for treating sepsis"},{"title3":"Corticosteroids for severe sepsis and septic shock: a systematic review and meta-analysis"},{"title3":"Association of corticosteroid treatment with outcomes in adult patients with sepsis: a systematic review and meta-analysis"},{"title3":"Reevaluating the role of corticosteroids in septic shock: an updated meta-analysis of randomized controlled trials"},{"title3":"Can corticosteroids reduce the mortality of patients with severe sepsis? A systematic review and meta-analysis"},{"title3":"Corticosteroid treatment for sepsis: a critical appraisal and meta-analysis of the literature"},{"title3":"Corticosteroids in sepsis: an updated systematic review and meta-analysis"},{"title3":"Effect of adjunctive corticosteroids on clinical outcomes in adult patients with septic shock-a meta-analysis of randomized controlled trials and trial sequential analysis"},{"title3":"Low-dose corticosteroids for adult patients with septic shock: a systematic review with meta-analysis and trial sequential analysis"},{"title3":"Adjunctive glucocorticoid therapy in patients with septic shock"},{"title3":"Hydrocortisone plus fludrocortisone for adults with septic shock"},{"title3":"2001 sccm/esicm/accp/ats/sis international sepsis definitions conference"},{"title3":"Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis"},{"title3":"Sepsis definitions: time for change"},{"title3":"The third international consensus definitions for sepsis and septic shock (Sepsis-3)"},{"title3":"Use of the SOFA score to assess the incidence of organ dysfunction/failure in intensive care units: results of a multicenter, prospective study"},{"title3":"Hydrocortisone Compared with Placebo in Patients with Septic Shock Satisfying the Sepsis-3 Diagnostic Criteria and APROCCHSS Study Inclusion CriteriaA Post Hoc Analysis of the ADRENAL Trial"},{"title3":"The reporting of studies conducted using observational routinely collected health data statement for pharmacoepidemiology (RECORD-PE)"},{"title3":"Using big data to emulate a target trial when a randomized trial is not available"},{"title3":"The eICU Collaborative Research Database, a freely available multi-center database for critical care research"},{"title3":"Identifying patients with severe sepsis using administrative claims: patient-level validation of the angus implementation of the international consensus conference definition of severe sepsis"},{"title3":"FDA-Approved Drugs: SOLU-MEDROL U.S. FOOD &amp; DRUG Web site. Accessed 18 April 2020 https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=BasicSearch.process"},{"title3":"FDA-Approved Drugs: SOLU-CORTEF U.S. FOOD &amp; DRUG Web site. Accessed 18 April 2020 https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&amp;ApplNo=009866"},{"title3":"Early initiation of low-dose hydrocortisone treatment for septic shock in adults: a randomized clinical trial"},{"title3":"Reversal of late septic shock with supraphysiologic doses of hydrocortisone"},{"title3":"Immortal time bias in pharmacoepidemiology"},{"title3":"Low-dose hydrocortisone in patients with cirrhosis and septic shock: a randomized controlled trial"},{"title3":"Value of glucocorticoid steroids in the treatment of patients with severe community-acquired pneumonia complicated with septic shock"},{"title3":"Hydrocortisone therapy for patients with septic shock"},{"title3":"National analysis of sepsis hospitalizations and factors contributing to sepsis in-hospital mortality in Canada"},{"title3":"Glucose variability and mortality in patients with sepsis"},{"title3":"Prognostic factors of mortality in patients with community-acquired bloodstream infection with severe sepsis and septic shock"},{"title3":"The effect of comorbidity and age on hospital mortality and length of stay in patients with sepsis"},{"title3":"Adjusted survival curves with inverse probability weights"},{"title3":"Balance diagnostics for comparing the distribution of baseline covariates between treatment groups in propensity-score matched samples"},{"title3":"Moving towards best practice when using inverse probability of treatment weighting (IPTW) using the propensity score to estimate causal treatment effects in observational studies"},{"title3":"Variance estimation when using inverse probability of treatment weighting (IPTW) with survival analysis"},{"title3":"The interaction of vasopressin and corticosteroids in septic shock: a pilot randomized controlled trial"},{"title3":"Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock"},{"title3":"Effect of hydrocortisone on development of shock among patients with severe sepsis: the HYPRESS randomized clinical trial"},{"title3":"Effect of early vasopressin vs norepinephrine on kidney failure in patients with septic shock: the VANISH randomized clinical trial"},{"title3":"Dexamethasone and length of hospital stay in patients with community-acquired pneumonia: a randomised, double-blind, placebo-controlled trial"},{"title3":"The effects of high-dose corticosteroids in patients with septic shock: a prospective, controlled study"},{"title3":"Ineffectiveness of high-dose methylprednisolone in preventing parenchymal lung injury and improving mortality in patients with septic shock"},{"title3":"Corticosteroids for treating sepsis in children and adults"},{"title3":"Steroids in the treatment of clinical septic shock"},{"title3":"Sepsis, severe sepsis and septic shock: changes in incidence, pathogens and outcomes"},{"title3":"Effect of corticosteroids on treatment failure among hospitalized patients with severe community-acquired pneumonia and high inflammatory response: a randomized clinical trial"},{"title3":"Reduced cortisol metabolism during critical illness"},{"title3":"Cortisol levels and mortality in severe sepsis"},{"title3":"Why Test for Proportional Hazards?"},{"title3":"Surviving sepsis campaign: international guidelines for management of sepsis and septic shock: 2016"},{"title3":"Problem of immortal time bias in cohort studies: example using statins for preventing progression of diabetes"}]},{"title2":"Serial evaluation of the SOFA score to predict outcome in critically ill patients","References":[]},{"title2":"Disease severity and clinical outcomes of community-acquired pneumonia caused by non-influenza respiratory viruses in adults: a multicentre prospective registry study from the CAP-China Network","References":[]},{"title2":"Community-acquired pneumonia requiring admission to an intensive care unit: a descriptive study","References":[]},{"title2":"Acute pneumonia and the cardiovascular system","References":[]},{"title2":"Association between influenza vaccination and cardiovascular outcomes in high-risk patients: a meta-analysis","References":[]},{"title2":"Laboratory-confirmed respiratory infections as predictors of hospital admission for myocardial infarction and stroke: time-series analysis of English data for 2004-2015","References":[{"title3":"Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980-2015: a systematic analysis for the Global Burden of Disease Study 2015"},{"title3":"Mortality from cardiovascular and cerebrovascular diseases in Europe and other areas of the world: an update"},{"title3":"Risk of myocardial infarction and stroke after acute infection or vaccination"},{"title3":"Recent respiratory infection and risk of cardiovascular disease: case-control study through a general practice database"},{"title3":"Influenza infection and risk of acute myocardial infarction in England and Wales: a CALIBER self-controlled case series study"},{"title3":"Association between influenza vaccination and cardiovascular outcomes in high-risk patients: a meta-analysis"},{"title3":"The art of modeling the mortality impact of winter-seasonal pathogens"},{"title3":"Seasonal influenza infections and cardiovascular disease mortality"},{"title3":"Influenza associated mortality in the subtropics and tropics: results from three Asian cities"},{"title3":"Circulating influenza virus, climatic factors, and acute myocardial infarction: a time series study in England and Wales and Hong Kong"},{"title3":"Mortality caused by influenza and respiratory syncytial virus by age group in England and Wales 1999-2010"},{"title3":"Mortality attributable to influenza in England and Wales prior to, during and after the 2009 pandemic"},{"title3":"Mortality attributable to 9 common infections: significant effect of influenza A, respiratory syncytial virus, influenza B, norovirus, and parainfluenza in elderly persons"},{"title3":"Global burden of influenza as a cause of cardiopulmonary morbidity and mortality"},{"title3":"Surveillance of antibiotic resistance"},{"title3":"The computation of equivalent potential temperature"},{"title3":"Third universal definition of myocardial infarction"},{"title3":"Influenza as a trigger for acute myocardial infarction or death from cardiovascular disease: a systematic review"},{"title3":"Triggering of acute myocardial infarction by respiratory infection"},{"title3":"Acute cardiac injury events &lt;/=30 days after laboratory-confirmed influenza virus infection among U.S. veterans, 2010-2012"},{"title3":"Influenza and coronary artery disease: exploring a clinical association with myocardial infarction and analyzing the utility of vaccination in prevention of myocardial infarction"},{"title3":"Influenza, influenza-like symptoms and their association with cardiovascular risks: a systematic review and meta-analysis of observational studies"},{"title3":"Influenza vaccine as a coronary intervention for prevention of myocardial infarction"},{"title3":"Influenza vaccines for preventing cardiovascular disease"},{"title3":"A matched influenza vaccine strain was effective in reducing the risk of acute myocardial infarction in elderly persons: a population-based study"},{"title3":"Acute myocardial infarctions, strokes and influenza: seasonal and pandemic effects"},{"title3":"The causes and diagnosis of influenza-like illness"},{"title3":"Epidemiology of parainfluenza infection in England and Wales, 1998-2013: any evidence of change"},{"title3":"Relationship between supra-annual trends in influenza rates and stroke occurrence"},{"title3":"Role of acute infection in triggering acute coronary syndromes"},{"title3":"Complications and outcomes of pandemic 2009 influenza A (H1N1) virus infection in hospitalized adults: how do they differ from those in seasonal influenza"},{"title3":"Clinical aspects of pandemic 2009 influenza A (H1N1) virus infection"},{"title3":"Influenza vaccination is associated with a reduced risk of stroke"},{"title3":"Influenza vaccination reduces hemorrhagic stroke risk in patients with atrial fibrillation: a population-based cohort study"},{"title3":"Influenza vaccination and cardiovascular risk in patients with recent TIA and stroke"},{"title3":"Comparison of two rapid influenza A/B test kits with reference methods showing high specificity and sensitivity for influenza A infection"},{"title3":"Model selection in time series studies of influenza-associated mortality"},{"title3":"Cardiac complications in patients with community-acquired pneumonia: a systematic review and meta-analysis of observational studies"},{"title3":"Neuraminidase inhibitors for preventing and treating influenza in healthy adults and children"},{"title3":"Cardiovascular disease as a complication of community-acquired pneumonia"},{"title3":"Rationale and design of a randomized controlled trial of pneumococcal polysaccharide vaccine for prevention of cardiovascular events: the Australian Study for the Prevention through Immunization of Cardiovascular Events (AUSPICE)"},{"title3":"Association between pneumococcal vaccination and cardiovascular outcomes: a systematic review and meta-analysis of cohort studies"}]},{"title2":"Prevalence and significance of coagulation abnormalities in community-acquired pneumonia","References":[]},{"title2":"D-dimer is a significant prognostic factor in patients with suspected infection and sepsis","References":[]},{"title2":"Risk of myocardial infarction and stroke after acute infection or vaccination","References":[]},{"title2":"Cardiac complications in patients with community-acquired pneumonia: incidence, timing, risk factors, and association with short-term mortality","References":[]},{"title2":"Cardiovascular complications of acute respiratory infections: current research and future directions","References":[]},{"title2":"Regulation of ACE2 in cardiac myocytes and fibroblasts","References":[]},{"title2":"ACE2 and vasoactive peptides: novel players in cardiovascular/renal remodeling and hypertension","References":[]},{"title2":"Pathological findings of COVID-19 associated with acute respiratory distress syndrome","References":[{"title3":"A new coronavirus associated with human respiratory disease in China"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster"},{"title3":"The clinical pathology of severe acute respiratory syndrome (SARS): a report from China"},{"title3":"Clinicopathologic, immunohistochemical, and ultrastructural findings of a fatal case of Middle East respiratory syndrome coronavirus infection in the United Arab Emirates, April 2014"}]},{"title2":"Persistent shedding of viable SARS-CoV in urine and stool of SARS patients during the convalescent phase","References":[{"title3":"World Health Organization (2004) Summary of probable SARS with onset of illness from 1 November 2002 to 31 July 2003. Available at: http://www.who.int/csr/sars/country/table2004_04_21/en/. Cited 8 May 2004"},{"title3":"SARS: responding to an unknown virus"},{"title3":"Identification of a novel coronavirus in patients with severe acute respiratory syndrome"},{"title3":"A novel coronavirus associated with severe acute respiratory syndrome"},{"title3":"The genome sequence of the SARS-associated coronavirus"},{"title3":"Coronavirus as a possible cause of severe acute respiratory syndrome"},{"title3":"Characterization of a novel coronavirus associated with severe acute respiratory syndrome"},{"title3":"Aetiology: Koch's postulates fulfilled for SARS virus"},{"title3":"Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study"},{"title3":"Profile of specific antibodies to the SARS-associated coronavirus"},{"title3":"Serology of severe acute respiratory syndrome: implications for surveillance and outcome"},{"title3":"SARS-CoV antibody prevalence in all Hong Kong patient contacts"},{"title3":"Early diagnosis of SARS coronavirus infection by real time RT-PCR"},{"title3":"Detection of SARS coronavirus in patients with severe acute respiratory syndrome by conventional and real-time quantitative reverse transcription-PCR assays"},{"title3":"Detection of SARS coronavirus in patients with suspected SARS"},{"title3":"Preclinical evaluation of two real-time, reverse transcription-PCR assays for detection of the severe acute respiratory syndrome coronavirus"},{"title3":"World Health Organization (2003) PCR primers for SARS developed by WHO network laboratories [monograph on the Internet]. Available at: http://www.who.int/csr/sars/primers/en/. Cited 20 April 2003"},{"title3":"Epidemiological features of severe acute respiratory syndrome in Beijing"},{"title3":"Epidemiologic features, clinical diagnosis and therapy of first cluster of patients with severe acute respiratory syndrome in Beijing area"},{"title3":"Severe acute respiratory syndrome (SARS)-paradigm of an emerging viral infection"},{"title3":"Performance and cost evaluation of one commercial and six in-house conventional and real-time reverse transcription-PCR assays for detection of severe acute respiratory syndrome coronavirus"},{"title3":"Genetic variation of SARS coronavirus in Beijing hospital"},{"title3":"Clinical analysis of pediatric SARS cases in Beijing"},{"title3":"Virus-specific RNA and antibody from convalescent-phase SARS patients discharged from hospital"},{"title3":"Microbiologic characteristics, serologic responses, and clinical manifestations in severe acute respiratory syndrome, Taiwan"},{"title3":"SARS-associated coronavirus quasispeies in individual patients"},{"title3":"Isolation and identification of SARS-CoV from stool of SARS patients in different phase of disease"}]},{"title2":"Viral shedding and antibody response in 37 patients with Middle East Respiratory Syndrome coronavirus infection","References":[]},{"title2":"Viral load kinetics of MERS coronavirus infection","References":[]},{"title2":"Factors associated with prolonged viral shedding in patients with avian influenza A(H7N9) virus infection","References":[{"title3":"Human infection with a novel avian-origin influenza A (H7N9) virus"},{"title3":"Epidemiology of avian influenza A H7N9 virus in human beings across five epidemics in mainland China, 2013-17: an epidemiological study of laboratory-confirmed case series"},{"title3":"Sudden increase in human infection with avian influenza A(H7N9) virus in China, September-December 2016"},{"title3":"Update: increase in human infections with novel Asian lineage avian influenza A(H7N9) viruses during the fifth epidemic - China, October 1, 2016-August 7, 2017"},{"title3":"Epidemiology of human infections with highly pathogenic avian influenza A(H7N9) virus in Guangdong, 2016 to 2017"},{"title3":"Preliminary epidemiology of human infections with highly pathogenic avian influenza A(H7N9) virus, China, 2017"},{"title3":"Novel influenza A viruses and pandemic threats"},{"title3":"Pathogenesis of influenza-induced acute respiratory distress syndrome"},{"title3":"Influenza virus-induced lung injury: pathogenesis and implications for treatment"},{"title3":"Viral loads and duration of viral shedding in adult patients hospitalized with influenza"},{"title3":"Antiviral therapy and outcomes of influenza requiring hospitalization in Ontario, Canada"},{"title3":"Outcomes from pandemic influenza A H1N1 infection in recipients of solid-organ transplants: a multicentre cohort study"},{"title3":"Effectiveness of oseltamivir on disease progression and viral RNA shedding in patients with mild pandemic 2009 influenza A H1N1: opportunistic retrospective study of medical charts in China"},{"title3":"Treatment with neuraminidase inhibitors for critically ill patients with influenza A (H1N1)pdm09"},{"title3":"Impact of neuraminidase inhibitor treatment on outcomes of public health importance during the 2009-2010 influenza A(H1N1) pandemic: a systematic review and meta-analysis in hospitalized patients"},{"title3":"Effectiveness of neuraminidase inhibitors in reducing mortality in patients admitted to hospital with influenza A H1N1pdm09 virus infection: a meta-analysis of individual participant data"},{"title3":"Determinants of antiviral effectiveness in influenza virus A subtype H5N1"},{"title3":"Systematic review of influenza A(H1N1)pdm09 virus shedding: duration is affected by severity, but not age"},{"title3":"Benefit of early initiation of neuraminidase inhibitor treatment to hospitalized patients with avian influenza A (H7N9) virus"},{"title3":"Adjuvant Corticosteroid Treatment in Adults With Influenza A (H7N9) Viral Pneumonia"},{"title3":"Clinical findings in 111 cases of influenza A (H7N9) virus infection"},{"title3":"Use of corticosteroids in acute lung injury and acute respiratory distress syndrome: a systematic review and meta-analysis"},{"title3":"Corticosteroid therapy for critically ill patients with the middle east respiratory syndrome"},{"title3":"Fatal outcome of human influenza A (H5N1) is associated with high viral load and hypercytokinemia"},{"title3":"H5N1 infection of the respiratory tract and beyond: a molecular pathology study"},{"title3":"The role of adjuvant immunomodulatory agents for treatment of severe influenza"},{"title3":"Effects of early corticosteroid treatment on plasma SARS-associated Coronavirus RNA concentrations in adult patients"},{"title3":"Association between adverse clinical outcome in human disease caused by novel influenza A H7N9 virus and sustained viral shedding and emergence of antiviral resistance"},{"title3":"Human infection with highly pathogenic avian influenza A(H7N9) virus, China"},{"title3":"Efficacy of oseltamivir-zanamivir combination compared to each monotherapy for seasonal influenza: a randomized placebo-controlled trial"},{"title3":"Effect of double dose oseltamivir on clinical and virological outcomes in children and adults admitted to hospital with severe influenza: double blind randomised controlled trial"},{"title3":"Effectiveness of antiviral treatment in human influenza A(H5N1) infections: analysis of a Global Patient Registry"},{"title3":"Antiviral therapy and outcomes of patients with pneumonia caused by influenza A pandemic (H1N1) virus"},{"title3":"A prospective intervention study on higher-dose oseltamivir treatment in adults hospitalized with influenza a and B infections"},{"title3":"Oseltamivir in seasonal, avian H5N1 and pandemic 2009 A/H1N1 influenza: pharmacokinetic and pharmacodynamic characteristics"},{"title3":"Comparison of the anti-influenza virus activity of RWJ-270201 with those of oseltamivir and zanamivir"},{"title3":"Pharmacokinetics of oseltamivir: an oral antiviral for the treatment and prophylaxis of influenza in diverse populations"},{"title3":"Efficacy of oseltamivir-peramivir combination therapy compared to oseltamivir monotherapy for Influenza A (H7N9) infection: a retrospective study"},{"title3":"Antiviral combinations for severe influenza"}]},{"title2":"SARS-CoV-2 viral load in upper respiratory specimens of infected patients","References":[{"title3":"Summary of probable SARS cases with onset of illness from 1 November 2002 to 31 July 2003. Geneva: World Health Organization, 2004 ()."},{"title3":"Transmission dynamics and control of severe acute respiratory syndrome."},{"title3":"Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study."},{"title3":"Influenza A virus shedding and infectivity in households."},{"title3":"Transmission of 2019-nCoV infection from an asymptomatic contact in Germany."}]}]},{"title1":"Clinical Findings of COVID-19 Patients Admitted to Intensive Care Units in Guangdong Province, China: A Multicenter, Retrospective, Observational Study","References":[{"title2":"The continuing 2019-nCoV epidemic threat of novel coronaviruses to global health - The latest 2019 novel coronavirus outbreak in Wuhan, China","References":[{"title3":"The Middle East Respiratory Syndrome (MERS)"},{"title3":"Severe acute respiratory syndrome: historical, epidemiologic, and clinical features"},{"title3":"Pneumonia in China: lack of information raises concerns among Hong Kong health workers"},{"title3":"Taking forward a' One Health' approach for turning the tide against the Middle East respiratory syndrome coronavirus and other zoonotic pathogens with epidemic potential"},{"title3":"ProMED &quot;Novel coronavirus - China (01): (HU) WHO, phylogenetic tree&quot;. Archive Number: 20200112.6885385. Accessed 13 Jan 2020. https://www.ecohealthalliance.org/2020/01/phylogenetic-analysis-shows-novel-wuhan-coronavirus-clusters-with-sars."}]},{"title2":"A novel coronavirus from patients with pneumonia in China, 2019","References":[{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study"},{"title3":"A novel coronavirus from patients with pneumonia in China, 2019"},{"title3":"Inferring the hosts of coronavirus using dual statistical models based on nucleotide composition"},{"title3":"Importation and human-to-human transmission of a novel coronavirus in Vietnam"},{"title3":"2019 novel coronavirus (2019-nCoV) outbreak: a new challenge"},{"title3":"Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan"},{"title3":"Identification of a novel coronavirus causing severe pneumonia in human: a descriptive study"},{"title3":"A new coronavirus associated with human respiratory disease in China"},{"title3":"Measures for diagnosing and treating infections by a novel coronavirus responsible for a pneumonia outbreak originating in Wuhan, China"},{"title3":"Novel Wuhan (2019-nCoV) coronavirus"},{"title3":"Severe acute respiratory syndrome coronavirus phylogeny: toward consensus"},{"title3":"Diagnosis and treatment of new coronavirus pneumonia (trial version 7) [J / OL]. Tianjin J Tradit Chin Med. 2020;1-5. http://kns.cnki.net/kcms/detail/12.1349.R.20200304.1638.006.html. Accessed 3 June 2020."},{"title3":"Clinical outcome of standardized oxygen therapy nursing strategy in COVID-19"},{"title3":"Radiological findings from 81 patients with COVID-19 pneumonia in Wuhan, China: a descriptive study"},{"title3":"Evolution of the novel coronavirus from the ongoing Wuhan outbreak and modeling of its spike protein for risk of human transmission"},{"title3":"Angiotensin-converting enzyme 2: a functional receptor for SARS coronavirus"},{"title3":"Single-cell RNA-seq data analysis on the receptor ACE2 expression reveals the potential risk of different human organs vulnerable to 2019-nCoV infection"},{"title3":"High expression of ACE2 receptor of 2019-nCoV on the epithelial cells of oral mucosa"},{"title3":"Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis"},{"title3":"Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation"},{"title3":"Organ distribution of severe acute respiratory syndrome (SARS) associated coronavirus (SARS-CoV) in SARS patients: implications for pathogenesis and virus transmission pathways"},{"title3":"Significant changes of peripheral T lymphocyte subsets in patients with severe acute respiratory syndrome"},{"title3":"Overlapping and discrete aspects of the pathology and pathogenesis of the emerging human pathogenic coronaviruses SARS-CoV, MERS-CoV, and 2019-nCoV"},{"title3":"Lactate dehydrogenase and C-reactive protein as predictors of respiratory failure in CoVID-19 patients"},{"title3":"Lactate dehydrogenase, an independent risk factor of severe COVID-19 patients: a retrospective and observational study"},{"title3":"C-reactive protein correlates with computed tomographic findings and predicts severe COVID-19 early"},{"title3":"Eosinopenia and elevated C-reactive protein facilitate triage of COVID-19 patients in fever clinic: a retrospective case-control study"},{"title3":"Association of cardiac injury with mortality in hospitalized patients with COVID-19 in Wuhan, China"},{"title3":"Cardiovascular implications of fatal outcomes of patients with coronavirus disease 2019 (COVID-19)"},{"title3":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study"},{"title3":"Human ipsc-derived cardiomyocytes are susceptible to Sars-Cov-2 infection"},{"title3":"Cardiovascular complications in COVID-19"},{"title3":"COVID-19 pandemic and troponin: indirect myocardial injury, myocardial inflammation or myocarditis?"},{"title3":"Endothelial cell infection and endotheliitis in COVID-19"}]},{"title2":"T-helper type 2-driven inflammation defines major subphenotypes of asthma","References":[]},{"title2":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study","References":[{"title3":"Outbreak of pneumonia of unknown etiology in Wuhan China: the mystery and the miracle"},{"title3":"The continuing 2019-nCoV epidemic threat of novel coronaviruses to global health - the latest 2019 novel coronavirus outbreak in Wuhan, China"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Clinical management of severe acute respiratory infection when Novel coronavirus (nCoV) infection is suspected: interim guidance"},{"title3":"MERS, SARS and other coronaviruses as causes of pneumonia"},{"title3":"Identification of a novel coronavirus in patients with severe acute respiratory syndrome"},{"title3":"Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia"},{"title3":"Clinical features predicting mortality risk in patients with viral pneumonia: the MuLBSTA score"},{"title3":"Discovery of a rich gene pool of bat SARS-related coronaviruses provides new insights into the origin of SARS coronavirus"},{"title3":"Cross-host evolution of severe acute respiratory syndrome coronavirus in palm civet and human"},{"title3":"Middle East respiratory syndrome coronavirus in dromedary camels: an outbreak investigation"},{"title3":"Evidence for camel-to-human transmission of MERS coronavirus"},{"title3":"Surveillance of bat coronaviruses in Kenya identifies relatives of human coronaviruses NL63 and 229E and their recombination history"},{"title3":"Origin and evolution of pathogenic coronaviruses"},{"title3":"Fatal swine acute diarrhoea syndrome caused by an HKU2-related coronavirus of bat origin"},{"title3":"Evolution of the novel coronavirus from the ongoing Wuhan outbreak and modeling of its spike protein for the risk of human transmission"},{"title3":"Wuhan coronavirus has strong ability to infect humans. Press release"},{"title3":"From SARS to MERS, thrusting coronaviruses into the spotlight"},{"title3":"Prevalence of comorbidities in the Middle East respiratory syndrome coronavirus (MERS-CoV): a systematic review and meta-analysis"},{"title3":"Sex-based differences in susceptibility to severe acute respiratory syndrome coronavirus infection"},{"title3":"Sexual dimorphism in innate immunity"},{"title3":"Pathophysiology and burden of infection in patients with diabetes mellitus and peripheral vascular disease: focus on skin and soft-tissue infections"},{"title3":"Clinical findings in 111 cases of influenza A (H7N9) virus infection"},{"title3":"Clinical features of three avian influenza H7N9 virus-infected patients in Shanghai"},{"title3":"T-cell immunity of SARS-CoV: implications for vaccine development against MERS-CoV"}]},{"title2":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China","References":[{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster"},{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: adescriptivestudy"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study"},{"title3":"First case of 2019 novel coronavirus in the United States"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Lung CT image of a confirmed case of the 2019 novel coronavirus (2019-nCoV) infected pneumonia (With differential diagnosis of the SARS)"},{"title3":"Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia"},{"title3":"Role of neutrophil to lymphocyte and monocyte to lymphocyte ratios in the diagnosis of bacterial infection in patients with fever"},{"title3":"Coronavirus infections-more than just the common cold"},{"title3":"The association between the neutrophil-to-lymphocyte ratio and mortality in critical illness: an observational cohort study"},{"title3":"A new coronavirus associated with human respiratory disease in China"},{"title3":"Monocyte/lymphocyte ratio as a better predictor of cardiovascular and all-cause mortality in hemodialysis patients: a prospective cohort study"},{"title3":"Ratio of neutrophil to lymphocyte counts-rapid and simple parameter of systemic inflammation and stress in critically ill"},{"title3":"Neutrophil-lymphocyte ratio as an early new marker in AIV-H7N9-infected patients: a retrospective study"}]},{"title2":"Clinical characteristics of 138 hospitalized patients With 2019 novel coronavirus-infected pneumonia in Wuhan, China","References":[]},{"title2":"Clinical characteristics of coronavirus disease 2019 in China","References":[{"title3":"Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia."},{"title3":"Challenges in laboratory diagnosis of the novel coronavirus SARS-CoV-2."},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China."},{"title3":"First case of 2019 novel Coronavirus in the United States."},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study."},{"title3":"A novel coronavirus associated with severe acute respiratory syndrome."},{"title3":"A preventive and control strategy for COVID-19 infection: an experience from a Third-Tier Chinese City."},{"title3":"An emerging coronavirus causing pneumonia outbreak in Wuhan, China: calling for developing therapeutic and prophylactic strategies."},{"title3":"Measures for diagnosing and treating infections by a novel coronavirus responsible for a pneumonia outbreak originating in Wuhan, China."},{"title3":"Perspectives on therapeutic neutralizing antibodies against the Novel Coronavirus SARS-CoV-2."},{"title3":"COVID-19, an emerging coronavirus infection: advances and prospects in designing and developing vaccines, immunotherapeutics, and therapeutics."},{"title3":"Transplantation of ACE2(-) mesenchymal stem cells improves the outcome of patients with COVID-19 pneumonia."},{"title3":"On the use of corticosteroids for 2019-nCoV pneumonia."},{"title3":"Comprehensive analysis of drugs to treat SARSCoV2 infection: mechanistic insights into current COVID19 therapies (Review)."},{"title3":"The role of telemedicine during the COVID-19 epidemic in China-experience from Shandong province."},{"title3":"Human umbilical cord-derived mesenchymal stem cell therapy in patients with COVID-19: a phase 1 clinical trial."},{"title3":"Intravenous infusion of human umbilical cord Wharton's jelly-derived mesenchymal stem cells as a potential treatment for patients with COVID-19 pneumonia."},{"title3":"Flattening the COVID-19 curve with natural killer cell based immunotherapies."},{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster."},{"title3":"Full-genome evolutionary analysis of the novel corona virus (2019-nCoV) rejects the hypothesis of emergence as a result of a recent recombination event."},{"title3":"Epidemiologic and clinical characteristics of novel coronavirus infections involving 13 patients outside Wuhan, China."},{"title3":"Spatio-temporal metabolokinetics and efficacy of human placenta-derived mesenchymal stem/stromal cells on mice with refractory Crohn's-like enterocutaneous fistula."},{"title3":"High-efficient generation of VCAM-1(+) mesenchymal stem cells with multidimensional superiorities in signatures and efficacy on aplastic anaemia mice."},{"title3":"Systematic comparison of hUC-MSCs at various passages reveals the variations of signatures and therapeutic effect on acute graft-versus-host disease."},{"title3":"JNKi- and DAC-programmed mesenchymal stem/stromal cells from hESCs facilitate hematopoiesis and alleviate hind limb ischemia."},{"title3":"Identification of a novel coronavirus in patients with severe acute respiratory syndrome."},{"title3":"Studies on viral pneumonia related to novel coronavirus SARS-CoV-2, SARS-CoV, and MERS-CoV: a literature review."},{"title3":"Three emerging coronaviruses in two decades."},{"title3":"The epidemic of 2019-novel-coronavirus (2019-nCoV) pneumonia and insights for emerging infectious diseases in the future."},{"title3":"Coronaviruses - drug discovery and therapeutic options."},{"title3":"The pathogenicity of SARS-CoV-2 in hACE2 transgenic mice."},{"title3":"Acute respiratory distress syndrome: the Berlin Definition."},{"title3":"Pediatric acute respiratory distress syndrome: definition, incidence, and epidemiology: proceedings from the Pediatric Acute Lung Injury Consensus Conference."},{"title3":"Eicosanoid storm in infection and inflammation."},{"title3":"Decoding the enigma of antiviral crisis: does one target molecule regulate all?"}]},{"title2":"Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study","References":[{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study"},{"title3":"A novel coronavirus from patients with pneumonia in China, 2019"},{"title3":"First case of 2019 novel coronavirus in the United States"},{"title3":"Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China"},{"title3":"Clinical management of severe acute respiratory infection when novel coronavirus (nCoV) infection is suspected"},{"title3":"Critically ill patients with 2009 influenza A(H1N1) in Mexico"},{"title3":"Critically ill patients with severe acute respiratory syndrome"},{"title3":"Critically ill patients with 2009 influenza A(H1N1) infection in Canada"},{"title3":"KDIGO clinical practice guideline for acute kidney injury"},{"title3":"Wuhan: Britons to be evacuated as scientists estimate 44 000 cases of 2019-nCOV in the city"},{"title3":"Acute respiratory distress syndrome in critically ill patients with severe acute respiratory syndrome"},{"title3":"Short-term outcome of critically ill patients with severe acute respiratory syndrome"},{"title3":"Clinical course and outcomes of critically ill patients with Middle East respiratory syndrome coronavirus infection"},{"title3":"SARS and MERS: recent insights into emerging coronaviruses"},{"title3":"Epidemiology, patterns of care, and mortality for patients with acute respiratory distress syndrome in intensive care units in 50 countries"},{"title3":"China built a hospital in 10 days to battle coronavirus"},{"title3":"Transmission of 2019-nCoV infection from an asymptomatic contact in Germany"},{"title3":"Asymptomatic cases complicate efforts"},{"title3":"Multiple organ infection and the pathogenesis of SARS"},{"title3":"Middle East respiratory syndrome coronavirus efficiently infects human primary T lymphocytes and activates the extrinsic and intrinsic apoptosis pathways"},{"title3":"T-cell immunity of SARS-CoV: implications for vaccine development against MERS-CoV"},{"title3":"Practice of diagnosis and management of acute respiratory distress syndrome in mainland China: a cross-sectional study"},{"title3":"Clinical evidence does not support corticosteroid treatment for 2019-nCoV lung injury"}]},{"title2":"Acute respiratory distress syndrome: the Berlin definition","References":[]},{"title2":"The third international consensus definitions for sepsis and septic shock (sepsis-3)","References":[{"title3":"The role of glucocorticoids as adjunctive treatment for sepsis in the modern era"},{"title3":"Corticosteroids for treating sepsis"},{"title3":"Corticosteroids for severe sepsis and septic shock: a systematic review and meta-analysis"},{"title3":"Association of corticosteroid treatment with outcomes in adult patients with sepsis: a systematic review and meta-analysis"},{"title3":"Reevaluating the role of corticosteroids in septic shock: an updated meta-analysis of randomized controlled trials"},{"title3":"Can corticosteroids reduce the mortality of patients with severe sepsis? A systematic review and meta-analysis"},{"title3":"Corticosteroid treatment for sepsis: a critical appraisal and meta-analysis of the literature"},{"title3":"Corticosteroids in sepsis: an updated systematic review and meta-analysis"},{"title3":"Effect of adjunctive corticosteroids on clinical outcomes in adult patients with septic shock-a meta-analysis of randomized controlled trials and trial sequential analysis"},{"title3":"Low-dose corticosteroids for adult patients with septic shock: a systematic review with meta-analysis and trial sequential analysis"},{"title3":"Adjunctive glucocorticoid therapy in patients with septic shock"},{"title3":"Hydrocortisone plus fludrocortisone for adults with septic shock"},{"title3":"2001 sccm/esicm/accp/ats/sis international sepsis definitions conference"},{"title3":"Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis"},{"title3":"Sepsis definitions: time for change"},{"title3":"The third international consensus definitions for sepsis and septic shock (Sepsis-3)"},{"title3":"Use of the SOFA score to assess the incidence of organ dysfunction/failure in intensive care units: results of a multicenter, prospective study"},{"title3":"Hydrocortisone Compared with Placebo in Patients with Septic Shock Satisfying the Sepsis-3 Diagnostic Criteria and APROCCHSS Study Inclusion CriteriaA Post Hoc Analysis of the ADRENAL Trial"},{"title3":"The reporting of studies conducted using observational routinely collected health data statement for pharmacoepidemiology (RECORD-PE)"},{"title3":"Using big data to emulate a target trial when a randomized trial is not available"},{"title3":"The eICU Collaborative Research Database, a freely available multi-center database for critical care research"},{"title3":"Identifying patients with severe sepsis using administrative claims: patient-level validation of the angus implementation of the international consensus conference definition of severe sepsis"},{"title3":"FDA-Approved Drugs: SOLU-MEDROL U.S. FOOD &amp; DRUG Web site. Accessed 18 April 2020 https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=BasicSearch.process"},{"title3":"FDA-Approved Drugs: SOLU-CORTEF U.S. FOOD &amp; DRUG Web site. Accessed 18 April 2020 https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&amp;ApplNo=009866"},{"title3":"Early initiation of low-dose hydrocortisone treatment for septic shock in adults: a randomized clinical trial"},{"title3":"Reversal of late septic shock with supraphysiologic doses of hydrocortisone"},{"title3":"Immortal time bias in pharmacoepidemiology"},{"title3":"Low-dose hydrocortisone in patients with cirrhosis and septic shock: a randomized controlled trial"},{"title3":"Value of glucocorticoid steroids in the treatment of patients with severe community-acquired pneumonia complicated with septic shock"},{"title3":"Hydrocortisone therapy for patients with septic shock"},{"title3":"National analysis of sepsis hospitalizations and factors contributing to sepsis in-hospital mortality in Canada"},{"title3":"Glucose variability and mortality in patients with sepsis"},{"title3":"Prognostic factors of mortality in patients with community-acquired bloodstream infection with severe sepsis and septic shock"},{"title3":"The effect of comorbidity and age on hospital mortality and length of stay in patients with sepsis"},{"title3":"Adjusted survival curves with inverse probability weights"},{"title3":"Balance diagnostics for comparing the distribution of baseline covariates between treatment groups in propensity-score matched samples"},{"title3":"Moving towards best practice when using inverse probability of treatment weighting (IPTW) using the propensity score to estimate causal treatment effects in observational studies"},{"title3":"Variance estimation when using inverse probability of treatment weighting (IPTW) with survival analysis"},{"title3":"The interaction of vasopressin and corticosteroids in septic shock: a pilot randomized controlled trial"},{"title3":"Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock"},{"title3":"Effect of hydrocortisone on development of shock among patients with severe sepsis: the HYPRESS randomized clinical trial"},{"title3":"Effect of early vasopressin vs norepinephrine on kidney failure in patients with septic shock: the VANISH randomized clinical trial"},{"title3":"Dexamethasone and length of hospital stay in patients with community-acquired pneumonia: a randomised, double-blind, placebo-controlled trial"},{"title3":"The effects of high-dose corticosteroids in patients with septic shock: a prospective, controlled study"},{"title3":"Ineffectiveness of high-dose methylprednisolone in preventing parenchymal lung injury and improving mortality in patients with septic shock"},{"title3":"Corticosteroids for treating sepsis in children and adults"},{"title3":"Steroids in the treatment of clinical septic shock"},{"title3":"Sepsis, severe sepsis and septic shock: changes in incidence, pathogens and outcomes"},{"title3":"Effect of corticosteroids on treatment failure among hospitalized patients with severe community-acquired pneumonia and high inflammatory response: a randomized clinical trial"},{"title3":"Reduced cortisol metabolism during critical illness"},{"title3":"Cortisol levels and mortality in severe sepsis"},{"title3":"Why Test for Proportional Hazards?"},{"title3":"Surviving sepsis campaign: international guidelines for management of sepsis and septic shock: 2016"},{"title3":"Problem of immortal time bias in cohort studies: example using statins for preventing progression of diabetes"}]},{"title2":"Diagnosis, evaluation, and management of acute kidney injury: a KDIGO summary (part 1)","References":[{"title3":"KDIGO clinical practice guideline for acute kidney injury"},{"title3":"Kidney Disease: Improving Global Outcomes"},{"title3":"KDIGO Clinical Practice Guidelines: Online Appendix F"},{"title3":"Grading evidence and recommendations for clinical practice guidelines in nephrology. A position statement from Kidney Disease: Improving Global Outcomes (KDIGO)"},{"title3":"Grading quality of evidence and strength of recommendations"},{"title3":"RIFLE criteria for acute kidney injury are associated with hospital mortality in critically ill patients: a cohort analysis"},{"title3":"An assessment of the RIFLE criteria for acute renal failure in hospitalized patients"},{"title3":"Acute renal failure - definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group"},{"title3":"A multi-centre evaluation of the RIFLE criteria for early acute kidney injury in critically ill patients"},{"title3":"Classification of acute kidney injury using RIFLE: what's the purpose?"},{"title3":"The RIFLE criteria and mortality in acute kidney injury: a systematic review"},{"title3":"Incidence and outcomes of acute kidney injury in intensive care units: a Veterans Administration study"},{"title3":"Acute kidney injury in critically ill patients classified by AKIN versus RIFLE using the SAPS 3 database"},{"title3":"Acute kidney injury in the intensive care unit according to RIFLE"},{"title3":"Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury"},{"title3":"Modified RIFLE criteria in critically ill children with acute kidney injury"},{"title3":"Acute renal failure in the critically ill: impact on morbidity and mortality"},{"title3":"Hospital versus community-acquired acute kidney injury in the critically ill: differences in epidemiology [abstract]"},{"title3":"Risk of poor outcomes with novel and traditional biomarkers at clinical AKI diagnosis"},{"title3":"Incidence and outcomes in acute kidney injury: a comprehensive population-based study"},{"title3":"Fluid accumulation, survival and recovery of kidney function in critically ill patients with acute kidney injury"},{"title3":"A positive fluid balance is associated with a worse outcome in patients with acute renal failure"},{"title3":"Continuous renal replacement therapy: recent advances and future research"},{"title3":"A comparison of albumin and saline for fluid resuscitation in the intensive care unit"},{"title3":"Colloids versus crystalloids for fluid resuscitation in critically ill patients"},{"title3":"Hyperoncotic colloids and acute kidney injury: a meta-analysis of randomized trials"},{"title3":"Fluid administration and the kidney"},{"title3":"Fluids, pH, ions and electrolytes"},{"title3":"Comparison of dopamine and norepinephrine in the treatment of shock"},{"title3":"Clinical review: Vasopressin and terlipressin in septic shock patients"},{"title3":"Vasopressin versus norepinephrine infusion in patients with septic shock"},{"title3":"The effects of vasopressin on acute kidney injury in septic shock"},{"title3":"Does perioperative hemodynamic optimization protect renal function in surgical patients? A meta-analytic study"},{"title3":"Benefits and risks of tight glucose control in critically ill adults: a meta-analysis"},{"title3":"Intensive insulin therapy and mortality among critically ill patients: a meta-analysis including NICE-SUGAR study data"},{"title3":"Intensive versus conventional glucose control in critically ill patients"},{"title3":"Amino acid requirements in critically ill patients with acute kidney injury treated with continuous renal replacement therapy"},{"title3":"ESPEN guidelines on enteral nutrition: adult renal failure"},{"title3":"Nutritional management of acute renal failure"},{"title3":"Clinical guidelines and nutrition therapy: better understanding and greater application to patient care"},{"title3":"Guidelines for the provision and assessment of nutrition support therapy in the adult critically ill patient: Society of Critical Care Medicine (SCCM) and American Society for Parenteral and Enteral Nutrition (A.S.P.E.N.)"},{"title3":"Metabolic aspects of continuous renal replacement therapies"},{"title3":"Protein catabolic rate in patients with acute renal failure on continuous arteriovenous hemofiltration and total parenteral nutrition"},{"title3":"Catabolism in critical illness: estimation from urea nitrogen appearance and creatinine production during continuous renal replacement therapy"},{"title3":"Urea kinetics during sustained low-efficiency dialysis in critically ill patients requiring renal replacement therapy"},{"title3":"Effect of acute renal failure requiring renal replacement therapy on outcome in critically ill patients"},{"title3":"Prospective randomized trial to assess caloric and protein needs of critically Ill, anuric, ventilated patients requiring continuous renal replacement therapy"},{"title3":"Normal nutritional requirements"},{"title3":"Protein and calorie prescription for children and young adults receiving continuous renal replacement therapy: a report from the Prospective Pediatric Continuous Renal Replacement Therapy Registry Group"},{"title3":"High-dose furosemide for established ARF: a prospective, randomized, double-blind, placebo-controlled, multicenter trial"},{"title3":"Lack of renoprotective effects of dopamine and furosemide during cardiac surgery"},{"title3":"Renal function after cardiac surgery: adverse effect of furosemide"},{"title3":"Effects of saline, mannitol, and furosemide to prevent acute decreases in renal function induced by radiocontrast agents"},{"title3":"Diuretics in acute kidney injury"},{"title3":"Furosemide (frusemide). A pharmacokinetic/pharmacodynamic review (Part II)"},{"title3":"Furosemide (frusemide). A pharmacokinetic/pharmacodynamic review (Part I)"},{"title3":"Diuretics, mortality, and nonrecovery of renal function in acute renal failure"},{"title3":"Diuretics and mortality in acute renal failure"},{"title3":"Meta-analysis of frusemide to prevent or treat acute renal failure"},{"title3":"Benefits and risks of furosemide in acute kidney injury"},{"title3":"Furosemide does not improve renal recovery after hemofiltration for acute renal failure in critically ill patients: a double blind randomized controlled trial"},{"title3":"Discontinuation of continuous renal replacement therapy: a post hoc analysis of a prospective multicenter observational study"},{"title3":"Should we use diuretics in acute renal failure?"},{"title3":"The effect of mannitol on renal function following cardio-pulmonary bypass in patients with normal pre-operative creatinine"},{"title3":"The effect of mannitol on renal function after cardiopulmonary bypass in patients with established renal dysfunction"},{"title3":"Perioperative fluid management in renal transplantation: a narrative review of the literature"},{"title3":"Mannitol as an indispensable constituent of an intraoperative hydration protocol for the prevention of acute renal failure after renal cadaveric transplantation"},{"title3":"A controlled study on the effect of mannitol on immediate renal function after cadaver donor kidney transplantation"},{"title3":"Mannitol therapy revisited (1940-1997)"},{"title3":"Management of crush-related injuries after disasters"},{"title3":"Rhabdomyolysis"},{"title3":"Recommendation for the management of crush victims in mass disasters"},{"title3":"Meta-analysis: low-dose dopamine increases urine output but does not prevent renal dysfunction or death"},{"title3":"Use of dopamine in acute renal failure: a meta-analysis"},{"title3":"Low-dose dopamine: asystematic review"},{"title3":"Use of dopaminergic agents for renoprotection in the ICU"},{"title3":"Fenoldopam: renal-dose dopamine redux?"},{"title3":"Fenoldopam reduces the need for renal replacement therapy and in-hospital death in cardiovascular surgery: a meta-analysis"},{"title3":"Prophylactic fenoldopam for renal protection in sepsis: a randomized, double-blind, placebo-controlled pilot trial"},{"title3":"Fenoldopam mesylate in early acute tubular necrosis: a randomized, double-blind, placebo-controlled clinical trial"},{"title3":"A comparison between fenoldopam and low-dose dopamine in early renal dysfunction of critically ill patients"},{"title3":"Atrial natriuretic peptide for management of acute kidney injury: a systematic review and meta-analysis"},{"title3":"Anaritide in acute tubular necrosis. Auriculin Anaritide Acute Renal Failure Study Group"},{"title3":"Atrial natriuretic factor in oliguric acute renal failure. Anaritide Acute Renal Failure Study Group"},{"title3":"Short-term risk of death after treatment with nesiritide for decompensated heart failure: a pooled analysis of randomized controlled trials"},{"title3":"Risk of worsening renal function with nesiritide in patients with acutely decompensated heart failure"},{"title3":"Nesiritide - not verified"},{"title3":"Predictors of mortality in adult patients with congestive heart failure receiving nesiritide - retrospective analysis showing a potential adverse interaction between nesiritide and acute renal dysfunction"},{"title3":"Prophylactic nesiritide does not prevent dialysis or all-cause mortality in patients undergoing high-risk cardiac surgery"},{"title3":"Long-term outcome of patients treated with prophylactic nesiritide for the prevention of acute kidney injury following cardiovascular surgery"},{"title3":"Nonoliguric and oliguric acute renal failure in asphyxiated term neonates"},{"title3":"Theophylline prevents the hypoxemia-induced renal hemodynamic changes in rabbits"},{"title3":"Prophylactic theophylline to prevent renal dysfunction in newborns exposed to perinatal asphyxia - a study in a developing country"},{"title3":"Theophylline for renal function in term neonates with perinatal asphyxia: a randomized, placebo-controlled trial"},{"title3":"A randomized, double-blind, placebo-controlled trial of the effects of prophylactic theophylline on renal function in term neonates with perinatal asphyxia"},{"title3":"A randomised, double blind, placebo controlled trial of the effect of theophylline in prevention of vasomotor nephropathy in very preterm neonates with respiratory distress syndrome"},{"title3":"Rolofylline, an adenosine A1-receptor antagonist, in acute heart failure"},{"title3":"Insulin-like growth factor I preserves renal function postoperatively"},{"title3":"Multicenter clinical trial of recombinant human insulin-like growth factor I in patients with acute renal failure"},{"title3":"A randomized, placebo-controlled trial of IGF-1 for delayed graft function: a human model to study postischemic ARF"},{"title3":"Inappropriate prescribing of aminoglycosides: risk factors and impact of an antibiotic control team"},{"title3":"Ciprofloxacin vs an aminoglycoside in combination with a beta-lactam for the treatment of febrile neutropenia: a meta-analysis of randomized controlled trials"},{"title3":"Initial low-dose gentamicin for Staphylococcus aureus bacteremia and endocarditis is nephrotoxic"},{"title3":"The role of aminoglycosides in combination with a beta-lactam for the treatment of bacterial endocarditis: a meta-analysis of comparative trials"},{"title3":"Meta-analysis: randomized controlled trials of clindamycin/aminoglycoside vs. beta-lactam monotherapy for the treatment of intra-abdominal infections"},{"title3":"An evidence-based evaluation of important aspects of empirical antibiotic therapy in febrile neutropenic patients"},{"title3":"Beta lactam monotherapy versus beta lactam-aminoglycoside combination therapy for sepsis in immunocompetent patients: systematic review and meta-analysis of randomised trials"},{"title3":"Beta lactam antibiotic monotherapy versus beta lactam-aminoglycoside antibiotic combination therapy for sepsis"},{"title3":"Aminoglycoside-associated nephrotoxicity in the elderly"},{"title3":"Once daily aminoglycoside therapy. Is it less toxic than multiple daily doses and how should it be monitored?"},{"title3":"Extended-interval aminoglycoside dosing for treatment of enterococcal and staphylococcal osteomyelitis"},{"title3":"An evaluation of amikacin nephrotoxicity in the hematology/oncology population"},{"title3":"Efficacy and tolerability of extended-interval aminoglycoside administration in pediatric patients"},{"title3":"Aminoglycoside extended interval dosing in neonates is safe and effective: a meta-analysis"},{"title3":"Aminoglycoside toxicity: daily versus thrice-weekly dosing for treatment of mycobacterial diseases"},{"title3":"Comparison of tobramycin nephrotoxicity in young adult and aged female rats"},{"title3":"Aminoglycoside nephrotoxicity: modeling, simulation, and control"},{"title3":"Aminoglycoside dosages and nephrotoxicity: quantitative relationships"},{"title3":"Prospective evaluation of the effect of an aminoglycoside dosing regimen on rates of observed nephrotoxicity and ototoxicity"},{"title3":"Once-daily versus multiple-daily dosing with intravenous aminoglycosides for cystic fibrosis"},{"title3":"A meta-analysis of the relative efficacy and toxicity of single daily dosing versus multiple daily dosing of aminoglycosides"},{"title3":"A meta-analysis of extended-interval dosing versus multiple daily dosing of aminoglycosides"},{"title3":"Single or multiple daily doses of aminoglycosides: a meta-analysis"},{"title3":"Effectiveness and safety of once-daily aminoglycosides: a meta-analysis"},{"title3":"Once-daily a minoglycoside dosing in immunocompetent adults: a meta-analysis"},{"title3":"A meta-analysis of studies on the safety and efficacy of aminoglycosides given either once daily or as divided doses"},{"title3":"Acute renal failure associated with inhaled tobramycin"},{"title3":"Acute renal failure associated with use of inhaled tobramycin for treatment of chronic airway colonization with Pseudomonas aeruginosa"},{"title3":"Study of renal safety in amphotericin B lipid complex-treated patients"},{"title3":"Liposomal amphotericin B as initial therapy for invasive mold infection: a randomized trial comparing a high-loading dose regimen with standard dosing (AmBiLoad trial)"},{"title3":"Use of high-dose liposomal amphotericin B: efficacy and tolerance"},{"title3":"Adverse effects of antifungal therapies in invasive fungal infections: review and meta-analysis"},{"title3":"Amphotericin B lipid complex versus liposomal amphotericin B monotherapy for invasive aspergillosis in patients with hematologic malignancy"},{"title3":"Amphotericin B lipid soluble formulations vs. amphotericin B in cancer patients with neutropenia"},{"title3":"Safety and efficacy of liposomal amphotericin B compared with conventional amphotericin B for induction therapy of histoplasmosis in patients with AIDS"},{"title3":"What is the current and future status of conventional amphotericin B?"},{"title3":"Comparative efficacies, toxicities, and tissue concentrations of amphotericin B lipid formulations in a murine pulmonary aspergillosis model"},{"title3":"Renal impairment and amphotericin B formulations in patients with invasive fungal infections"},{"title3":"Prospective study of amphotericin B formulations in immunocompromised patients in 4 European countries"},{"title3":"Lipid-based formulations of amphotericin B"},{"title3":"Liposomal amphotericin B for empirical therapy in patients with persistent fever and neutropenia. National Institute of Allergy and Infectious Diseases Mycoses Study Group"},{"title3":"Intravenous and oral itraconazole versus intravenous amphotericin B deoxycholate as empirical antifungal therapy for persistent fever in neutropenic patients with cancer who are receiving broad-spectrum antibacterial therapy. A randomized, controlled trial"},{"title3":"Amphotericin B versus fluconazole for controlling fungal infections in neutropenic cancer patients"},{"title3":"Intravenous itraconazole vs. amphotericin B deoxycholate for empirical antifungal therapy in patients with persistent neutropenic fever"},{"title3":"Novel antifungal agents as salvage therapy for invasive aspergillosis in patients with hematologic malignancies: posaconazole compared with high-dose lipid formulations of amphotericin B alone or in combination with caspofungin"},{"title3":"Caspofungin is less nephrotoxic than amphotericin B in vitro and predominantly damages distal renal tubular cells"},{"title3":"Off-pump coronary artery bypass surgery and acute kidney injury: a meta-analysis of randomized controlled trials"},{"title3":"Meta-analysis of N-acetylcysteine to prevent acute renal failure after major surgery"},{"title3":"N-acetylcysteine for patients with prolonged hypotension as prophylaxis for acute renal failure (NEPHRON)"}]},{"title2":"Cardiac complications associated with the influenza viruses A subtype H7N9 or pandemic H1N1 in critically ill patients under intensive care","References":[{"title3":"Influenza and the live poultry trade"},{"title3":"Clinical findings in 111 cases of influenza A (H7N9) virus infection"},{"title3":"Cardiovascular manifestations associated with influenza virus infection"},{"title3":"The cardiovascular manifestations of influenza: a systematic review"},{"title3":"Influenza A1 myocarditis in conscripts"},{"title3":"Observations on the A2 England influenza epidemic: a clinic pathological study"},{"title3":"The prevalence of myocarditis and skeletal muscle injury during acute viral infection in adults: measurement of cardiac troponins I and T in 152 patients with acute influenza infection"},{"title3":"Constrictive pericarditis accompanied by swine-origin influenza A (H1N1) infection"},{"title3":"Fulminant myocarditis associated with pandemic H1N1 influenza A virus"},{"title3":"Fulminant myopericarditis in an immunocompetent adult due to pandemic 2009 (H1N1) influenza A virus infection"},{"title3":"Acute fulminant myocarditis and the 2009 pandemic influenza A virus (H1N1)"},{"title3":"Diagnosis of ventilator-associated pneumonia by bacteriologic analysis of bronchoscopic and nonbronchoscopic &quot;blind&quot; bronchoalveolar lavage fluid"},{"title3":"SMART-COP: a tool for predicting the need for intensive respiratory or vasopressor support in community-acquired pneumonia"},{"title3":"APACHE II: a severity of disease classification system"},{"title3":"Use of the SOFA score to assess the incidence of organ dysfunction/failure in intensive care unit: results of a multicenter, prospective study. Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine"},{"title3":"Raised cardiac troponins"},{"title3":"Biomarkers and heart disease"},{"title3":"Right and left heart failure in severe H1N1 influenza A infection"},{"title3":"The pulmonary vascular lesions of the adult respiratory distress syndrome"},{"title3":"Positive end-expiratory setting in adults with acute lung injury and acute respiratory distress syndrome: a randomized controlled trial"},{"title3":"Epidemiological, clinical and viral characteristics of fatal cases of human avian influenza A (H7N9) virus in Zhejiang Province, China"},{"title3":"A detailed epidemiological and clinical description of 6 human cases of avian-origin influenza A (H7N9) virus infection in Shanghai"},{"title3":"Cardiac manifestations in patients with pandemic (H1N1) 2009 virus infection needing intensive care"},{"title3":"Clinical findings and demographicfactors associated with ICU admission in Utah due to novel 2009 influenza A (H1N1) infection"},{"title3":"Echocardiographic manifestations of pandemic 2009 (H1N1) influenza a virus infection"},{"title3":"Cardiac tamponade and heart failure due to myopericarditis as a presentation of infection with the pandemic H1N1 2009 influenza A virus"},{"title3":"Characterization of cardiac dysfunction in sepsis: an ongoing challenge"},{"title3":"Clinical spectrum, frequency, and significance of myocardial dysfunction in severe sepsis and septic shock"},{"title3":"Clinical manifestations of influenza A myocarditis during the influenza epidemic of winter 1998-1999"},{"title3":"Influenza, autoimmunity and atherogenesis"}]},{"title2":"The prevalence and findings of subclinical influenza-associated cardiac abnormalities among Japanese patients","References":[{"title3":"Viral myocarditis"},{"title3":"Viral myocarditis: potential defense mechanisms within the cardiomyocyte against virus infection"},{"title3":"Viral myocarditis--diagnosis, treatment options, and current controversies"},{"title3":"The hidden burden of influenza: a review of the extra-pulmonary complications of influenza infection"},{"title3":"Unusual association of ST-T abnormalities, myocarditis and cardiomyopathy with H1N1 influenza in pregnancy: two case reports and review of the literature"},{"title3":"Influenza myocarditis and myositis: case presentation and review of the literature"},{"title3":"Influenza A positive but H1N1 negative myocarditis in a patient coming from a high outbreak region of new influenza"},{"title3":"Fulminant myocarditis associated with pandemic H1N1 influenza A virus"},{"title3":"Surveillance for influenza admissions among children hospitalized in Canadian immunization monitoring program active centers, 2003-2004"},{"title3":"Clinical and epidemiologic characteristics of hospitalized patients with 2009 H1N1 influenza infection"},{"title3":"Comparison of the clinical presentation, treatment, and outcome of fulminant and acute myocarditis in children"},{"title3":"A national survey on myocarditis associated with the 2009 influenza A (H1N1) pandemic in Japan"},{"title3":"A case of influenza associated fulminant myocarditis successfully treated with intravenous peramivir"},{"title3":"Repetitive fulminant influenza myocarditis requiring the use of circulatory assist devices"},{"title3":"Influenza as a trigger for acute myocardial infarction or death from cardiovascular disease: a systematic review"},{"title3":"Cardiac findings during uncomplicated acute influenza in ambulatory adults"},{"title3":"Observations on the A2 England influenza epidemic: a clinicopathological study"},{"title3":"Influenza A1 myocarditis in conscripts"},{"title3":"Elevated serum myosin light chain I in influenza patients"},{"title3":"The prevalence of myocarditis and skeletal muscle injury during acute viral infection in adults: measurement of cardiac troponins I and T in 152 patients with acute influenza infection"},{"title3":"Echocardiographic manifestations of pandemic 2009 (H1N1) influenza a virus infection"},{"title3":"Cardiovascular manifestations associated with influenza virus infection"},{"title3":"Electrocardiographic studies in Asian influenza"},{"title3":"Etiology of mild acute infectious myocarditis. Relation to clinical features"},{"title3":"Influenza H1N1 infection leading to cardiac tamponade in a previously healthy patient: a case report"},{"title3":"Clinical manifestations of influenza a myocarditis during the influenza epidemic of winter 1998-1999"},{"title3":"Clinical clues to the causes of large pericardial effusions"},{"title3":"Pericardial effusion complicating swine origin influenzae A (H1N1) infection in a 50-year-old woman"},{"title3":"Myopericarditis and exertional rhabdomyolysis following an influenza A (H3N2) infection"},{"title3":"Myocardial dysfunction in severe sepsis and septic shock: more questions than answers?"},{"title3":"A prospective study of the incidence of myocarditis/pericarditis and new onset cardiac symptoms following smallpox and influenza vaccination"},{"title3":"Clinical features of acute and fulminant myocarditis in children - 2nd Nationwide Survey by Japanese Society of Pediatric Cardiology and Cardiac Surgery"}]},{"title2":"Prospective evaluation of the risk of upper gastrointestinal bleeding after admission to a medical intensive care unit","References":[]},{"title2":"Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome","References":[]},{"title2":"Predictive factors for pneumonia development and progression to respiratory failure in MERS-CoV infected patients","References":[{"title3":"Middle East respiratory syndrome"},{"title3":"An unexpected outbreak of Middle East respiratory syndrome coronavirus infection in the Republic of Korea, 2015"},{"title3":"The characteristics of middle eastern respiratory syndrome coronavirus transmission dynamics in South Korea"},{"title3":"Preliminary epidemiological assessment of MERS-CoV outbreak in South Korea, May to June 2015"},{"title3":"Identifying determinants of heterogeneous transmission dynamics of the Middle East respiratory syndrome (MERS) outbreak in the Republic of Korea, 2015: a retrospective epidemiological analysis"},{"title3":"Transmission characteristics of MERS and SARS in the healthcare setting: a comparative study"},{"title3":"Control of an outbreak of Middle East respiratory syndrome in a tertiary hospital in Korea"},{"title3":"MERS-CoV outbreak following a single patient exposure in an emergency room in South Korea: an epidemiological outbreak study"},{"title3":"Real-time characterization of risks of death associated with the Middle East respiratory syndrome (MERS) in the Republic of Korea, 2015"},{"title3":"Viral shedding and antibody response in 37 patients with Middle East respiratory syndrome coronavirus infection"},{"title3":"Association of higher MERS-CoV virus load with severe disease and death, Saudi Arabia, 2014"},{"title3":"Mortality risk factors for Middle East respiratory syndrome outbreak, South Korea, 2015"},{"title3":"Clinical aspects and outcomes of 70 patients with Middle East respiratory syndrome coronavirus infection: a single-center experience in Saudi Arabia"},{"title3":"Risk factors for severity and mortality in patients with MERS-CoV: analysis of publicly available data from Saudi Arabia"},{"title3":"Case definition and management of patients with MERS coronavirus in Saudi Arabia"},{"title3":"2014 MERS-CoV outbreak in Jeddah - a link to health care facilities"},{"title3":"On estimating the relation between blood group and disease"},{"title3":"Treatment outcomes for patients with Middle Eastern respiratory syndrome coronavirus (MERS CoV) infection at a coronavirus referral center in the Kingdom of Saudi Arabia"},{"title3":"Treatment strategies for Middle East respiratory syndrome coronavirus"},{"title3":"Treatment with lopinavir/ritonavir or interferon-beta1b improves outcome of MERS-CoV infection in a nonhuman primate model of common marmoset"},{"title3":"Comparative and kinetic analysis of viral shedding and immunological responses in MERS patients representing a broad spectrum of disease severity"},{"title3":"Clinical course and outcomes of critically ill patients with Middle East respiratory syndrome coronavirus infection"},{"title3":"Clinical features and viral diagnosis of two cases of infection with Middle East respiratory syndrome coronavirus: a report of nosocomial transmission"},{"title3":"Outcomes and prognostic factors in 267 patients with severe acute respiratory syndrome in Hong Kong"},{"title3":"White cell differential count and influenza A"},{"title3":"Thrombocytopenia in patients with severe acute respiratory syndrome (review)"},{"title3":"Platelet activation and aggregation promote lung inflammation and influenza virus pathogenesis"},{"title3":"Discovery of T cell infection and apoptosis by MERS Coronavirus"},{"title3":"Middle East Respiratory syndrome coronavirus efficiently infects human primary T lymphocytes and activates both the extrinsic and intrinsic apoptosis pathways"},{"title3":"Epidemiological, demographic, and clinical characteristics of 47 cases of Middle East respiratory syndrome coronavirus disease from Saudi Arabia: a descriptive study"},{"title3":"Middle East respiratory syndrome coronavirus: another zoonotic betacoronavirus causing SARS-like disease"}]},{"title2":"SARS: understanding the coronavirus: apoptosis may explain lymphopenia of SARS","References":[]},{"title2":"Clinical features predicting mortality risk in patients with viral pneumonia: the MuLBSTA score","References":[]},{"title2":"Surviving sepsis campaign: guidelines on the management of critically ill adults with coronavirus disease 2019 (COVID-19)","References":[{"title3":"Clinical Characteristics of Coronavirus Disease 2019 in China."},{"title3":"Conflicts of interest disclosure forms and management in critical care clinical practice guidelines."},{"title3":"Understanding conflicts of interest."},{"title3":"GRADE guidelines: 2. Framing the question and deciding on important outcomes."},{"title3":"Addressing dichotomous data for participants excluded from trial analysis: a guide for systematic reviewers."},{"title3":"GRADE: an emerging consensus on rating quality of evidence and strength of recommendations."},{"title3":"GRADE guidelines: 3. Rating the quality of evidence."},{"title3":"GRADE guidelines: 14. Going from evidence to recommendations: the significance and presentation of recommendations."},{"title3":"GRADE guidelines: 12. Preparing summary of findings tables-binary outcomes."},{"title3":"GRADE Evidence to Decision (EtD) frameworks for adoption, adaptation, and de novo development of trustworthy recommendations: GRADE-ADOLOPMENT."},{"title3":"Influenza virus aerosols in human exhaled breath: particle size, culturability, and effect of surgical masks."},{"title3":"Control measures for severe acute respiratory syndrome (SARS) in Taiwan."},{"title3":"Minimise nosocomial spread of 2019-nCoV when treating acute respiratory failure."},{"title3":"SARS: ventilatory and intensive care."},{"title3":"Particle removal efficiency of the portable HEPA air cleaner in a simulated hospital ward."},{"title3":"Effectiveness of N95 respirators versus surgical masks in protecting health care workers from acute respiratory infection: a systematic review and meta-analysis."},{"title3":"N95 Respirators vs Medical Masks for Preventing Influenza Among Health Care Personnel: A Randomized Clinical Trial."},{"title3":"Surgical mask vs N95 respirator for preventing influenza among health care workers: a randomized trial."},{"title3":"A cluster randomized clinical trial comparing fit-tested and non-fit-tested N95 respirators to medical masks to prevent respiratory virus infection in health care workers."},{"title3":"Efficacy of face masks and respirators in preventing upper respiratory tract bacterial colonization and co-infection in hospital healthcare workers."},{"title3":"A randomized clinical trial of three options for N95 respirators and medical masks in health workers."},{"title3":"Effectiveness of N95 respirators versus surgical masks against influenza: A systematic review and meta-analysis."},{"title3":"Reporting, Epidemic Growth, and Reproduction Numbers for the 2019 Novel Coronavirus (2019-nCoV) Epidemic."},{"title3":"Estimates of the reproduction number for seasonal, pandemic, and zoonotic influenza: a systematic review of the literature."},{"title3":"Aerosol generating procedures and risk of transmission of acute respiratory infections to healthcare workers: a systematic review."},{"title3":"Videolaryngoscopy versus direct laryngoscopy for adult patients requiring tracheal intubation: a Cochrane Systematic Review."},{"title3":"Videolaryngoscopy versus direct laryngoscopy for adult patients requiring tracheal intubation."},{"title3":"Should the Glidescope video laryngoscope be used first line for all oral intubations or only in those with a difficult airway? A review of current literature."},{"title3":"Incubation Period and Other Epidemiological Characteristics of 2019 Novel Coronavirus Infections with Right Truncation: A Statistical Analysis of Publicly Available Case Data."},{"title3":"Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR."},{"title3":"Molecular Diagnosis of a Novel Coronavirus (2019-nCoV) Causing an Outbreak of Pneumonia."},{"title3":"Comparison of different samples for 2019 novel coronavirus detection by nucleic acid amplification tests."},{"title3":"Evaluation of reverse transcription-PCR assays for rapid diagnosis of severe acute respiratory syndrome associated with a novel coronavirus."},{"title3":"Co-infection with SARS-CoV-2 and Influenza A Virus in Patient with Pneumonia, China."},{"title3":"Laboratory diagnosis of SARS."},{"title3":"Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study."},{"title3":"Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China."},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China."},{"title3":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study."},{"title3":"Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China."},{"title3":"Incorporating Dynamic Assessment of Fluid Responsiveness Into Goal-Directed Therapy: A Systematic Review and Meta-Analysis."},{"title3":"Will This Hemodynamically Unstable Patient Respond to a Bolus of Intravenous Fluids?"},{"title3":"Relative efficacy and safety of early lactate clearance-guided therapy resuscitation in patients with sepsis: A meta-analysis."},{"title3":"Effect of a Resuscitation Strategy Targeting Peripheral Perfusion Status vs Serum Lactate Levels on 28-Day Mortality Among Patients With Septic Shock: The ANDROMEDA-SHOCK Randomized Clinical Trial."},{"title3":"Lower versus higher fluid volumes during initial management of sepsis: a systematic review with meta-analysis and trial sequential analysis."},{"title3":"Conservative fluid management or deresuscitation for patients with sepsis or acute respiratory distress syndrome following the resuscitation phase of critical illness: a systematic review and meta-analysis."},{"title3":"Mortality after fluid bolus in African children with severe infection."},{"title3":"Colloids versus crystalloids for fluid resuscitation in critically ill people."},{"title3":"Buffered solutions versus 0.9% saline for resuscitation in critically ill adults and children."},{"title3":"Scandinavian SSAI clinical practice guideline on choice of first-line vasopressor for patients with acute circulatory failure."},{"title3":"Vasopressors for hypotensive shock."},{"title3":"Canadian Critical Care Society clinical practice guideline: The use of vasopressin and vasopressin analogues in critically ill adults with distributive shock."},{"title3":"Association of Vasopressin Plus Catecholamine Vasopressors vs Catecholamines Alone With Atrial Fibrillation in Patients With Distributive Shock: A Systematic Review and Meta-analysis."},{"title3":"Pooled analysis of higher versus lower blood pressure targets for vasopressor therapy septic and vasodilatory shock."},{"title3":"Effect of Reduced Exposure to Vasopressors on 90-Day Mortality in Older Critically Ill Patients With Vasodilatory Hypotension: A Randomized Clinical Trial."},{"title3":"Scandinavian SSAI clinical practice guideline on choice of inotropic agent for patients with acute circulatory failure."},{"title3":"Low-dose corticosteroids for adult patients with septic shock: a systematic review with meta-analysis and trial sequential analysis."},{"title3":"Corticosteroid therapy for sepsis: a clinical practice guideline."},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study."},{"title3":"The Search for Optimal Oxygen Saturation Targets in Critically Ill Patients: Observational Data From Large ICU Databases."},{"title3":"Mortality and morbidity in acutely ill adults treated with liberal versus conservative oxygen therapy (IOTA): a systematic review and meta-analysis."},{"title3":"Oxygen therapy for acutely ill medical patients: a clinical practice guideline."},{"title3":"Conservative Oxygen Therapy during Mechanical Ventilation in the ICU."},{"title3":"Liberal or Conservative Oxygen Therapy for Acute Respiratory Distress Syndrome."},{"title3":"High-flow oxygen through nasal cannula in acute hypoxemic respiratory failure."},{"title3":"The effect of high-flow nasal cannula in reducing the mortality and the rate of endotracheal intubation when used before mechanical ventilation compared with conventional oxygen therapy and noninvasive positive pressure ventilation. A systematic review and meta-analysis."},{"title3":"Effect of high-flow nasal cannula oxygen therapy in adults with acute hypoxemic respiratory failure: a meta-analysis of randomized controlled trials."},{"title3":"High flow nasal cannula compared with conventional oxygen therapy for acute hypoxemic respiratory failure: a systematic review and meta-analysis."},{"title3":"Risk factors for SARS transmission from patients requiring intubation: a multicentre investigation in Toronto, Canada."},{"title3":"Transmission of severe acute respiratory syndrome during intubation and mechanical ventilation."},{"title3":"Comparison of high-flow nasal cannula versus oxygen face mask for environmental bacterial contamination in critically ill pneumonia patients: a randomized controlled crossover trial."},{"title3":"Staff safety during emergency airway management for COVID-19 in Hong Kong."},{"title3":"Noninvasive ventilation in critically ill patients with the Middle East respiratory syndrome."},{"title3":"Clinical course and outcomes of critically ill patients with Middle East respiratory syndrome coronavirus infection."},{"title3":"Noninvasive Oxygenation Strategies in Immunocompromised Patients With Acute Hypoxemic Respiratory Failure: A Pairwise and Network Meta-Analysis of Randomized Controlled Trials."},{"title3":"Noninvasive Ventilation in Acute Hypoxemic Nonhypercapnic Respiratory Failure: A Systematic Review and Meta-Analysis."},{"title3":"Noninvasive versus invasive mechanical ventilation for immunocompromised patients with acute respiratory failure: a systematic review and meta-analysis."},{"title3":"Noninvasive mechanical ventilation in high-risk pulmonary infections: a clinical review."},{"title3":"Noninvasive ventilation for patients with hypoxemic acute respiratory failure."},{"title3":"Ventilator-induced lung injury."},{"title3":"Severe Acute Respiratory Syndrome: Historical, Epidemiologic, and Clinical Features."},{"title3":"Noninvasive ventilation for acute exacerbations of chronic obstructive pulmonary disease."},{"title3":"Official ERS/ATS clinical practice guidelines: noninvasive ventilation for acute respiratory failure."},{"title3":"Effect of Noninvasive Ventilation Delivered by Helmet vs Face Mask on the Rate of Endotracheal Intubation in Patients With Acute Respiratory Distress Syndrome: A Randomized Clinical Trial."},{"title3":"Exhaled air dispersion during noninvasive ventilation via helmets and a total facemask."},{"title3":"Low Tidal Volume versus Non-Volume-Limited Strategies for Patients with Acute Respiratory Distress Syndrome. A Systematic Review and Meta-Analysis."},{"title3":"Effect of a protective-ventilation strategy on mortality in the acute respiratory distress syndrome."},{"title3":"A high positive end-expiratory pressure, low tidal volume ventilatory strategy improves outcome in persistent acute respiratory distress syndrome: a randomized, controlled trial."},{"title3":"Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome."},{"title3":"Prospective, randomized, controlled clinical trial comparing traditional versus reduced tidal volume ventilation in acute respiratory distress syndrome patients."},{"title3":"Pulmonary function and health-related quality of life in survivors of acute respiratory distress syndrome."},{"title3":"(The application of low tidal volume pressure-controlled ventilation in patients with acute respiratory distress syndrome)."},{"title3":"An Official American Thoracic Society/European Society of Intensive Care Medicine/Society of Critical Care Medicine Clinical Practice Guideline: Mechanical Ventilation in Adult Patients with Acute Respiratory Distress Syndrome."},{"title3":"Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock: 2016."},{"title3":"Patient-ventilator asynchrony during assisted mechanical ventilation."},{"title3":"Optimal plateau pressure for patients with acute respiratory distress syndrome: a protocol for a systematic review and meta-analysis with meta-regression."},{"title3":"Higher versus lower positive end-expiratory pressures in patients with the acute respiratory distress syndrome."},{"title3":"Ventilation strategy using low tidal volumes, recruitment maneuvers, and high positive end-expiratory pressure for acute lung injury and acute respiratory distress syndrome: a randomized controlled trial."},{"title3":"Positive end-expiratory pressure setting in adults with acute lung injury and acute respiratory distress syndrome: a randomized controlled trial."},{"title3":"Higher vs lower positive end-expiratory pressure in patients with acute lung injury and acute respiratory distress syndrome: systematic review and meta-analysis."},{"title3":"Higher PEEP improves outcomes in ARDS patients with clinically objective positive oxygenation response to PEEP: a systematic review and meta-analysis."},{"title3":"Higher PEEP versus Lower PEEP Strategies for Patients with Acute Respiratory Distress Syndrome. A Systematic Review and Meta-Analysis."},{"title3":"Comparison of two fluid-management strategies in acute lung injury."},{"title3":"Radiological findings from 81 patients with COVID-19 pneumonia in Wuhan, China: a descriptive study."},{"title3":"Effects of prone positioning on lung protection in patients with acute respiratory distress syndrome."},{"title3":"The prone position eliminates compression of the lungs by the heart."},{"title3":"Lung ventilation and perfusion in prone and supine postures with reference to anesthetized and mechanically ventilated healthy volunteers."},{"title3":"Prone Position for Acute Respiratory Distress Syndrome. A Systematic Review and Meta-Analysis."},{"title3":"Prone position for acute respiratory failure in adults."},{"title3":"The effects of prone position ventilation in patients with acute respiratory distress syndrome. A systematic review and metaanalysis."},{"title3":"The efficacy and safety of prone positional ventilation in acute respiratory distress syndrome: updated study-level meta-analysis of 11 randomized controlled trials."},{"title3":"Enteral feeding in the critically ill: comparison between the supine and prone positions: a prospective crossover study in mechanically ventilated patients."},{"title3":"Early enteral nutrition in critically ill patients: ESICM clinical practice guidelines."},{"title3":"Clinical Practice Guidelines for Sustained Neuromuscular Blockade in the Adult Critically Ill Patient."},{"title3":"New UK guidelines for the management of adult patients with ARDS."},{"title3":"Scandinavian clinical practice guideline on fluid and drug therapy in adults with acute respiratory distress syndrome."},{"title3":"Formal guidelines: management of acute respiratory distress syndrome."},{"title3":"Neuromuscular blocking agents in acute respiratory distress syndrome: a systematic review and meta-analysis of randomized controlled trials."},{"title3":"Early Neuromuscular Blockade in the Acute Respiratory Distress Syndrome."},{"title3":"Inhaled nitric oxide for acute respiratory distress syndrome (ARDS) in children and adults."},{"title3":"Lung recruitment in patients with the acute respiratory distress syndrome."},{"title3":"Open Lung Approach for the Acute Respiratory Distress Syndrome: A Pilot, Randomized Controlled Trial."},{"title3":"Clinical efficacy and safety of recruitment maneuver in patients with acute respiratory distress syndrome using low tidal volume ventilation: a multicenter randomized controlled clinical trial."},{"title3":"Effect of Lung Recruitment and Titrated Positive End-Expiratory Pressure (PEEP) vs Low PEEP on Mortality in Patients With Acute Respiratory Distress Syndrome: A Randomized Clinical Trial."},{"title3":"A randomised controlled trial of an open lung strategy with staircase recruitment, titrated PEEP and targeted low airway pressures in patients with acute respiratory distress syndrome."},{"title3":"Maximal Recruitment Open Lung Ventilation in Acute Respiratory Distress Syndrome (PHARLAP). A Phase II, Multicenter Randomized Controlled Clinical Trial."},{"title3":"Efficacy of positive end-expiratory pressure titration after the alveolar recruitment manoeuvre in patients with acute respiratory distress syndrome."},{"title3":"Lung Recruitment Maneuvers for Adult Patients with Acute Respiratory Distress Syndrome. A Systematic Review and Meta-Analysis."},{"title3":"Extracorporeal membrane oxygenation for severe Middle East respiratory syndrome coronavirus."},{"title3":"Extracorporeal Membrane Oxygenation for Severe Acute Respiratory Distress Syndrome."},{"title3":"Extracorporeal Membrane Oxygenation for Severe Acute Respiratory Distress Syndrome and Posterior Probability of Mortality Benefit in a Post Hoc Bayesian Analysis of a Randomized Clinical Trial."},{"title3":"Venovenous extracorporeal membrane oxygenation for acute respiratory distress syndrome: a systematic review and meta-analysis."},{"title3":"Preparing for the Most Critically Ill Patients With COVID-19: The Potential Role of Extracorporeal Membrane Oxygenation."},{"title3":"Development and validation of the HScore, a score for the diagnosis of reactive hemophagocytic syndrome."},{"title3":"COVID-19: consider cytokine storm syndromes and immunosuppression."},{"title3":"Early, low-dose and short-term application of corticosteroid treatment in patients with severe COVID-19 pneumonia: single-center experience from Wuhan, China."},{"title3":"Corticosteroid Therapy for Patients Hospitalized With Community-Acquired Pneumonia: A Systematic Review and Meta-analysis."},{"title3":"Corticosteroids as adjunctive therapy in the treatment of influenza."},{"title3":"Pharmacological agents for adults with acute respiratory distress syndrome."},{"title3":"Dexamethasone treatment for the acute respiratory distress syndrome: a multicentre, randomised controlled trial."},{"title3":"Effect of Intravenous Interferon beta-1a on Death and Days Free From Mechanical Ventilation Among Patients With Moderate to Severe Acute Respiratory Distress Syndrome: A Randomized Clinical Trial."},{"title3":"Risk Factors Associated With Acute Respiratory Distress Syndrome and Death in Patients With Coronavirus Disease 2019 Pneumonia in Wuhan, China."},{"title3":"Corticosteroids in Sepsis: An Updated Systematic Review and Meta-Analysis."},{"title3":"Reevaluating the Role of Corticosteroids in Septic Shock: An Updated Meta-Analysis of Randomized Controlled Trials."},{"title3":"Corticosteroid Therapy for Critically Ill Patients with Middle East Respiratory Syndrome."},{"title3":"Systemic Corticosteroid Therapy May Delay Viral Clearance in Patients with Middle East Respiratory Syndrome Coronavirus Infection."},{"title3":"Effects of early corticosteroid treatment on plasma SARS-associated Coronavirus RNA concentrations in adult patients."},{"title3":"Clinical Practice Guidelines by the Infectious Diseases Society of America: 2018 Update on Diagnosis, Treatment, Chemoprophylaxis, and Institutional Outbreak Management of Seasonal Influenzaa."},{"title3":"Critically Ill Patients With the Middle East Respiratory Syndrome: A Multicenter Retrospective Cohort Study."},{"title3":"Critical illness from 2009 pandemic influenza A virus and bacterial coinfection in the United States."},{"title3":"2009 pandemic influenza A (H1N1): pathology and pathogenesis of 100 fatal cases in the United States."},{"title3":"Do specific virus-bacteria pairings drive clinical outcomes of pneumonia?"},{"title3":"Clinical, laboratory and imaging features of COVID-19: A systematic review and meta-analysis,"},{"title3":"The effect of antipyretic therapy upon outcomes in critically ill patients: a randomized, prospective study."},{"title3":"Acetaminophen for Fever in Critically Ill Patients with Suspected Infection."},{"title3":"Effect of ibuprofen in patients with severe sepsis: a randomized, double-blind, multicenter study. The Ibuprofen Study Group."},{"title3":"The effects of ibuprofen on the physiology and survival of patients with sepsis. The Ibuprofen in Sepsis Study Group."},{"title3":"Is it worth treating fever in intensive care unit patients? Preliminary results from a randomized trial of the effect of external cooling."},{"title3":"Effects of lornoxicam on the physiology of severe sepsis."},{"title3":"Randomized trial of the effect of intravenous paracetamol on inflammatory biomarkers and outcome in febrile critically ill adults."},{"title3":"Fever control using external cooling in septic shock: a randomized controlled trial."},{"title3":"Assessment of the safety and feasibility of administering antipyretic therapy in critically ill adults: a pilot randomized clinical trial."},{"title3":"Body temperature control in patients with refractory septic shock: too much may be harmful."},{"title3":"Randomized, placebo-controlled trial of acetaminophen for the reduction of oxidative injury in severe sepsis: the Acetaminophen for the Reduction of Oxidative Injury in Severe Sepsis trial."},{"title3":"Respective impact of lowering body temperature and heart rate on mortality in septic shock: mediation analysis of a randomized trial."},{"title3":"Clinical Characteristics of Imported Cases of COVID-19 in Jiangsu Province: A Multicenter Descriptive Study."},{"title3":"Adverse effects of human immunoglobulin therapy."},{"title3":"Anti-influenza hyperimmune intravenous immunoglobulin for adults with influenza A or B infection (FLU-IVIG): a double-blind, randomised, placebo-controlled trial."},{"title3":"Critical care management of adults with community-acquired severe respiratory viral infection."},{"title3":"The convalescent sera option for containing COVID-19."},{"title3":"Hyperimmune IV immunoglobulin treatment: a multicenter double-blind randomized controlled trial for patients with severe 2009 influenza A(H1N1) infection."},{"title3":"SARS: systematic review of treatment effects."},{"title3":"Convalescent plasma treatment reduced mortality in patients with severe pandemic influenza A (H1N1) 2009 virus infection."},{"title3":"Meta-analysis: convalescent blood products for Spanish influenza pneumonia: a future H5N1 treatment?"},{"title3":"Successful treatment of avian influenza with convalescent plasma."},{"title3":"The effectiveness of convalescent plasma and hyperimmune immunoglobulin for the treatment of severe acute respiratory infections of viral aetiology: a systematic review and exploratory meta-analysis."},{"title3":"Feasibility of Using Convalescent Plasma Immunotherapy for MERS-CoV Infection, Saudi Arabia."},{"title3":"Evaluation of Convalescent Plasma for Ebola Virus Disease in Guinea."},{"title3":"Anti-influenza immune plasma for the treatment of patients with severe influenza A: a randomised, double-blind, phase 3 trial."},{"title3":"Efficacy and biological safety of lopinavir/ritonavir based anti-retroviral therapy in HIV-1-infected patients: a meta-analysis of randomized controlled trials."},{"title3":"Role of lopinavir/ritonavir in the treatment of SARS: initial virological and clinical findings."},{"title3":"Screening of an FDA-approved compound library identifies four small-molecule inhibitors of Middle East respiratory syndrome coronavirus replication in cell culture."},{"title3":"Treatment With Lopinavir/Ritonavir or Interferon-beta1b Improves Outcome of MERS-CoV Infection in a Nonhuman Primate Model of Common Marmoset."},{"title3":"Treatment of Middle East respiratory syndrome with a combination of lopinavir/ritonavir and interferon-beta1b (MIRACLE trial): statistical analysis plan for a recursive two-stage group sequential randomized controlled trial."},{"title3":"Informal consultation on prioritization of candidate therapeutic agents for use in novel coronavirus 2019 infection."},{"title3":"A Trial of Lopinavir-Ritonavir in Adults Hospitalized with Severe Covid-19."},{"title3":"Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro."},{"title3":"Comparative therapeutic efficacy of remdesivir and combination lopinavir, ritonavir, and interferon beta against MERS-CoV."},{"title3":"Prophylactic and therapeutic remdesivir (GS-5734) treatment in the rhesus macaque model of MERS-CoV infection."},{"title3":"A Randomized, Controlled Trial of Ebola Virus Disease Therapeutics."},{"title3":"Inhibition of novel beta coronavirus replication by a combination of interferon-alpha2b and ribavirin."},{"title3":"Treatment with interferon-alpha2b and ribavirin improves outcome in MERS-CoV-infected rhesus macaques."},{"title3":"Therapeutic options for Middle East respiratory syndrome coronavirus (MERS-CoV)--possible lessons from a systematic review of SARS-CoV therapy."},{"title3":"Interferon-beta and mycophenolic acid are potent inhibitors of Middle East respiratory syndrome coronavirus in cell-based assays."},{"title3":"Ribavirin and Interferon Therapy for Critically Ill Patients With Middle East Respiratory Syndrome: A Multicenter Observational Study."},{"title3":"Broad-spectrum antivirals for the emerging Middle East respiratory syndrome coronavirus."},{"title3":"Treatment of Middle East Respiratory Syndrome with a combination of lopinavir-ritonavir and interferon-beta1b (MIRACLE trial): study protocol for a randomized controlled trial."},{"title3":"Chloroquine is a potent inhibitor of SARS coronavirus infection and spread."},{"title3":"Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro."},{"title3":"In Vitro Antiviral Activity and Projection of Optimized Dosing Design of Hydroxychloroquine for the Treatment of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)."},{"title3":"Of chloroquine and COVID-19."},{"title3":"Paradoxical Effect of Chloroquine Treatment in Enhancing Chikungunya Virus Infection."},{"title3":"Breakthrough: Chloroquine phosphate has shown apparent efficacy in treatment of COVID-19 associated pneumonia in clinical studies."},{"title3":"(Expert consensus on chloroquine phosphate for the treatment of novel coronavirus pneumonia)."},{"title3":"A systematic review on the efficacy and safety of chloroquine for the treatment of COVID-19."},{"title3":"Efficacy and safety of tocilizumab in patients with polyarticular-course juvenile idiopathic arthritis: results from a phase 3, randomised, double-blind withdrawal trial."},{"title3":"Two years of sarilumab in patients with rheumatoid arthritis and an inadequate response to MTX: safety, efficacy and radiographic outcomes."},{"title3":"Efficacy and safety of tocilizumab in patients with systemic-onset juvenile idiopathic arthritis: a randomised, double-blind, placebo-controlled, withdrawal phase III trial."},{"title3":"FDA approval summary: tocilizumab for treatment of chimeric antigen receptor T cell-induced severe or life-threatening cytokine release syndrome."},{"title3":"Detectable serum SARS-CoV-2 viral load (RNAaemia) is closely associated with drastically elevated interleukin 6 (IL-6) level in critically ill COVID-19 patients."},{"title3":"Risk of adverse events including serious infections in rheumatoid arthritis patients treated with tocilizumab: a systematic literature review and meta-analysis of randomized controlled trials."},{"title3":"Tocilizumab and the risk of respiratory adverse events in patients with rheumatoid arthritis: a systematic review and meta-analysis of randomised controlled trials."},{"title3":"Effect of nitazoxanide in adults and adolescents with acute uncomplicated influenza: a double-blind, randomised, placebo-controlled, phase 2b/3 trial."},{"title3":"Efficacy and Safety of Nitazoxanide in Addition to Standard of Care for the Treatment of Severe Acute Respiratory Illness."}]},{"title2":"Intensive care during the coronavirus epidemic","References":[{"title3":"Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72314 cases from the Chinese center for disease control and prevention"},{"title3":"Director-General's remarks at the media briefing on 2019-nCoV on March 2020"},{"title3":"Characteristics and outcomes of children with coronavirus disease 2019 (COVID-19) infection admitted to US and Canadian pediatric intensive care units"},{"title3":"Clinical characteristics of children and young people admitted to hospital with covid-19 in United Kingdom: prospective multicentre observational cohort study"},{"title3":"Characteristics of severe acute respiratory syndrome coronavirus-2 infection and comparison with influenza in children admitted to U.K. PICUs"},{"title3":"Paediatric intensive care challenges caused by indirect effects of the COVID-19 pandemic"},{"title3":"Early impact of the COVID-19 pandemic on congenital heart surgery programs across the world: assessment by a global multi-societal consortium"},{"title3":"Impact of early Coronavirus Disease 2019 pandemic on pediatric cardiac surgery in China"},{"title3":"Reduced PICU respiratory admissions during COVID-19"},{"title3":"Changes in pediatric ICU utilization and clinical trends during the coronavirus pandemic"},{"title3":"In the eye of the storm: impact of COVID-19 pandemic on admission patterns to paediatric intensive care units in the UK and Eire"},{"title3":"A hybrid model of pediatric and adult critical care during the coronavirus disease 2019 surge: the experience of two tertiary hospitals in london and New York"},{"title3":"Caring for critically ill adults in paediatric intensive care units in England during the COVID-19 pandemic: planning, implementation and lessons for the future"},{"title3":"Public health interventions for the COVID-19 pandemic reduce respiratory tract infection-related visits at pediatric emergency departments in taiwan"},{"title3":"WHO coronavirus (COVID-19) dashboard"},{"title3":"First case of coronavirus disease 2019 (COVID-19) pneumonia in taiwan"},{"title3":"Initial rapid and proactive response for the COVID-19 outbreak - taiwan's experience"},{"title3":"Response to COVID-19 in taiwan: big data analytics, new technology, and proactive testing"},{"title3":"Review of epidemic, containment strategies, clinical management, and economic evaluation of COVID-19 pandemic"},{"title3":"Taiwan government-guided strategies contributed to combating and controlling COVID-19 Pandemic"},{"title3":"Epidemic trend of COVID-19 in taiwan, may to June 2021"},{"title3":"CECC raises epidemic warning to Level 3 nationwide from May 19 to May 28; strengthened measures and restrictions introduced across Taiwan to reduce community transmission"},{"title3":"CECC extends nationwide Level 3 epidemic alert until July 26 to safeguard disease prevention efforts in the community"},{"title3":"How taiwan succeeded in containing its 2021 COVID-19 outbreak"},{"title3":"National notifiable disease surveillance report:monthly report"},{"title3":"Validation of the paediatric logistic organ dysfunction (PELOD) score: prospective, observational, multicentre study"},{"title3":"Paediatric logistic organ dysfunction (PELOD) score"},{"title3":"A locally transmitted case of SARS-CoV-2 infection in taiwan"},{"title3":"Brazilian research network in pediatric intensive C. The impact of the novel coronavirus on Brazilian PICUs"},{"title3":"Unplanned and medical admissions to pediatric intensive care units significantly decreased during COVID-19 outbreak in Northern Italy"},{"title3":"The impact of strict public health restrictions on pediatric critical illness"},{"title3":"Indirect effects of the COVID-19 pandemic on paediatric healthcare use and severe disease: a retrospective national cohort study"},{"title3":"Caring for critically ill children with suspected or proven coronavirus disease 2019 infection: recommendations by the scientific sections' collaborative of the European society of pediatric and neonatal intensive care"},{"title3":"The effect of different personal protective equipment masks on health care workers' cardiopulmonary resuscitation performance during the covid-19 pandemic"},{"title3":"Influence of personal protective equipment on the performance of life-saving interventions by emergency medical service personnel"},{"title3":"Paved with good intentions: hospital visitation restrictions in the age of coronavirus disease 2019"},{"title3":"COVID-19 in children: initial characterization of the pediatric disease"}]},{"title2":"Convalescent plasma treatment reduced mortality in patients with severe pandemic influenza A (H1N1) 2009 virus infection","References":[{"title3":"Delayed decrease of viral load and marked cytokine activation in severe cases of pandemic H1N1 2009 influenza virus infection"},{"title3":"Differences in the epidemiological characteristics and clinical outcomes of pandemic (H1N1) 2009 influenza, compared with seasonal influenza"},{"title3":"Comparison of adult patients hospitalised with pandemic (H1N1) 2009 influenza and seasonal influenza during the &quot;PROTECT&quot; phase of the pandemic response"},{"title3":"Infection and death from influenza A H1N1 virus in Mexico: a retrospective analysis"},{"title3":"Factors associated with death or hospitalization due to pandemic 2009 influenza A(H1N1) infection in California"},{"title3":"Critical care services and 2009 H1N1 influenza in Australia and New Zealand"},{"title3":"An epidemiological study of 1348 cases of pandemic H1N1 influenza admitted to Singapore hospitals from July to September 2009"},{"title3":"Hospitalized patients with 2009 H1N1 influenza in the United States, April-June 2009"},{"title3":"Clinical features of the initial cases of 2009 pandemic influenza A (H1N1) virus infection in China"},{"title3":"Concurrent comparison of epidemiology, clinical presentation outcome between adult patients suffering from the pandemic influenza A (H1N1) 2009 virus and seasonal influenza A virus infection"},{"title3":"Cross-reactive antibody responses to the 2009 pandemic H1N1 influenza virus"},{"title3":"Intravenous zanamivir for patients with pneumonitis due to pandemic (H1N1) 2009 influenza virus"},{"title3":"The Emergency Use Authorization of peramivir for treatment of 2009 H1N1 influenza"},{"title3":"Extracorporeal membrane oxygenation for 2009 influenza A(H1N1) acute respiratory distress syndrome"},{"title3":"Hark back: passive immunotherapy for influenza and other serious infections"},{"title3":"Treatment of Argentine hemorrhagic fever"},{"title3":"Parvovirus B19 infection in pediatric transplant patients"},{"title3":"Experience of using convalescent plasma for severe acute respiratory syndrome among healthcare workers in a Taiwan hospital"},{"title3":"Meta-analysis: convalescent blood products for Spanish influenza pneumonia: a future H5N1 treatment?"},{"title3":"Treatment with convalescent plasma for influenza A (H5N1) infection"},{"title3":"Prophylactic and therapeutic efficacy of human monoclonal antibodies against H5N1 influenza"},{"title3":"Logistical feasibility and potential benefits of a population-wide passive-immunotherapy program during an influenza pandemic"},{"title3":"Viral load in patients infected with pandemic H1N1 2009 influenza A virus"},{"title3":"The natural viral load profile of patients with pandemic 2009 influenza A(H1N1) and the effect of oseltamivir treatment"},{"title3":"Practical limitations of convalescent plasma collection: a case scenario in pandemic preparation for influenza A (H1N1) infection"},{"title3":"Effect of clinical and virological parameters on the level of neutralizing antibody against pandemic influenza A virus H1N1 2009"},{"title3":"Confirmation of the first Hong Kong case of human infection by novel swine origin influenza A (H1N1) virus diagnosed using ultrarapid, real-time reverse transcriptase PCR"},{"title3":"Passive immunoprophylaxis and therapy with humanized monoclonal antibody specific for influenza A H5 hemagglutinin in mice"},{"title3":"Acute renal impairment in coronavirus-associated severe acute respiratory syndrome"},{"title3":"The infection attack rate and severity of 2009 pandemic influenza (H1N1) in Hong Kong"},{"title3":"Long-term immunogenicity of influenza vaccine among the elderly: risk factors for poor immune response and persistence"},{"title3":"Oseltamivir-resistant influenza A pandemic (H1N1) 2009 virus, Hong Kong, China"},{"title3":"Rapid selection of oseltamivir- and peramivir-resistant pandemic H1N1 virus during therapy in 2 immunocompromised hosts"},{"title3":"Identification of influenza A nucleoprotein as an antiviral target"},{"title3":"Host defense mechanisms against influenza virus: interaction of influenza virus with murine macrophages in vitro"},{"title3":"Neutralization of human respiratory syncytial virus infectivity by antibodies low molecular weight compounds targeted against the fusion (F) glycoprotein"}]},{"title2":"Meta-analysis: convalescent blood products for Spanish influenza pneumonia: a future H5N1 treatment?","References":[]},{"title2":"The effectiveness of convalescent plasma and hyperimmune immunoglobulin for the treatment of severe acute respiratory infections of viral etiology: a systematic review and exploratory meta-analysis","References":[{"title3":"Middle East respiratory syndrome coronavirus (MERS-CoV):update (26 May 2014)"},{"title3":"Clinical management of severe acute respiratory infections when novel coronavirus is suspected: what to do and what not to do"},{"title3":"Treatment of MERS-CoV: decision support tool v.1.0"},{"title3":"State of knowledge and data gaps of middle east respiratory syndrome coronavirus (MERS-CoV) in humans"},{"title3":"Hyperimmune iv immunoglobulin treatment: A multicenter double-blind randomized controlled trial for patients with severe 2009 influenza a(H1N1) infection"},{"title3":"Treatment of severe acute respiratory syndrome"},{"title3":"SARS: systematic review of treatment effects"},{"title3":"Experience of using convalescent plasma for severe acute respiratory syndrome among healthcare workers in a Taiwan hospital"},{"title3":"The management of coronavirus infections with particular reference to SARS"},{"title3":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement"},{"title3":"Middle East Respiratory Syndrome Coronavirus (MERS-CoV) and the effectiveness of convalescent plasma for the treatment of severe acute respiratory infections of viral aetiology: a systematic review. PROSPERO 2013CRD42013005091"},{"title3":"Cochrane handbook for systematic reviews of interventions. Version 5.1.0. Updated March 2011"},{"title3":"The Newcastle-Ottawa Scale (NOS) for assessing the quality of non-randomised studies in meta-analyses"},{"title3":"Influenza vaccination for immunocompromised patients: systematic review and meta-analysis from a public health policy perspective"},{"title3":"Use of serum in the treatment of influenza-pneumonia"},{"title3":"Treatment of influenza with injections of blood from convalescents"},{"title3":"Treatment of influenza pneumonia with serum from convalescents"},{"title3":"Treatment of influenza pneumonia by use of convalescent human serum"},{"title3":"Meta-analysis: convalescent blood products for Spanish influenza pneumonia: a future H5N1 treatment?"},{"title3":"Clinical research during a public health emergency: a systematic review of severe pandemic influenza management"},{"title3":"Successful treatment of avian influenza with convalescent plasma"},{"title3":"Convalescent plasma for prophylaxis and treatment of severe pandemic influenza A (H1N1) 2009 infection: Case reports"},{"title3":"Treatment of severe acute respiratory syndrome with convalescent plasma"},{"title3":"Treatment with convalescent plasma for influenza A (H5N1) infection"},{"title3":"Clinical characteristics and therapeutic experience of case of severe highly pathogenic A/H5N1 avian influenza with bronchopleural fistula"},{"title3":"Letter to the editor"},{"title3":"Treatment of severe acute respiratory syndrome with convalescent plasma, author reply"},{"title3":"Hong Kong's experience on the use of extracorporeal membrane oxygenation for the treatment of influenza A (H1N1)"},{"title3":"Use of convalescent plasma therapy in SARS patients in Hong Kong"},{"title3":"Epidemiologic features, clinical diagnosis and therapy of first cluster of patients with severe acute respiratory syndrome in Beijing area"},{"title3":"Treatment of influenzal pneumonia with plasma of convalescent patients"},{"title3":"Treatment of influenzal pneumonia by the use of convalescent human serum"},{"title3":"Human serum in influenza"},{"title3":"Clinical characteristics of 26 human cases of highly pathogenic avian 36]influenza A (H5N1) virus infection in China"},{"title3":"Retrospective study on collecting convalescent donors's plasma in treatment of patients with pandemic influenza A (H1N1) virus infection"},{"title3":"Human serum in the treatment of influenza bronchopneumonia"},{"title3":"Convalescent serum in treatment of influenza"},{"title3":"Convalescent serum in the prevention and treatment of influenza"},{"title3":"Plasma therapy in influenza"},{"title3":"Report of influenza treated with serum from recovered cases"},{"title3":"Convalescent serum in the treatment of influenza pneumonia"},{"title3":"The use of the serum of convalescents in the treatment of influenza pneumonia: A summary of the results in a series of one hundred and one cases"},{"title3":"Advances in clinical diagnosis and treatment of severe acute respiratory syndrome"},{"title3":"Retrospective comparison of convalescent plasma with continuing high-dose methylprednisolone treatment in SARS patients"},{"title3":"Serum treatment of postinfluenzal bronchopneumonia"},{"title3":"Convalescent plasma treatment reduced mortality in patients with severe pandemic influenza A (H1N1) 2009 virus infection"},{"title3":"Treatment of Severe Pandemic Influenza A/H1N1 Infection"},{"title3":"Convalescent transfusion for pandemic influenza: preparing blood banks for a new plasma product?"}]},{"title2":"Potential interventions for novel coronavirus in China: a systematic review","References":[{"title3":"Bats and coronaviruses"},{"title3":"Coronavirus envelope protein: current knowledge"},{"title3":"Middle East respiratory syndrome"},{"title3":"New SARS-like virus in China triggers alarm"},{"title3":"A novel coronavirus from patients with pneumonia in China, 2019"},{"title3":"Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia"},{"title3":"Coronaviruses: genome structure, replication, and pathogenesis"},{"title3":"Recent advances in the detection of respiratory virus infection in humans"},{"title3":"Genomic characterization of the 2019 novel human-pathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan"},{"title3":"Selenium, selenoproteins and viral infection"},{"title3":"Importance of vitamin A deficiency in pathology and immunology of viral infections"},{"title3":"Vitamin A and immunity to viral, bacterial and protozoan infections"},{"title3":"Vitamin A supplements ameliorate the adverse effect of HIV-1, malaria, and diarrheal infections on child growth"},{"title3":"Effects of dietary vitamin A content on antibody responses of feedlot calves inoculated intramuscularly with an inactivated bovine coronavirus vaccine"},{"title3":"Epithelia-damaging virus infections affect vitamin A status in chickens"},{"title3":"Retinoids inhibit measles virus through a type I IFN-dependent bystander effect"},{"title3":"Riboflavin (vitamin B-2) and health"},{"title3":"Inactivation of Middle East respiratory syndrome coronavirus (MERS-CoV) in plasma products using a riboflavin-based and ultraviolet light-based photochemical treatment"},{"title3":"C/EBPepsilon mediates nicotinamide-enhanced clearance of Staphylococcus aureus in mice"},{"title3":"Nicotinamide exacerbates hypoxemia in ventilator-induced lung injury independent of neutrophil infiltration"},{"title3":"Vitamin C and SARS coronavirus"},{"title3":"The effect of ascorbic acid on infection chick-embryo ciliated tracheal organ cultures by coronavirus"},{"title3":"Nutrients and their role in host resistance to infection"},{"title3":"Vitamin C intake and susceptibility to pneumonia"},{"title3":"Vitamin D insufficiency among free-living healthy young adults"},{"title3":"Sunlight and vitamin D for bone health and prevention of autoimmune diseases, cancers, and cardiovascular disease"},{"title3":"Acute phase response elicited by experimental bovine diarrhea virus (BVDV) infection is associated with decreased vitamin D and E status of vitamin-replete preruminant calves"},{"title3":"Vitamin E metabolic effects and genetic variants: a challenge for precision nutrition in obesity and associated disturbances"},{"title3":"Vitamin E deficiency intensifies the myocardial injury of coxsackievirus B3 infection of mice"},{"title3":"Increased virulence of coxsackievirus B3 in mice due to vitamin E or selenium deficiency"},{"title3":"Macrophage-derived extracellular vesicles induce long-lasting immunity against hepatitis C virus which is blunted by polyunsaturated fatty acids"},{"title3":"Plasma fatty acid levels in patients with acquired immune deficiency syndrome and in controls"},{"title3":"The lipid mediator protectin D1 inhibits influenza virus replication and improves severe influenza"},{"title3":"Anti-HCV activities of selective polyunsaturated fatty acids"},{"title3":"Selenium and human health"},{"title3":"Micronutrients and host resistance to viral infection"},{"title3":"Review: micronutrient selenium deficiency influences evolution of some viral infectious diseases"},{"title3":"Selenium deficiency increases the pathology of an influenza virus infection"},{"title3":"Rapid genomic evolution of a non-virulent coxsackievirus B3 in selenium-deficient mice results in selection of identical virulent isolates"},{"title3":"Combined adjuvant effect of ginseng stem-leaf saponins and selenium on immune responses to a live bivalent vaccine of Newcastle disease virus and infectious bronchitis virus in chickens"},{"title3":"Zinc and immunity: an essential interrelation"},{"title3":"Zinc deficiency"},{"title3":"Zinc supplementation for the treatment of measles in children"},{"title3":"Zn(2+) inhibits coronavirus and arterivirus RNA polymerase activity in vitro and zinc ionophores block the replication of these viruses in cell culture"},{"title3":"Crossing the iron gate: why and how transferrin receptors mediate viral entry"},{"title3":"Childhood iron deficiency anemia leads to recurrent respiratory tract infections and gastroenteritis"},{"title3":"Chicken interferon type I inhibits infectious bronchitis virus replication and associated respiratory illness"},{"title3":"Prevention of experimental coronavirus colds with intranasal alpha-2b interferon"},{"title3":"Ribavirin and interferon-beta synergistically inhibit SARS-associated coronavirus replication in animal and human cell lines"},{"title3":"In vitro susceptibility of 10 clinical isolates of SARS coronavirus to selected antiviral compounds"},{"title3":"Interferon priming enables cells to partially overturn the SARS coronavirus-induced block in innate immune activation"},{"title3":"Inhibition of SARS coronavirus infection in vitro with clinically approved antiviral drugs"},{"title3":"Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial"},{"title3":"Pegylated interferon-alpha protects type 1 pneumocytes against SARS coronavirus infection in macaques"},{"title3":"Proposal for vaccination against SARS coronavirus using avian infectious bronchitis virus strain H from The Netherlands"},{"title3":"Interferon alfacon-1 plus corticosteroids in severe acute respiratory syndrome: a preliminary study"},{"title3":"Current treatment options and the role of peptides as potential therapeutic components for Middle East Respiratory Syndrome (MERS): a review"},{"title3":"Uses of intravenous gammaglobulin in immune hematologic disease"},{"title3":"Acute respiratory distress syndrome in critically ill patients with severe acute respiratory syndrome"},{"title3":"Strokes, thromboembolic events, and IVIg: rare incidents blemish an excellent safety record"},{"title3":"Thymosin alpha 1 and HIV-1: recent advances and future perspectives"},{"title3":"A reappraisal of thymosin alpha1 in cancer therapy"},{"title3":"Serum thymosin alpha 1 levels in normal and pathological conditions"},{"title3":"Thymosin alpha 1 antagonizes dexamethasone and CD3-induced apoptosis of CD4+ CD8+ thymocytes through the activation of cAMP and protein kinase C dependent second messenger pathways"},{"title3":"Clinical investigation of outbreak of nosocomial severe acute respiratory syndrome"},{"title3":"Anti-SARS coronavirus agents: a patent review (2008-present)"},{"title3":"Modulation of immune response in aged humans through different administration modes of thymopentin"},{"title3":"Phase variation in the modulation of the human immune response"},{"title3":"Thymopentin as adjuvant in non-responders or hyporesponders to hepatitis B vaccination"},{"title3":"The general immunopharmacology of levamisole"},{"title3":"Lymphocyte subsets in measles. Depressed helper/inducer subpopulation reversed by in vitro treatment with levamisole and ascorbic acid"},{"title3":"Systemic cyclosporine and corneal transplantation"},{"title3":"Nucleocapsid protein of SARS coronavirus tightly binds to human cyclophilin A"},{"title3":"Factor in virus replication and potential target for anti-viral therapy"},{"title3":"The SARS-coronavirus-host interactome: identification of cyclophilins as target for pan-coronavirus inhibitors"},{"title3":"Glycyrrhizin, an active component of liquorice roots, and replication of SARS-associated coronavirus"},{"title3":"Diarylheptanoids from Alnus japonica inhibit papain-like protease of severe acute respiratory syndrome coronavirus"},{"title3":"Cinanserin is an inhibitor of the 3C-like proteinase of severe acute respiratory syndrome coronavirus and strongly reduces virus replication in vitro"},{"title3":"Flavonoids: an overview"},{"title3":"Flavonoids from pterogyne nitens inhibit hepatitis C virus entry"},{"title3":"Inhibition of SARS-CoV 3CL protease by flavonoids"},{"title3":"Characteristics of flavonoids as potent MERS-CoV 3C-like protease inhibitors"},{"title3":"Biflavonoids from Torreya nucifera displaying SARS-CoV 3CL(pro) inhibition"},{"title3":"Angiotensin-converting enzyme-2: a molecular and cellular perspective"},{"title3":"Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus"},{"title3":"The secret life of ACE2 as a receptor for the SARS virus"},{"title3":"Characterization of severe acute respiratory syndrome-associated coronavirus (SARS-CoV) spike glycoprotein-mediated viral entry"},{"title3":"Severe acute respiratory syndrome coronavirus entry into host cells: Opportunities for therapeutic intervention"},{"title3":"Potent neutralization of severe acute respiratory syndrome (SARS) coronavirus by a human mAb to S1 protein that blocks receptor association"},{"title3":"Effects of chloroquine on viral infections: an old drug against today's diseases?"},{"title3":"Chloroquine is a potent inhibitor of SARS coronavirus infection and spread"},{"title3":"Membrane-related effects underlying the biological activity of the anthraquinones emodin and barbaloin"},{"title3":"Emodin blocks the SARS coronavirus spike protein and angiotensin-converting enzyme 2 interaction"},{"title3":"Old drugs as lead compounds for a new disease? Binding analysis of SARS coronavirus main proteinase with HIV, psychotic and parasite drugs"},{"title3":"The transition metal chelator nicotianamine is synthesized by filamentous fungi"},{"title3":"Nicotianamine is a novel angiotensin-converting enzyme 2 inhibitor in soybean"},{"title3":"Managing SARS amidst uncertainty"},{"title3":"Critics slam treatment for SARS as ineffective and perhaps dangerous"},{"title3":"Clinical features and short-term outcomes of 144 patients with SARS in the greater Toronto area"},{"title3":"SARS: pharmacotherapy"},{"title3":"Comparative therapeutic efficacy of remdesivir and combination lopinavir, ritonavir, and interferon beta against MERS-CoV"},{"title3":"Role of lopinavir/ritonavir in the treatment of SARS: initial virological and clinical findings"},{"title3":"Combination therapy with lopinavir/ritonavir, ribavirin and interferon-alpha for Middle East respiratory syndrome"},{"title3":"Coronavirus susceptibility to the antiviral remdesivir (GS-5734) is mediated by the viral polymerase and the proofreading exoribonuclease"},{"title3":"First case of 2019 novel coronavirus in the United States"},{"title3":"Nelfinavir. A review of its therapeutic efficacy in HIV infection"},{"title3":"HIV protease inhibitor nelfinavir inhibits replication of SARS-associated coronavirus"},{"title3":"Arbidol as a broad-spectrum antiviral: an update"},{"title3":"Arbidol: a broad-spectrum antiviral compound that blocks viral fusion"},{"title3":"The synthetic antiviral drug arbidol inhibits globally prevalent pathogenic viruses"},{"title3":"[Antiviral activity of arbidol and its derivatives against the pathogen of severe acute respiratory syndrome in the cell cultures]"},{"title3":"Nitric oxide"},{"title3":"Nitric oxide and airway disease"},{"title3":"Efficacy of inhaled nitric oxide in patients with severe ARDS"},{"title3":"An overview on severe acute respiratory syndrome (SARS)"},{"title3":"Nitric oxide inhibits the replication cycle of severe acute respiratory syndrome coronavirus"},{"title3":"Efficacy of thioctic acid in the therapy of peripheral diabetic neuropathy"},{"title3":"Biochemical and clinical relevance of alpha lipoic acid: antioxidant and anti-inflammatory activity, molecular pathways and therapeutic potential"},{"title3":"Effects of dietary vitamin C, vitamin E, and alpha-lipoic acid supplementation on the antioxidant defense system and immune-related gene expression in broilers exposed to oxidative stress by dexamethasone"},{"title3":"Glucose-6-phosphate dehydrogenase deficiency enhances human coronavirus 229E infection"},{"title3":"Alpha-lipoic acid is an effective inhibitor of human immuno-deficiency virus (HIV-1) replication"},{"title3":"Sexual dimorphism in innate immune responses to infectious organisms"},{"title3":"Do men have a higher case fatality rate of severe acute respiratory syndrome than women do?"},{"title3":"SARS in Singapore--predictors of disease severity"},{"title3":"The pattern of Middle East respiratory syndrome coronavirus in Saudi Arabia: a descriptive epidemiological analysis of data from the Saudi Ministry of Health"},{"title3":"Sex-based differences in susceptibility to severe acute respiratory syndrome coronavirus infection"},{"title3":"Endocrine cells of the adenohypophysis in severe acute respiratory syndrome (SARS)"},{"title3":"Estrogenic compounds reduce influenza A virus replication in primary human nasal epithelial cells derived from female, but not male, donors"},{"title3":"Effective inhibition of MERS-CoV infection by resveratrol"},{"title3":"Virucidal activity of a scorpion venom peptide variant mucroporin-M1 against measles, SARS-CoV and influenza H5N1 viruses"},{"title3":"Severe acute respiratory syndrome vaccine development: experiences of vaccination against avian infectious bronchitis coronavirus"},{"title3":"Protection from SARS coronavirus conferred by live measles vaccine expressing the spike glycoprotein"},{"title3":"Live-attenuated bivalent measles virus-derived vaccines targeting Middle East respiratory syndrome coronavirus induce robust and multifunctional T cell responses against both viruses in an appropriate mouse model"},{"title3":"Measles-derived vaccines to prevent emerging viral diseases"},{"title3":"Human monoclonal antibody combination against SARS coronavirus: synergy and coverage of escape mutants"},{"title3":"Human monoclonal antibody as prophylaxis for SARS coronavirus infection in ferrets"},{"title3":"Convalescent plasma: new evidence for an old therapeutic tool?"},{"title3":"Feasibility, safety, clinical, and laboratory effects of convalescent plasma therapy for patients with Middle East respiratory syndrome coronavirus infection: a study protocol"},{"title3":"Use of convalescent plasma therapy in SARS patients in Hong Kong"},{"title3":"Retrospective comparison of convalescent plasma with continuing high-dose methylprednisolone treatment in SARS patients"}]},{"title2":"Characteristics and outcomes of 21 critically Ill patients with COVID-19 in Washington state","References":[]},{"title2":"Covid-19 in critically Ill patients in the seattle region - case series","References":[{"title3":"Novel coronavirus : China"},{"title3":"Coronavirus COVID-19 global cases"},{"title3":"First case of 2019 novel coronavirus in the United States."},{"title3":"2019 Novel coronavirus outbreak (COVID-19)"},{"title3":"Cryptic transmission of novel coronavirus revealed by genomic epidemiology"},{"title3":"Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study."},{"title3":"Critical care utilization for the COVID-19 outbreak in Lombardy, Italy: early experience and forecast during an emergency response."},{"title3":"Characteristics and outcomes of 21 critically ill patients with COVID-19 in Washington State."},{"title3":"Priorities for the US health community responding to COVID-19."},{"title3":"Acute respiratory distress syndrome: the Berlin Definition."},{"title3":"Coronavirus disease 2019 (COVID-19)"},{"title3":"Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR."},{"title3":"Clinical characteristics of coronavirus disease 2019 in China."},{"title3":"Early neuromuscular blockade in the acute respiratory distress syndrome."},{"title3":"Prone positioning in severe acute respiratory distress syndrome."},{"title3":"Bacterial coinfection in influenza: a grand rounds review."},{"title3":"Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study."},{"title3":"Effects of early corticosteroid treatment on plasma SARS-associated coronavirus RNA concentrations in adult patients."},{"title3":"Corticosteroid therapy for critically ill patients with Middle East respiratory syndrome."},{"title3":"Corticosteroids as adjunctive therapy in the treatment of influenza: an updated Cochrane systematic review and meta-analysis."},{"title3":"Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan, China."},{"title3":"Care of the critically ill and injured during pandemics and disasters: groundbreaking results from the Task Force on Mass Critical Care."},{"title3":"Introduction and executive summary: care of the critically ill and injured during pandemics and disasters: CHEST consensus statement."}]},{"title2":"Baseline characteristics and outcomes of 1591 patients infected with SARS-CoV-2 admitted to ICUs of the lombardy region, Italy","References":[]},{"title2":"Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in the New York City area","References":[]},{"title2":"Spike mutation pipeline reveals the emergence of a more transmissible form of SARS-CoV-2","References":[]},{"title2":"On the origin and continuing evolution of SARS-CoV-2","References":[]},{"title2":"SARS-CoV-2 viral spike G614 mutation exhibits higher case fatality rate","References":[{"title3":"Structure, function, and antigenicity of the SARS-CoV-2 spike glycoprotein"},{"title3":"Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation"},{"title3":"Biased probability Monte Carlo conformational searches and electrostatic calculations for peptides and proteins"},{"title3":"How internal cavities destabilize a protein"},{"title3":"Brief history and characterization of enhanced respiratory syncytial virus disease"},{"title3":"Immunodominant SARS coronavirus epitopes in humans elicited both enhancing and neutralizing effects on infection in non-human primates"},{"title3":"A highly conserved cryptic epitope in the receptor-binding domains of SARS-CoV-2 and SARS-CoV"}]},{"title2":"Could the D614G substitution in the SARS-CoV-2 spike (S) protein be associated with higher COVID-19 mortality?","References":[{"title3":"Next strain: real-time tracking of pathogen evolution"},{"title3":"Case-fatality rate and characteristics of patients dying in relation to COVID-19 in Italy"},{"title3":"Genetic diversity and evolution of SARS-CoV-2"},{"title3":"GISAID: global initiative on sharing all influenza data - from vision to reality"},{"title3":"A novel coronavirus outbreak of global health concern"}]},{"title2":"SARS-CoV-2 genomic variations associated with mortality rate of COVID-19","References":[{"title3":"A new coronavirus associated with human respiratory disease in China"},{"title3":"A pneumonia outbreak associated with a new coronavirus of probable bat origin"},{"title3":"One severe acute respiratory syndrome coronavirus protein complex integrates processive RNA polymerase and exonuclease activities"},{"title3":"A novel coronavirus outbreak of global health concern"},{"title3":"GISAID: Global initiative on sharing all influenza data:from vision to reality"},{"title3":"Bioinformatic prediction of potential T cell epitopes for SARS-Cov-2"},{"title3":"BLAT-the BLAST-like alignment tool"},{"title3":"Allele frequency net database (AFND) 2020 update: gold-standard data classification, open access genotype data and new query tools"},{"title3":"Ozdemir C, Kucuksezer UC, Tamay ZU. Is BCG vaccination affecting the spread and severity of COVID-19? Allergy. 2020;75:1824-7."},{"title3":"Mapping the global use of different BCG vaccine strains"},{"title3":"The BCG World Atlas: a database of global BCG vaccination policies and practices"},{"title3":"Haploview: analysis and visualization of LD and haplotype maps"},{"title3":"Becerra-Flores M, Cardozo T. SARS-CoV-2 viral spike G614 mutation exhibits higher case fatality rate. Int J Clin Pract. 2020;00:e13525."},{"title3":"Gursel M, Gursel I. Is global BCG vaccination-induced trained immunity relevant to the progression of SARS-CoV-2 pandemic? Allergy. 2020;75:1815-9."},{"title3":"SARS-CoV-2 rates in BCG-vaccinated and unvaccinated young adults"},{"title3":"Phylogenetic network analysis of SARS-CoV-2 genomes"},{"title3":"Emergence of drift variants that may affect COVID-19 vaccine development and antibody treatment"},{"title3":"Gonzalez-Reiche AS, Hernandez MM, Sullivan MJ, Ciferri B, Alshammary H, Obla A, et al. Introductions and early spread of SARS-CoV-2 in the New York City area. Science. 2020;369:297-301."},{"title3":"Deng X, Gu W, Federman S, du Plessis L, Pybus OG, Faria N, et al. Genomic surveillance reveals multiple introductions of SARS-CoV-2 into Northern California. Science. 2020. In press."},{"title3":"Functional assessment of cell entry and receptor usage for SARS-CoV-2 and other lineage B betacoronaviruses"},{"title3":"SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor"},{"title3":"Could the D614G substitution in the SARS-CoV-2 spike (S) protein be associated with higher COVID-19 mortality?"},{"title3":"Association of HLA class I with severe acute respiratory syndrome coronavirus infection"},{"title3":"Association of human-leukocyte-antigen class I (B*0703) and class II (DRB1*0301) genotypes with susceptibility and resistance to the development of severe acute respiratory syndrome"},{"title3":"Epidemiological and genetic correlates of severe acute respiratory syndrome coronavirus infection in the hospital with the highest nosocomial infection rate in Taiwan in 2003"},{"title3":"Association of human leukocyte antigen class II alleles with severe Middle East respiratory syndrome-coronavirus infection"}]},{"title2":"clinical characteristics of patients who died of coronavirus disease 2019 in China","References":[{"title3":"Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China"},{"title3":" Bulletin of the National Health Commission of the People's Republic of China on the 2019 new coronavirus infection. Accessed March 8, 2020. http://www.nhc.gov.cn/xcs/xxgzbd/gzbd_index.shtml"},{"title3":" Clinical management of severe acute respiratory infection when novel coronavirus (nCoV) infection is suspected. Accessed March 8, 2020. https://www.who.int/publications-detail/clinical-management-of-severe-acute-respiratory-infection-when-novel-coronavirus-(ncov)-infection-is-suspected"},{"title3":"Noninvasive ventilation for acute respiratory failure"},{"title3":"The epidemiology of sepsis in Chinese ICUs: a national cross-sectional survey"}]}]},{"title1":"Clinical characteristics of 34 COVID-19 patients admitted to intensive care unit in Hangzhou, China<","References":[{"title2":"Blood urea nitrogen (BUN) is independently associated with mortality in critically ill patients admitted to ICU","References":[{"title3":"New scoring system (APACHE-HF) for predicting adverse outcomes in patients with acute heart failure: evaluation of the APACHE II and Modified APACHE II scoring systems"},{"title3":"SwissScoring:a nationwide survey of SAPS II assessing practices and its accuracy"},{"title3":"Renal impairment, worsening renal function, and outcome in patients with heart failure: an updated meta-analysis"},{"title3":"Biomarkers of renal injury and function: diagnostic, prognostic and therapeutic implications in heart failure"},{"title3":"Predictive value of cystatin C for the identification of illness severity in adult patients in a mixed intensive care unit"},{"title3":"Effect of elevated admission serum creatinine and its worsening on outcome in hospitalized patients with decompensated heart failure"},{"title3":"Prognostic value of blood urea nitrogen in patients hospitalized with worsening heart failure: insights from the Acute and Chronic Therapeutic Impact of a Vasopressin Antagonist in Chronic Heart Failure (ACTIV in CHF) study"},{"title3":"Blood urea nitrogen in the prediction of in-hospital mortality of patients with acute aortic dissection"},{"title3":"Elevated blood urea nitrogen is an independent risk factor of prolonged intensive care unit stay due to acute necrotizing pancreatitis"},{"title3":"Elevated Blood Urea Nitrogen is Associated With Critical Limb Ischemia in Peripheral Arterial Disease Patients"},{"title3":"Elevated blood urea nitrogen level as a predictor of mortality in patients admitted for decompensated heart failure"},{"title3":"The association of blood urea nitrogen levels with mortality in acute pulmonary embolism"},{"title3":"Blood urea nitrogen in the early assessment of acute pancreatitis: an international validation study"},{"title3":"Investigators of the Acute Decompensated Heart Failure Syndromes r. Serum sodium concentration, blood urea nitrogen, and outcomes in patients hospitalized for acute decompensated heart failure"},{"title3":"Association between an increase in blood urea nitrogen at 24 hours and worse outcomes in acute nonvariceal upper GI bleeding"},{"title3":"Does blood urea nitrogen level predict severity and high-risk endoscopic lesions in patients with nonvariceal upper gastrointestinal bleeding?"},{"title3":"Synergistic impact of low serum albumin on intensive care unit admission and high blood urea nitrogen during intensive care unit stay on post-intensive care unit mortality in critically ill elderly patients requiring mechanical ventilation"},{"title3":"Serum blood urea nitrogen as an independent marker of subsequent mortality among patients with acute coronary syndromes and normal to mildly reduced glomerular filtration rates"},{"title3":"Defining community acquired pneumonia severity on presentation to hospital: an international derivation and validation study"}]},{"title2":"Extracorporeal membrane oxygenation for ARDS in adults","References":[]},{"title2":"Dynamic changes of lymphocyte counts in adult patients with severe pandemic H1N1 influenza A","References":[{"title3":"Pneumonia and respiratory failure from swine-origin influenza A (H1N1) in Mexico"},{"title3":"Systematic review of respiratory viral pathogens identified in adults with community-acquired pneumonia in Europe"},{"title3":"Characteristics of patients with hospital-acquired influenza A (H1N1)pdm09 virus admitted to the intensive care unit"},{"title3":"Influenza A(H1N1)pdm 2009 and influenza B virus co-infection in hospitalized and non-hospitalized patients during the 2015-2016 epidemic season in Israel"},{"title3":"A comparison of H1N1 influenza among pediatric inpatients in the pandemic and post pandemic era"},{"title3":"Detecting 2009 pandemic influenza A (H1N1) virus infection: availability of diagnostic testing led to rapid pandemic response"},{"title3":"Diagnostic importance of relative lymphopenia as a marker of swine influenza (H1N1) in adults"},{"title3":"Clinical features of human influenza A (H5N1) infection in Vietnam: 2004-2006"},{"title3":"Predictors and outcomes of respiratory failure among hospitalized pneumonia patients with 2009 H1N1 influenza in Taiwan"},{"title3":"Before influenza tests results are available can droplet precautions be instituted if influenza is suggested by leukopenia, relative lymphopenia or thrombopenia?"},{"title3":"Relative lymphopenia and monocytosis may be considered as a surrogate marker of pandemic influenza A (H1N1)"},{"title3":"Factors associated with death in hospitalized pneumonia patients with 2009 H1N1 influenza in Shenyang, China"},{"title3":"Analysis on epidemiology and etiology genetic characteristics of novel swine origin influenza A (H1N1) in Jiangsu province, 2009"},{"title3":"Protocols for diagnosis and treatment of pandemic H1N1 influenza A"},{"title3":"Differences in clinical features observed between childhood-onset versus adult-onset systemic lupus erythematosus: a systematic review and meta-analysis"},{"title3":"T lymphocytes and fractalkine contribute to myocardial ischemia/reperfusion injury in patients"},{"title3":"Lymphocytopenia is an independent predictor of unfavorable functional outcome in spontaneous intracerebral hemorrhage"},{"title3":"Baseline lymphopenia should not be used as exclusion criteria in early clinical trials investigating immune checkpoint blockers (PD-1/PD-L1 inhibitors)"},{"title3":"Lymphocyte nadir and esophageal cancer survival outcomes after chemoradiation therapy"},{"title3":"Phase I dose-escalation and pharmacokinetic study of intravenous aflibercept in combination with docetaxel, cisplatin, and 5-fluorouracil in patients with advanced solid malignancies"},{"title3":"Investigating an incidental finding of lymphopenia"},{"title3":"Measles virus infection causes transient depletion of activated T cells from peripheral circulation"},{"title3":"Prognostic importance of lymphopenia in West Nile encephalitis"},{"title3":"Ebola virus glycoprotein directly triggers T lymphocyte death despite of the lack of infection"},{"title3":"Screening for Chikungunya virus infection in aged people: development and internal validation of a new score"},{"title3":"Lymphopenia in SARS"},{"title3":"Mechanisms of lymphocyte loss in SARS coronavirus infection"},{"title3":"Human parainfluenza virus type 3 (HPIV 3) viral community-acquired pneumonia (CAP) mimicking swine influenza (H1N1) during the swine flu pandemic"},{"title3":"Longitudinal analysis of leukocyte differentials in peripheral blood of patients with acute respiratory viral infections"},{"title3":"The human immune response to respiratory syncytial virus infection"},{"title3":"Human infection with a novel, highly pathogenic avian influenza A (H5N6) virus: virological and clinical findings"},{"title3":"A case report of avian influenza H7N9 killing a young doctor in Shanghai, China"},{"title3":"The clinical usefulness of lymphocyte:monocyte ratios in differentiating influenza from viral non-influenza-like illnesses in hospitalized adults during the 2015 influenza A (H3N2) epidemic: the uniqueness of HPIV-3 mimicking influenza A"},{"title3":"Reduction of natural killer but not effector CD8 T lymphocytes in three consecutive cases of severe/lethal H1N1/09 influenza A virus infection"}]},{"title2":"Middle East respiratory syndrome coronavirus efficiently infects human primary T lymphocytes and activates the extrinsic and intrinsic apoptosis pathways","References":[]},{"title2":"Expression of lymphocytes and lymphocyte subsets in patients with severe acute respiratory syndrome","References":[]},{"title2":"Systematic review and meta-analysis: macrolides- and amoxicillin/clavulanate-induced acute liver injury","References":[]},{"title2":"Trends in prevalence and prognosis in subjects with acute chronic respiratory failure treated with noninvasive and/or invasive ventilation","References":[]},{"title2":"Multiple organ infection and the pathogenesis of SARS","References":[{"title3":"World Health Organization. Communicable Disease Surveillance &amp; Response (CSR). Severe Acute Respiratory Syndrome (SARS). Available at: http://www.who.int/csr/sars/en (accessed July 11, 2005)."},{"title3":"World Health Organization. May 1, 2003. Case definitions for surveillance of severe acute respiratory syndrome (SARS). Available at: http://www.who.int/csr/sars/casedefinition/en/."},{"title3":"Lossi L., P. Aimar, E. Beltramo, and A. Merighi. 2002. Immunogold labeling techniques for transmission electron microscopy: applications in cell and molecular biology. Gold and Silver Staining: Techniques in Molecular Morphology. G.W. Hacker and J. Gu, editors. CRC Press, Boca Raton, FL. 147-167"},{"title3":"Shi, S.R., J. Gu, J.F. Turrens, R.J. Cote, and C.R. Taylor. 2000. Development of AR technique: philosophy and theoretical base. Antigen Retrieval. S.R. Shi, J. Gu, C.R. Taylor, editors., Eaton Publishing Co. Natick, MA. 17-39."}]},{"title2":"Effects of severe acute respiratory syndrome (SARS) coronavirus infection on peripheral blood lymphocytes and their subsets","References":[{"title3":"Summary table of SARS cases by country 1 November 2002-7 August 2003. Severe acute respiratory syndrome (SARS), World Health Organization Communicable Disease Surveillance and Response (CSR), World Health Organization Website, www.who.int/csr/sars (Date last accessed 1 September 2003)."},{"title3":"A novel coronavirus associated with severe acute respiratory syndrome"},{"title3":"Identification of a novel virus in patients with severe acute respiratory syndrome"},{"title3":"Identification of severe acute respiratory syndrome in Canada"},{"title3":"Newly discovered coronavirus as the primary cause of severe acute respiratory syndrome"},{"title3":"Coronavirus as a possible cause of severe acute respiratory syndrome"},{"title3":"A cluster of cases of severe acute respiratory syndrome in Hong Kong"},{"title3":"A major outbreak of severe acute respiratory syndrome in Hong Kong"},{"title3":"Clinical features and short-term outcomes of 144 patients with SARS in the Greater Toronto Area"},{"title3":"Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study"},{"title3":"Haematogical manifestations in patients with severe acute respiratory syndrome: Retrospective analysis"},{"title3":"Kinetics of severe acute respiratory syndrome (SARS) coronavirus-specific antibodies in 271 laboratory-confirmed cases of SARS"},{"title3":"Children hospitalized with severe acute respiratory syndrome-related illness in Toronto"},{"title3":"Clinical presentations and outcome of severe acute respiratory syndrome in children"},{"title3":"Rhinovirus and coronavirus infection-associated hospitalizations among older adults"},{"title3":"Coronavirus 229E-related pneumonia in immunocompromised patients"},{"title3":"An outbreak of coronavirus OC43 respiratory infection in Normandy, France"},{"title3":"The time course of the immune response to experimental coronavirus infection of man"},{"title3":"Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus"},{"title3":"Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis"},{"title3":"A clinicopathological study of three cases of severe acute respiratory syndrome (SARS)"},{"title3":"Functional and phenotypic changes in circulating lymphocytes from hospitalized Zambian children with measles"},{"title3":"In vitro detection of apoptosis in monocytes/macrophages infected with human coronavirus"},{"title3":"Measles virus infection in rhesus macaques: altered immune responses and comparison of the virulence of six different virus strains"}]},{"title2":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China","References":[{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster"},{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: adescriptivestudy"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study"},{"title3":"First case of 2019 novel coronavirus in the United States"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Lung CT image of a confirmed case of the 2019 novel coronavirus (2019-nCoV) infected pneumonia (With differential diagnosis of the SARS)"},{"title3":"Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia"},{"title3":"Role of neutrophil to lymphocyte and monocyte to lymphocyte ratios in the diagnosis of bacterial infection in patients with fever"},{"title3":"Coronavirus infections-more than just the common cold"},{"title3":"The association between the neutrophil-to-lymphocyte ratio and mortality in critical illness: an observational cohort study"},{"title3":"A new coronavirus associated with human respiratory disease in China"},{"title3":"Monocyte/lymphocyte ratio as a better predictor of cardiovascular and all-cause mortality in hemodialysis patients: a prospective cohort study"},{"title3":"Ratio of neutrophil to lymphocyte counts-rapid and simple parameter of systemic inflammation and stress in critically ill"},{"title3":"Neutrophil-lymphocyte ratio as an early new marker in AIV-H7N9-infected patients: a retrospective study"}]},{"title2":"Prevalence and mortality associated with cytomegalovirus infection in nonimmunosuppressed patients in the intensive care unit","References":[]},{"title2":"Kdigo clinical practice guidelines for acute kidney injury","References":[]},{"title2":"Epstein-Barr virus reactivation in critically ill immunocompetent patients","References":[]},{"title2":"Cytomegalovirus reactivation in critically ill immunocompetent patients","References":[{"title3":"Cytomegalovirus reactivation in a general, nonimmunosuppressed intensive care unit population: incidence, risk factors, associations with organ dysfunction, and inflammatory biomarkers"},{"title3":"Cytomegalovirus reactivation and associated outcome of critically ill patients with severe sepsis"},{"title3":"Cytomegalovirus reactivation in critically ill immunocompetent patients"},{"title3":"Prevalence and mortality associated with cytomegalovirus infection in nonimmunosuppressed patients in the intensive care unit"},{"title3":"Association Between Cytomegalovirus Reactivation and Clinical Outcomes in Immunocompetent Critically Ill Patients: A Systematic Review and Meta-Analysis"},{"title3":"Cytomegalovirus infection in critically ill patients: a systematic review"},{"title3":"Cytomegalovirus reactivation and mortality in patients with acute respiratory distress syndrome"},{"title3":"Epidemiology of Multiple Herpes Viremia in Previously Immunocompetent Patients With Septic Shock"},{"title3":"Active cytomegalovirus infection is common in mechanically ventilated medical intensive care unit patients"},{"title3":"Interferon-gamma production by natural killer cells and cytomegalovirus in critically ill patients"},{"title3":"Evaluation of cytomegalovirus (CMV)-specific T-cell immunity for the assessment of the risk of active CMV infection in non-immunosuppressed surgical and trauma intensive care unit patients"},{"title3":"Human cytomegalovirus infections in nonimmunosuppressed critically ill patients"},{"title3":"Cytomegalovirus reactivation in ICU patients"},{"title3":"Human cytomegalovirus: clinical aspects, immune regulation, and emerging treatments"},{"title3":"A contributive result of open-lung biopsy improves survival in acute respiratory distress syndrome patients"},{"title3":"CMV in critically ill patients: pathogen or bystander?"},{"title3":"Cytomegalovirus-induced immunopathology and its clinical consequences"},{"title3":"Reactivation of multiple viruses in patients with sepsis"},{"title3":"The 'indirect' effects of cytomegalovirus infection"},{"title3":"Virological and immunological features of active cytomegalovirus infection in nonimmunosuppressed patients in a surgical and trauma intensive care unit"},{"title3":"Effect of Ganciclovir on IL-6 Levels Among Cytomegalovirus-Seropositive Adults With Critical Illness: A Randomized Clinical Trial"},{"title3":"Cytokine assays: an assessment of the preparation and treatment of blood and tissue samples"},{"title3":"Effect of anticoagulants on 162 circulating immune related proteins in healthy subjects"},{"title3":"Statistics Notes: Percentage differences, symmetry, and natural logarithms"},{"title3":"Using the general linear mixed model to analyse unbalanced repeated measures and longitudinal data"},{"title3":"Lower tidal volume ventilation and plasma cytokine markers of inflammation in patients with acute lung injury"},{"title3":"Why have clinical trials in sepsis failed?"},{"title3":"Unexplained mortality differences between septic shock trials: a systematic analysis of population characteristics and control-group mortality rates"},{"title3":"Immunological insights into the pathogenesis of active CMV infection in non-immunosuppressed critically ill patients"}]},{"title2":"Outcomes associated with invasive and noninvasive ventilation among patients hospitalized with exacerbations of chronic obstructive pulmonary disease","References":[{"title3":"Overview of Hospitalizations among Patients with COPD, 2008: Statistical Brief No. 106"},{"title3":"Contemporary management of acute exacerbations of COPD: a systematic review and metaanalysis"},{"title3":"Non-invasive positive pressure ventilation to treat respiratory failure resulting from exacerbations of chronic obstructive pulmonary disease: Cochrane systematic review and meta-analysis"},{"title3":"Association of noninvasive ventilation with nosocomial infections and survival in critically ill patients"},{"title3":"Noninvasive positive pressure ventilation in the acute care setting: where are we?"},{"title3":"Noninvasive ventilation in acute respiratory failure"},{"title3":"Noninvasive ventilation for acute respiratory failure: a national survey of Veterans Affairs hospitals"},{"title3":"Bilevel noninvasive positive pressure ventilation for acute respiratory failure: survey of Ontario practice"},{"title3":"The use of noninvasive mechanical ventilation for the treatment of acute exacerbations of chronic obstructive pulmonary disease in Canada"},{"title3":"Utilization of noninvasive ventilation in acute care hospitals: a regional survey"},{"title3":"A survey of the use of noninvasive ventilation in academic emergency departments in the United States"},{"title3":"Outcomes of noninvasive ventilation for acute exacerbations of chronic obstructive pulmonary disease in the United States, 1998-2008"},{"title3":"Noninvasive versus conventional mechanical ventilation: an epidemiologic survey"},{"title3":"Comparative effectiveness of noninvasive ventilation vs invasive mechanical ventilation in chronic obstructive pulmonary disease patients with acute respiratory failure"},{"title3":"Predictors of failure of noninvasive positive pressure ventilation in patients with acute hypoxemic respiratory failure: a multi-center study"},{"title3":"Quality of care for patients hospitalized for acute exacerbations of chronic obstructive pulmonary disease"},{"title3":"Association of corticosteroid dose and route of administration with risk of treatment failure in acute exacerbation of chronic obstructive pulmonary disease"},{"title3":"Antibiotic therapy and treatment failure in patients hospitalized for acute exacerbations of chronic obstructive pulmonary disease"},{"title3":"Specificity of ICD-9 diagnosis codes for identifying patients hospitalized for COPD"},{"title3":"Comorbidity measures for use with administrative data"},{"title3":"A combined comorbidity score predicted mortality in elderly patients better than existing scores"},{"title3":"Results of multivariable logistic regression, propensity matching, propensity adjustment, and propensity-based weighting under conditions of nonuniform effect"},{"title3":"Use of stabilized inverse propensity scores as weights to directly estimate relative risk and its confidence intervals"},{"title3":"Modeling treatment effects on binary outcomes with grouped-treatment variables and individual covariates"},{"title3":"Assessing the sensitivity of regression results to unmeasured confounders in observational studies"},{"title3":"Epidemiology and outcomes of acute respiratory failure in the United States, 2001 to 2009: a national survey"},{"title3":"Acute respiratory failure in patients with severe community-acquired pneumonia: a prospective randomized evaluation of noninvasive ventilation"},{"title3":"Noninvasive vs conventional mechanical ventilation in acute respiratory failure: a multicenter, randomized controlled trial"},{"title3":"Palliative care in COPD patients: is it only an end-of-life issue?"}]},{"title2":"T-cell immunity of SARS-CoV: implications for vaccine development against MERS-CoV","References":[{"title3":"Evaluation of serologic and antigenic relationships between Middle Eastern respiratory syndrome coronavirus and other coronaviruses to develop vaccine platforms for the rapid response to emerging coronaviruses"},{"title3":"DNA vaccination: transfection and activation of dendritic cells as key events for immunity"},{"title3":"Hospital-associated outbreak of Middle East respiratory syndrome coronavirus: a serologic, epidemiologic, and clinical description"},{"title3":"Antibody response and disease severity in healthcare worker MERS survivors"},{"title3":"Feasibility of using convalescent plasma immunotherapy for MERS-CoV infection, Saudi Arabia"},{"title3":"High-resolution structure of HLA-A*1101 in complex with SARS nucleocapsid peptide"},{"title3":"Interferon-mediated immunopathological events are associated with atypical innate and adaptive immune responses in patients with severe acute respiratory syndrome"},{"title3":"Cross-reactive antibodies in convalescent SARS patients' sera against the emerging novel human coronavirus EMC (2012) by both immunofluorescent and neutralizing antibody tests"},{"title3":"Dysregulated type I interferon and inflammatory monocyte-macrophage responses cause lethal pneumonia in SARS-CoV-infected mice"},{"title3":"Virus-specific memory CD8 T cells provide substantial protection from lethal severe acute respiratory syndrome coronavirus infection"},{"title3":"Response of memory CD8+ T cells to severe acute respiratory syndrome (SARS) coronavirus in recovered SARS patients and healthy individuals"},{"title3":"Cellular immune responses to severe acute respiratory syndrome coronavirus (SARS-CoV) infection in senescent BALB/c mice: CD4+ T cells are important in control of SARS-CoV infection"},{"title3":"SARS coronavirus papain-like protease inhibits the type I interferon signaling pathway through interaction with the STING-TRAF3-TBK1 complex"},{"title3":"Identification of SARS-COV spike protein-derived and HLA-A2-restricted human CTL epitopes by using a new muramyl dipeptidederivative adjuvant"},{"title3":"Induction of T-cell response by a DNA vaccine encoding a novel HLA-A*0201 severe acute respiratory syndrome coronavirus epitope"},{"title3":"Middle East respiratory syndrome coronavirus efficiently infects human primary T Lymphocytes and activates the extrinsic and intrinsic apoptosis pathways"},{"title3":"Viral shedding and antibody response in 37 patients with Middle East respiratory syndrome coronavirus infection"},{"title3":"Rooting the phylogenetic tree of Middle East respiratory syndrome coronavirus by characterization of a conspecific virus from an African bat"},{"title3":"Prophylactic and postexposure efficacy of a potent human monoclonal antibody against MERS coronavirus"},{"title3":"Characteristics of traveler with Middle East respiratory syndrome, China, 2015"},{"title3":"The HLA-A2-supermotif: a QSAR definition"},{"title3":"The spike protein of SARS-CoV-a target for vaccine and therapeutic development"},{"title3":"Antibodies induced by receptor-binding domain in spike protein of SARS-CoV do not cross-neutralize the novel human coronavirus hCoV-EMC"},{"title3":"Vaccines for the prevention against the threat of MERS-CoV"},{"title3":"A 219-mer CHO-expressing receptor-binding domain of SARS-CoV S protein induces potent immune responses and protective immunity"},{"title3":"Antigenicity and immunogenicity of SARS-CoV S protein receptor-binding domain stably expressed in CHO cells"},{"title3":"Intranasal vaccination of recombinant adeno-associated virus encoding receptor-binding domain of severe acute respiratory syndrome coronavirus (SARS-CoV) spike protein induces strong mucosal immune responses and provides long-term protection against SARS-CoV infection"},{"title3":"Characterization of SARS-CoV-specific memory T cells from recovered individuals 4 years after infection"},{"title3":"Distinct immune response in two MERS-CoV-infected patients: can we go from bench to bedside?"},{"title3":"Towards our understanding of SARS-CoV, an emerging and devastating but quickly conquered virus"},{"title3":"SARS-CoV pathogenesis is regulated by a STAT1 dependent but a type I, II and III interferon receptor independent mechanism"},{"title3":"Multiple organ infection and the pathogenesis of SARS"},{"title3":"Identification of immunodominant epitopes on the membrane protein of the severe acute respiratory syndrome-associated coronavirus"},{"title3":"Novel coronavirus infections in Jordan, April 2012: epidemiological findings from a retrospective investigation"},{"title3":"From SARS to MERS: 10 years of research on highly pathogenic human coronaviruses"},{"title3":"Chronological evolution of IgM, IgA, IgG and neutralisation antibodies after infection with SARS-associated coronavirus"},{"title3":"Priming with SARS CoV S DNA and boosting with SARS CoV S epitopes specific for CD4+ and CD8+ T cells promote cellular immune responses"},{"title3":"Improved transgenic mouse model for studying HLA class I antigen presentation"},{"title3":"Identification of residues of SARS-CoV nsp1 that differentially affect inhibition of gene expression and antiviral signaling"},{"title3":"Structural insights into key sites of vulnerability on HIV-1 Env and influenza HA"},{"title3":"Clinical and laboratory findings of the first imported case of Middle East respiratory syndrome coronavirus to the United States"},{"title3":"Efficient induction of cytotoxic T lymphocytes specific for severe acute respiratory syndrome (SARS)-associated coronavirus by immunization with surface-linked liposomal peptides derived from a non-structural polyprotein 1a"},{"title3":"Severe acute respiratory syndrome coronavirus open reading frame (ORF) 3b, ORF 6, and nucleocapsid proteins function as interferon antagonists"},{"title3":"A novel coronavirus associated with severe acute respiratory syndrome"},{"title3":"A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus-induced lung injury"},{"title3":"Tailoring subunit vaccine immunity with adjuvant combinations and delivery routes using the Middle East respiratory coronavirus (MERS-CoV) receptor-binding domain as an antigen"},{"title3":"Genetic characterization of Betacoronavirus lineage C viruses in bats reveals marked sequence divergence in the spike protein of pipistrellus bat coronavirus HKU5 in Japanese pipistrelle: implications for the origin of the novel Middle East respiratory syndrome coronavirus"},{"title3":"Immunopathology of mouse hepatitis virus type 3 infection. Role of humoral and cell-mediated immunity in resistance mechanisms"},{"title3":"Antibody response of patients with severe acute respiratory syndrome (SARS) targets the viral nucleocapsid"},{"title3":"T cell responses to whole SARS coronavirus in humans"},{"title3":"Structure of SARS coronavirus spike receptor-binding domain complexed with receptor"},{"title3":"Recombinant duck enteritis viruses expressing major structural proteins of the infectious bronchitis virus provide protection against infectious bronchitis in chickens"},{"title3":"Bats are natural reservoirs of SARS-like coronaviruses"},{"title3":"A humanized neutralizing antibody against MERS-CoV targeting the receptor-binding domain of the spike protein"},{"title3":"Identification of an epitope of SARS-coronavirus nucleocapsid protein"},{"title3":"Functional and structural definition of a clustering region of HLA-A2-restricted cytotoxic T lymphocyte epitopes"},{"title3":"The membrane protein of severe acute respiratory syndrome coronavirus acts as a dominant immunogen revealed by a clustering region of novel functionally and structurally defined cytotoxic T-lymphocyte epitopes"},{"title3":"Novel immunodominant peptide presentation strategy: a featured HLA-A*2402-restricted cytotoxic T-lymphocyte epitope stabilized by intrachain hydrogen bonds from severe acute respiratory syndrome coronavirus nucleocapsid protein"},{"title3":"Revival of the identification of cytotoxic T-lymphocyte epitopes for immunological diagnosis, therapy and vaccine development"},{"title3":"Characterization of human alphabetaTCR repertoire and discovery of D-D fusion in TCRbeta chains"},{"title3":"Two-year prospective study of the humoral immune response of patients with severe acute respiratory syndrome"},{"title3":"Protective T-cell responses featured by concordant recognition of MERS-CoV-derived CD8+ T-cell epitopes and host MHC"},{"title3":"Chimeric severe acute respiratory syndrome coronavirus (SARS-CoV) S glycoprotein and influenza matrix 1 efficiently form virus-like particles (VLPs) that protect mice against challenge with SARS-CoV"},{"title3":"Chimeric coronavirus-like particles carrying severe acute respiratory syndrome coronavirus (SCoV) S protein protect mice against challenge with SCoV"},{"title3":"Molecular basis of binding between novel human coronavirus MERS-CoV and its receptor CD26"},{"title3":"Bat-to-human: spike features determining 'host jump' of coronaviruses SARS-CoV, MERS-CoV, and beyond"},{"title3":"Identification of a novel conserved HLA-A*0201-restricted epitope from the spike protein of SARS-CoV"},{"title3":"Priming of CD8+ T cells during central nervous system infection with a murine coronavirus is strain dependent"},{"title3":"A SARS DNA vaccine induces neutralizing antibody and cellular immune responses in healthy adults in a Phase I clinical trial"},{"title3":"Attenuation and restoration of severe acute respiratory syndrome coronavirus mutant lacking 2'-o-methyltransferase activity"},{"title3":"Serological assays for emerging coronaviruses: challenges and pitfalls"},{"title3":"Comparative and kinetic analysis of viral shedding and immunological responses in MERS patients representing a broad spectrum of disease severity"},{"title3":"The structure and function of CD26 in the T-cell immune response"},{"title3":"Memory T cell responses targeting the SARS coronavirus persist up to 11 years post-infection"},{"title3":"Middle East respiratory syndrome coronavirus accessory protein 4a is a type I interferon antagonist"},{"title3":"Engineering T cells specific for a dominant severe acute respiratory syndrome coronavirus CD8 T cell epitope"},{"title3":"Synthetic peptides coupled to the surface of liposomes effectively induce SARS coronavirus-specific cytotoxic T lymphocytes and viral clearance in HLA-A*0201 transgenic mice"},{"title3":"Kinetics of serologic responses to MERS coronavirus infection in humans, South Korea"},{"title3":"Long-lived memory T lymphocyte responses against SARS coronavirus nucleocapsid protein in SARS-recovered patients"},{"title3":"Characterization of cytotoxic T-lymphocyte epitopes and immune responses to SARS coronavirus spike DNA vaccine expressing the RGD-integrin-binding motif"},{"title3":"Dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMC"},{"title3":"Specific serology for emerging human coronaviruses by protein microarray"},{"title3":"Geographic distribution of MERS coronavirus among dromedary camels, Africa"},{"title3":"Defining CD8+ T cell determinants during human viral infection in populations of Asian ethnicity"},{"title3":"Structure of a SARS coronavirus-derived peptide bound to the human major histocompatibility complex class I molecule HLA-B*1501"},{"title3":"Characterization of a novel coronavirus associated with severe acute respiratory syndrome"},{"title3":"A comprehensive comparison of transmembrane domains reveals organelle-specific properties"},{"title3":"Mouse hepatitis virus-specific cytotoxic T lymphocytes protect from lethal infection without eliminating virus from the central nervous system"},{"title3":"MERS in South Korea and China: a potential outbreak threat?"},{"title3":"Epidemiology, genetic recombination, and pathogenesis of coronaviruses"},{"title3":"A new unconventional HLA-A2-restricted epitope from HBV core protein elicits antiviral cytotoxic T lymphocytes"},{"title3":"Evaluation of protective efficacy of the synthetic peptide vaccine containing the T-helper 1 epitope with CpG oligodeoxynucleotide against feline infectious peritonitis virus infection in cats"},{"title3":"Lack of peripheral memory B cell responses in recovered patients with severe acute respiratory syndrome: a six-year follow-up study"},{"title3":"Identification of human neutralizing antibodies against MERS-CoV and their role in virus adaptive evolution"},{"title3":"From SARS coronavirus to novel animal and human coronaviruses"},{"title3":"Structural and functional correlates of enhanced antiviral immunity generated by heteroclitic CD8 T cell epitopes"},{"title3":"HLA-A*0201 T-cell epitopes in severe acute respiratory syndrome (SARS) coronavirus nucleocapsid and spike proteins"},{"title3":"Immunization with SARS coronavirus vaccines leads to pulmonary immunopathology on challenge with the SARS virus"},{"title3":"Middle East respiratory syndrome and severe acute respiratory syndrome"},{"title3":"Protective efficacy of recombinant modified vaccinia virus ankara delivering Middle East respiratory syndrome coronavirus spike glycoprotein"},{"title3":"Identification of an HLA-A*0201-restricted CD8(+) T-cell epitope SSp-1 of SARS-CoV spike protein"},{"title3":"Bat origins of MERS-CoV supported by bat coronavirus HKU4 usage of human receptor CD26"},{"title3":"MERS-CoV spike protein: targets for vaccines and therapeutics"},{"title3":"Serological study of an imported case of Middle East respiratory syndrome and his close contacts in China, 2015"},{"title3":"Origin and possible genetic recombination of the Middle East respiratory syndrome coronavirus from the first imported case in China: phylogenetics and coalescence analysis"},{"title3":"T-cell epitopes in severe acute respiratory syndrome (SARS) coronavirus spike protein elicit a specific T-cell immune response in patients who recover from SARS"},{"title3":"MERS, SARS, and Ebola: the role of super-spreaders in infectious disease"},{"title3":"Detection of specific antibodies to severe acute respiratory syndrome (SARS) coronavirus nucleocapsid protein for serodiagnosis of SARS coronavirus pneumonia"},{"title3":"Immune responses to T-cell epitopes of SARS CoV-N protein are enhanced by N immunization with a chimera of lysosome-associated membrane protein"},{"title3":"Persistent memory CD4+ and CD8+ T-cell responses in recovered severe acute respiratory syndrome (SARS) patients to SARS coronavirus M antigen"},{"title3":"Long-lived effector/central memory T-cell responses to severe acute respiratory syndrome coronavirus (SARS-CoV) S antigen in recovered SARS patients"},{"title3":"Middle East respiratory syndrome coronavirus ORF4b protein inhibits type I interferon production through both cytoplasmic and nuclear targets"},{"title3":"Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia"},{"title3":"Current advancements and potential strategies in the development of MERS-CoV vaccines"},{"title3":"Frequency, private specificity, and cross-reactivity of preexisting hepatitis C virus (HCV)-Specific CD8+ T cells in HCV-seronegative individuals: implications for vaccine responses"},{"title3":"Identification and characterization of dominant helper T-cell epitopes in the nucleocapsid protein of severe acute respiratory syndrome coronavirus"},{"title3":"Passive immunotherapy with dromedary immune serum in an experimental animal model for Middle East respiratory syndrome coronavirus infection"},{"title3":"Airway memory CD4(+) T cells mediate protective immunity against emerging respiratory coronaviruses"},{"title3":"T cell responses are required for protection from clinical disease and for virus clearance in severe acute respiratory syndrome coronavirus-infected mice"},{"title3":"The immune responses of HLA-A*0201 restricted SARS-CoV S peptide-specific CD8(+) T cells are augmented in varying degrees by CpG ODN, PolyI: C and R848"},{"title3":"CD8+ T cell response in HLA-A*0201 transgenic mice is elicited by epitopes from SARS-CoV S protein"},{"title3":"Identification of murine CD8 T cell epitopes in codon-optimized SARS-associated coronavirus spike protein"},{"title3":"Active replication of Middle East respiratory syndrome coronavirus and aberrant induction of inflammatory cytokines and chemokines in human macrophages: implications for pathogenesis"},{"title3":"Screening and identification of severe acute respiratory syndrome-associated coronavirus-specific CTL epitopes"},{"title3":"Structural basis for broad and potent neutralization of HIV-1 by antibody VRC01"},{"title3":"Coronavirus non-structural protein 1 is a major pathogenicity factor: implications for the rational design of coronavirus vaccines"}]},{"title2":"MERS-CoV infection in humans is associated with a pro-inflammatory Th1 and Th17 cytokine profile","References":[{"title3":"MERS coronavirus: diagnostics, epidemiology and transmission"},{"title3":"MERS-CoV: where are we now?"},{"title3":"Middle East respiratory syndrome coronavirus (MERS-CoV) infection"},{"title3":"T-cell immunity of SARS-CoV: implications for vaccine development against MERS-CoV"},{"title3":"Molecular basis of binding between novel human coronavirus MERS-CoV and its receptor CD26"},{"title3":"Identification of residues on human receptor DPP4 critical for MERS-CoV binding and entry"},{"title3":"Emerging respiratory viral infections: MERS-CoV and influenza"},{"title3":"Prevalence of comorbidities in the Middle East respiratory syndrome coronavirus (MERS-CoV): a systematic review and meta-analysis"},{"title3":"Middle East respiratory syndrome coronavirus &quot;MERS-CoV&quot;: current knowledge gaps"},{"title3":"2015 Middle East Respiratory Syndrome Coronavirus (MERS-CoV) nosocomial outbreak in South Korea: insights from modeling"},{"title3":"Severe respiratory illness caused by a novel coronavirus, in a patient transferred to the United Kingdom from the Middle East, September 2012"},{"title3":"The epidemiology of MERS-CoV"},{"title3":"Emerging viral respiratory tract infections-environmental risk factors and transmission"},{"title3":"Dromedary camels and the transmission of Middle East Respiratory Syndrome Coronavirus (MERS-CoV)"},{"title3":"A. Mailles, K. Blanckaert, P. Chaud, S. van der Werf, B. Lina, V. Caro, et al., First cases of Middle East Respiratory Syndrome Coronavirus (MERS-CoV) infections in France, investigations and implications for the prevention of human-to-human transmission, France, May 2013. Euro surveillance: bulletin Europeen sur les maladies transmissibles = European Communicable Disease Bulletin 18 (2013)."},{"title3":"J. Premila Devi, W. Noraini, R. Norhayati, C. Chee Kheong, A.S. Badrul, S. Zainah, et al., Laboratory-confirmed case of Middle East respiratory syndrome coronavirus (MERS-CoV) infection in Malaysia: preparedness and response, April 2014. Euro surveillance: bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin 19 (2014)."},{"title3":"Tracing airline travelers for a public health investigation: Middle East Respiratory Syndrome Coronavirus (MERS-CoV) Infection in the United States, 2014"},{"title3":"T. Briese, N. Mishra, K. Jain, I.S. Zalmout, O.J. Jabado, W.B. Karesh, et al., Middle East respiratory syndrome coronavirus quasispecies that include homologues of human isolates revealed through whole-genome analysis and virus cultured from dromedary camels in Saudi Arabia, mBio 5 (2014) e01146-e01214."},{"title3":"Middle East respiratory syndrome coronavirus (MERS-CoV): animal to human interaction"},{"title3":"MERS-CoV geography and ecology in the Middle East: analyses of reported camel exposures and a preliminary risk map"},{"title3":"Dromedary MERS-CoV replicates in human respiratory tissues"},{"title3":"Prevalence of Middle East respiratory syndrome coronavirus (MERS-CoV) in dromedary camels in Abu Dhabi Emirate, United Arab Emirates"},{"title3":"Unraveling the drivers of MERS-CoV transmission"},{"title3":"Predictors of MERS-CoV infection: a large case control study of patients presenting with ILI at a MERS-CoV referral hospital in Saudi Arabia"},{"title3":"Infection control and MERS-CoV in health-care workers"},{"title3":"Severe neurologic syndrome associated with Middle East respiratory syndrome corona virus (MERS-CoV)"},{"title3":"Renal complications and their prognosis in Korean patients with Middle East Respiratory Syndrome-Coronavirus from the central MERS-CoV designated hospital"},{"title3":"Acute management and long-term survival among subjects with severe Middle East Respiratory Syndrome coronavirus Pneumonia and Ards"},{"title3":"Hospital outbreak of Middle East respiratory syndrome coronavirus"},{"title3":"Predictive factors for pneumonia development and progression to respiratory failure in MERS-CoV infected patients"},{"title3":"Middle East respiratory syndrome coronavirus in Al-Madinah City, Saudi Arabia: demographic, clinical and survival data"},{"title3":"Guidelines for the laboratory diagnosis of Middle East respiratory syndrome coronavirus in Korea"},{"title3":"Cytometric bead array: a multiplexed assay platform with applications in various areas of biology"},{"title3":"Interferon-gamma: biologic functions and HCV terapy (type I/II) (2 of 2 parts)"},{"title3":"Safety, tolerability, and immunogenicity of interferons"},{"title3":"A tale of two cytokines: IL-17 and IL-22 in asthma and infection"},{"title3":"Tumor necrosis factor (TNF)-alpha and TNF receptors in viral pathogenesis"},{"title3":"Viral and cellular interleukin-10 (IL-10)-related cytokines: from structures to functions"},{"title3":"Infection-induced IL-10 and JAK-STAT: a review of the molecular circuitry controlling immune hyperactivity in response to pathogenic microbes"},{"title3":"MicroRNA regulation of viral immunity, latency, and carcinogenesis of selected tumor viruses and HIV"},{"title3":"Distinct immune response in two MERS-CoV-infected patients: can we go from bench to bedside?"},{"title3":"Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia"},{"title3":"Virus multiplicity of infection affects type I interferon subtype induction profiles and interferon-stimulated genes"},{"title3":"Interferon-stimulated genes response in endothelial cells following Hantaan virus infection"},{"title3":"Type I interferon induced epigenetic regulation of macrophages suppresses innate and adaptive immunity in acute respiratory viral infection"},{"title3":"T cell-, interleukin-12-, and gamma interferon-driven viral clearance in measles virus-infected brain tissue"},{"title3":"Active replication of Middle East respiratory syndrome coronavirus and aberrant induction of inflammatory cytokines and chemokines in human macrophages: implications for pathogenesis"},{"title3":"Cytokine systems approach demonstrates differences in innate and pro-inflammatory host responses between genetically distinct MERS-CoV isolates"},{"title3":"Coronavirus virulence genes with main focus on SARS-CoV envelope gene"},{"title3":"Tumor necrosis factor alpha exerts powerful anti-influenza virus effects in lung epithelial cells"},{"title3":"L. Josset, V.D. Menachery, L.E. Gralinski, S. Agnihothram, P. Sova, V.S. Carter, et al., Cell host response to infection with novel human coronavirus EMC predicts potential antivirals and important differences with SARS coronavirus, mBio 4 (2013) e00165-e00213."},{"title3":"IL-17 cytokines in immunity and inflammation"},{"title3":"IL-10, T cell exhaustion and viral persistence"},{"title3":"Interleukin-17 promotes autoimmunity by triggering a positive-feedback loop via interleukin-6 induction"},{"title3":"The interleukin-10 signal transduction pathway and regulation of gene expression in mononuclear phagocytes"},{"title3":"Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins"},{"title3":"Interaction between STAT-3 and HNF-3 leads to the activation of liver-specific hepatitis B virus enhancer 1 function"},{"title3":"Hepatitis C virus targets the interferon-alpha JAK/STAT pathway by promoting proteasomal degradation in immune cells and hepatocytes"},{"title3":"Influenza virus non-structural protein 1 (NS1) disrupts interferon signaling"},{"title3":"Tyrosine dephosphorylation of STAT3 in SARS coronavirus-infected Vero E6 cells"},{"title3":"IL-15-PI3K-AKT-mTOR: a critical pathway in the life journey of natural killer cells"},{"title3":"TLR-mediated activation of NK cells and their role in bacterial/viral immune responses in mammals"},{"title3":"The IL-12 family of cytokines in infection, inflammation and autoimmune disorders"},{"title3":"Productive replication of Middle East respiratory syndrome coronavirus in monocyte-derived dendritic cells modulates innate immune response"},{"title3":"Stimulation of IRF-7 gene expression by tumor necrosis factor alpha requirement for NFkappaB transcription factor and gene accessibility"}]},{"title2":"Diagnosis and treatment of COVID-19 (Version 6)","References":[]},{"title2":"Notification of 2020-NCOV infection","References":[]},{"title2":"Acute respiratory distress syndrome: the Berlin definition","References":[]},{"title2":"Middle East respiratory syndrome coronavirus (MERS-CoV)","References":[]},{"title2":"Summary of probable SARS cases with onset of illness from 1 November 2002 to 31 July 2003","References":[]},{"title2":"Plasma inflammatory cytokines and chemokines in severe acute respiratory syndrome","References":[{"title3":"A major outbreak of severe acute respiratory syndrome in Hong Kong"},{"title3":"A cluster of cases of severe acute respiratory syndrome in Hong Kong"},{"title3":"Identification of severe acute respiratory syndrome in Canada"},{"title3":"Haematological changes in patients with severe acute respiratory syndrome"},{"title3":"Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study"},{"title3":"Coronavirus as a possible cause of severe acute respiratory syndrome"},{"title3":"Identification of a novel coronavirus in patients with severe acute respiratory syndrome"},{"title3":"A novel coronavirus associated with severe acute respiratory syndrome"},{"title3":"The genome sequence of the SARS-associated coronavirus"},{"title3":"Characterization of a novel coronavirus associated with severe acute respiratory syndrome"},{"title3":"Rapid diagnosis of a coronavirus associated with severe acute respiratory syndrome (SARS)"},{"title3":"Quantitative analysis and prognostic implication of SARS coronavirus RNA in the plasma and serum of patients with severe acute respiratory syndrome"},{"title3":"Clinical presentations and outcome of severe acute respiratory syndrome in children"},{"title3":"Molecular pathways in virus-induced cytokine production"},{"title3":"Induction of proinflammatory cytokines in human macrophages by influenza A (H5N1) viruses: a mechanism for the unusual severity of human disease?"},{"title3":"In vivo studies on cytokine involvement during acute viral respiratory disease of swine: troublesome but rewarding"},{"title3":"Host defense response and outcome in ARDS"},{"title3":"The role of chemokines in the immunopathology of pulmonary disease"},{"title3":"Severe acute respiratory syndrome (SARS)"},{"title3":"Clinical applications of cytokine assays"},{"title3":"Cytometric bead array to measure six cytokines in twenty-five microliters of serum"},{"title3":"The cytokines: physiological and pathophysiological aspects"},{"title3":"Differential role of interleukin-6 in lung inflammation induced by lipoteichoic acid and peptidoglycan from Staphylococcus aureus"},{"title3":"Interleukin-10 and viral IL-10 strongly reduce antigen-specific human T cell proliferation by diminishing the antigen presenting capacity of monocytes via down-regulation of class II major histocompatibility complex expression"},{"title3":"IL-12: a key cytokine in immune regulation"},{"title3":"Interleukin-12 regulates the proliferation of Th1, but not Th2 or Th0, clones"},{"title3":"Interleukin 12 induces stable priming for interferon gamma (IFN-gamma) production during differentiation of human T helper (Th) cells and transient IFN-gamma production in established Th2 cell clones"},{"title3":"Interleukin 12: a key modulator of immune function"},{"title3":"Interleukin-12. Biologic activity, therapeutic utility, and role in disease"},{"title3":"Chemokines in acute lung injury"},{"title3":"Evolution of bronchoalveolar cell populations in the adult respiratory distress syndrome"},{"title3":"Lung neutrophils in the adult respiratory distress syndrome. Clinical and pathophysiologic significance"},{"title3":"The role of neutrophil elastase in acute lung injury"},{"title3":"Interactions between neutrophils and cytokines in blood and alveolar spaces during ARDS"},{"title3":"GRO alpha and interleukin-8 in Pneumocystis carinii or bacterial pneumonia and adult respiratory distress syndrome"},{"title3":"Inflammatory cytokines in patients with persistence of the acute respiratory distress syndrome"},{"title3":"Phenotypic characterization of alveolar monocyte recruitment in acute respiratory distress syndrome"},{"title3":"Lung pathology of fatal severe acute respiratory syndrome"},{"title3":"Distinct functions of interferon-gamma for chemokine expression in models of acute lung inflammation"},{"title3":"Induction of cytokines in mice with parainfluenza pneumonia"},{"title3":"Invited review. Cytokine regulation of fever: studies using gene knockout mice"},{"title3":"Chemokines in infectious diseases of the lung"},{"title3":"Anti-interleukin 8 autoantibody: interleukin 8 complexes in the acute respiratory distress syndrome. Relationship between the complexes and clinical disease activity"},{"title3":"Transforming growth factor-beta: a mediator of cell regulation in acute respiratory distress syndrome"},{"title3":"The strategy of blocking the chemokine system to combat disease"},{"title3":"Antichemokine immunotherapy for allergic diseases"}]},{"title2":"Haematological manifestations in patients with severe acute respiratory syndrome: retrospective analysis","References":[]},{"title2":"Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study","References":[{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study"},{"title3":"A novel coronavirus from patients with pneumonia in China, 2019"},{"title3":"First case of 2019 novel coronavirus in the United States"},{"title3":"Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China"},{"title3":"Clinical management of severe acute respiratory infection when novel coronavirus (nCoV) infection is suspected"},{"title3":"Critically ill patients with 2009 influenza A(H1N1) in Mexico"},{"title3":"Critically ill patients with severe acute respiratory syndrome"},{"title3":"Critically ill patients with 2009 influenza A(H1N1) infection in Canada"},{"title3":"KDIGO clinical practice guideline for acute kidney injury"},{"title3":"Wuhan: Britons to be evacuated as scientists estimate 44 000 cases of 2019-nCOV in the city"},{"title3":"Acute respiratory distress syndrome in critically ill patients with severe acute respiratory syndrome"},{"title3":"Short-term outcome of critically ill patients with severe acute respiratory syndrome"},{"title3":"Clinical course and outcomes of critically ill patients with Middle East respiratory syndrome coronavirus infection"},{"title3":"SARS and MERS: recent insights into emerging coronaviruses"},{"title3":"Epidemiology, patterns of care, and mortality for patients with acute respiratory distress syndrome in intensive care units in 50 countries"},{"title3":"China built a hospital in 10 days to battle coronavirus"},{"title3":"Transmission of 2019-nCoV infection from an asymptomatic contact in Germany"},{"title3":"Asymptomatic cases complicate efforts"},{"title3":"Multiple organ infection and the pathogenesis of SARS"},{"title3":"Middle East respiratory syndrome coronavirus efficiently infects human primary T lymphocytes and activates the extrinsic and intrinsic apoptosis pathways"},{"title3":"T-cell immunity of SARS-CoV: implications for vaccine development against MERS-CoV"},{"title3":"Practice of diagnosis and management of acute respiratory distress syndrome in mainland China: a cross-sectional study"},{"title3":"Clinical evidence does not support corticosteroid treatment for 2019-nCoV lung injury"}]}]}]}